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Abstract 
Viral DNA-packaging motors are molecular machines that enable viruses to replicate by 
providing the means of storing the viral genome into empty procapsids. In double stranded 
DNA bacteriophages the molecular motor is comprised by three elements: the portal protein and 
the small and large terminases. The portal protein nucleates polymerisation of the capsid and 
scaffold proteins, initiating procapsid assembly, besides allowing passage of DNA. The small 
terminase recognises the viral genome and presents it to the large terminase which possesses 
both nuclease activity to cleave concatemeric DNA at the initiation of the packaging, and 
ATPase activity to drive translocation.  
Although currently several X-ray structures for the different components of the motor from 
different bacteriophages are available fundamental questions regarding the DNA recognition 
mechanism, stoichiometry and orientation of the motor components in vivo and the mechanism 
of ATP-driven DNA-translocation remain.  This project focused on elucidating the X-ray crystal 
structures of (i) the major capsid protein, from Bacillus subtilis bacteriophage SPP1 and (ii) the 
small terminase protein from Thermus thermophilus bacteriophage G20C. 
Several constructs of the SPP1 capsid protein, including truncations at the N- and C-termini, 
single and double mutants and engineered proteins were generated in order to produce a protein 
suitable for crystallisation. Mutant uG13P;T104Y;A261W was the only construct that produced 
native and Se-Met crystals. The X-ray structure of the SPP1 capsid protein was determined at 
3.0 Å resolution by single wavelength anomalous diffraction. The structure exhibited the HK97-
fold consisting of the axial and peripheral domains and the extended E-loop.  
The X-ray structure of the small terminase from phage G20C was solved at 2.5 Å resolution by 
single wavelength anomalous diffraction. The structure consisted of circular nine-mers where 
the N- terminal domains of each subunit reside at the periphery of the assembly and the C-
terminal oligomerisation domains form a central channel. The conserved structural features 
between small terminases suggest that the DNA-recognition mechanism might be conserved. 
DNA-binding experiments demonstrated that the G20C small terminase binds to viral and non-
viral DNA with both the N- and C- terminal domains playing an important role.  
The structural information generated from these two elements of SPP1 and G20C 
bacteriophages provides insight into two different aspects of the assembly process: (i) how the 
capsid protein’s conformational plasticity may assist the assembly and (ii) DNA-recognition 
during virus particle construction. This information is critical for understanding similar 
processes in other viruses, in particular, in the evolutionarily related herpes viruses. 
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Author’s preface 
 
This thesis describes the experimental work performed on producing, purifying, crystallising 
and solving the X-ray structure of two phage proteins, one from the SPP1 and one from the 
G20C bacteriophages. Structural data are analysed in order to gain insight into the phage 
assembly and in particular, into DNA packaging. 
The introduction provides the reader with the necessary information, ordered to follow the 
content to acquire a general perspective of the knowledge available for their counterparts in 
other dsDNA phages. Moreover, the introduction highlights questions regarding DNA-
translocation that remain unclear to date and that several research groups around the world 
strive to answer. Due to the Antson Laboratory’s long history of working with the SPP1 phage 
as a model regarding the single components of the molecular motor, and the amount of 
biochemical data available for this system from other laboratories, the SPP1 molecular motor is 
used as a reference point in the introduction in the same way as the HK97 capsid protein serves 
as a reference for the common fold in capsid proteins in dsDNA phages.  
The outcome of this four-year project is organised in eight chapters that describe the efforts to 
produce crystals of the SPP1 capsid protein and G20C small terminase, the progress made in 
elucidating the X-ray structure of each protein and the biochemical characterisation of the G20C 
small terminase. A wealth of data was produced, however, only the most relevant information 
for the project will be presented. Where necessary, additional data will be presented in figures, 
tables or appendices. Not-shown data will also be referred to where similar results were found in 
repeated experiments.  
Most of the protocols used to develop this project are common practice in protein production 
laboratories or X-ray crystallography facilities, therefore just a brief description of each protocol 
will be provided, with the understanding that the specific settings were varied for each protein 
or construct in turn.   
Finally, it is important to mention the significance of studying each protein. For SPP1, there are 
X-ray structures for the large terminase nuclease domain, portal protein and small terminase 
from the SPP1-like phage SF6, all from the Antson Laboratory. NMR structures are available 
for proteins connecting the portal with the tail and 3D cryo-EM reconstructions are available for 
the whole capsid and tail (as detailed in the Introduction section). The crystal structure of the 
capsid protein will account for one of the key structural components of the phage. Structural 
plasticity of this protein plays a key role during capsid maturation and capsid assembly allowing 
(i) construction of 5-fold and 6-fold symmetrical circular assemblies that are the building blocks 
13 
 
of the capsid and (ii) controlling changes in capsid’s shape and volume during different steps in 
its assembly.  
Investigation of the G20C small terminase adds one more structure to the available collection of 
small terminase structures. How exactly this protein interacts with DNA remains a matter of 
debate in the scientific community. Thus biochemical and structural characterisation of the 
G20C small terminase is valuable for understanding how this protein functions. Moreover, to 
date little is known about proteins from thermophilic phages, and no accurate structural 
information was available about their components.  
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Chapter 1 
1. Introduction  
1.1 dsDNA bacteriophages SPP1 and G20C 
Bacteriophages, or phages, are viruses whose hosts are bacteria, and are the most abundant 
organisms on earth (1). They can be classified according to the type of infection they produce 
(lytic or lysogenic), the genome nucleic acid type they contain and the morphology and 
symmetry of their capsid (2).  
Double stranded (ds) DNA tailed bacteriophages belong to the order Caudovirales, that is 
further divided into three main families: Myoviridae that includes phages with contractile tails; 
Podoviridae, with phages that have short non-contractile tails, and Siphoviridae, that groups 
phages with long non-contractile tails (2). 
The mesophilic Siphovirus SPP1 that infects the Gram-positive rod bacterium Bacillus subtilis 
was isolated from soil and initially characterised by Riva et al (3). Subsequently, other research 
groups sequenced the complete genome (4) and characterised genomic sections comprising the 
DNA-packaging operon (5). The 44,007 bp long SPP1 genome contains 81 orfs organised in 
five early and four late operons (GenBank accession code: NC_004166.2) (4). Examples of the 
identified proteins include the products of genes 1 and 2 (G1P and G2P), which correspond to 
the small and large terminase subunits, respectively. G6P, G7P, G11P, G12P, and G13P were 
identified respectively as the structural proteins: portal protein, minor head protein, scaffolding, 
decoration and capsid (also known as head protein or major coat protein) proteins (4).  
Thermus thermophilus phage G20C, a thermophilic Siphovirus, was isolated from hot springs in 
the Kamchatka region in Siberia, Russia (6). The G20C genome, which is 81,159 bp long, 
shares high DNA sequence homology with the thermophilic phages P23-45 and P74-26 
(GenBank codes EU100883.1 and EU100884.1) (7). From the 117 putative orfs predicted for 
phage P23-45, a number of encoded proteins were annotated on the basis of their homology to 
proteins or domains with known function and on the basis of genomic context. Examples of 
putative proteins are the large terminase, portal, scaffolding and capsid proteins, encoded by 
genes 85, 86, 87, and 89 respectively (7).  
1.2 Assembly of dsDNA viruses 
dsDNA bacteriophages exhibit a general assembly process (Figure 1), although particular stages 
are present for distinct phages. Initially, multiple copies of the capsid protein are polymerised 
around the portal protein by the scaffolding protein to form an empty procapsid (prohead). Once 
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the procapsid is complete the complex of concatemeric DNA-small and large terminases is 
docked to the portal protein to start the ATP-fuelled translocation of DNA, beginning with the 
priming of the lead end of the DNA by cleavage at the genome pac site. The hetero oligomer 
formed by the portal protein and terminase subunits is called the molecular motor. After a one-
genome length fragment has been packaged, the concatemer bound-small and large terminase 
complex leaves to find another empty procapsid and repeat the cycle. The final step to produce 
the infective phage is the attachment of completion proteins to the portal vertex to avoid the 
leakage of DNA from the capsid and mediate in the docking of the tail. Minor completion 
proteins, decoration and/or glue proteins may also be involved at certain stages of the assembly 
(8-10).  
 
Figure 1. General assembly process in dsDNA bacteriophages 
Figure adapted from Lebedev et al (11). 
 
In the following sections, the SPP1 molecular motor will be described in detail as an example of 
molecular motors found in dsDNA phages. Although this project involved X-ray structure 
determination of the small terminase from another Siphovirus, G20C bacteriophage, close 
evolutionary relationship suggests that any data on this protein will be relevant also to other 
phages. 
1.3 DNA-packaging molecular motor 
The components of the molecular motor from phage SPP1 are the portal protein (G6P), the 
small (G1P) and large (G2P) terminase proteins (Figure 2) (12).  
1.3.1 Small terminase 
The translocation of DNA starts when the small terminase (ST) protein is believed to 
specifically recognise the viral genomic DNA synthesised by the host machinery from an 
environment that also contains host DNA. More information about the nature of ST-DNA 
interaction is presented in sections 1.9 and 1.10. Once the ST has recognised DNA it presents it 
to the large terminase (LT) which makes a cut that generates a free end in the DNA concatemer 
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(see section 1.3.2 ) (9,10). In some phages it has been shown that the ST regulates the large 
terminase enzymatic activities (13-15). 
 
Figure 2. Model of SPP1 molecular motor 
Portal protein (blue), large terminase (cyan) and small terminase (magenta) are docked to reflect 
biochemical data, but no structure of a complex is available. The portal and ST models are derived from 
PDB entries 2JES and 3ZQQ (11,16). Large terminase PDB 3CPE (17). DNA is in yellow. All figures, 
unless otherwise indicated, were made using CCP4mg (18) 
The SPP1 ST has been the focus of extensive work, leading to the accumulation of a vast 
amount of biochemical and structural data that has allowed partial understanding of how the ST 
interacts with a specific region of DNA (5,19,20) and how it is related to the ST from other 
phages (21).  
In 2012, the X-ray structure of the ST from phage SF6, another Siphovirus closely related to 
SPP1 (16,21) was solved. Besides sharing 82 % sequence identity and exhibiting similar domain 
arrangement (21), SF6 ST is able to supply the small terminase function to SPP1 phages 
defective in gene 1 (21). 
The SF6 full-length ST forms ring-like structures of nine subunits in solution and in the crystal 
(Figure 3a). The nine subunits define a central channel that consists of two structural parts: a 
nine β-stranded barrel on top, and the base at the bottom of the assembly, formed by the N-
terminal domains and the central oligomerisation domain (OD) of the monomer. The OD is 
composed by two short antiparallel α-helices and one β-hairpin. The N- terminal domain (NTD) 
of every subunit consists of the DNA-binding domain, which hangs at the periphery of the ring 
(16). More details and figures about the SF6 ST and that from other dsDNA phages are given in 
section 1.8. 
1.3.2 Large terminase 
One LT subunit is a dual-activity enzyme, one activity of which is to cleave the concatemeric 
DNA twice to produce single genome-length DNA fragments, after the ST has recognised its 
binding site. The second enzymatic activity, ATPase, provides the energy required for the 
molecular motor to translocate DNA into the procapsid (9,22). The endonuclease and ATPase 
19 
 
activities are associated with the C- and N-termini, respectively. Additionally, both the C- and 
N-terminal domains comprise interaction sites with the portal protein and ST (Figure 2) (23-25).  
 
Figure 3. X-ray structures of the individual components of the SPP1 molecular motor 
(a) Full-length SF6 ST oligomer (left) and monomer (right) (PDB 3ZQQ). The DBDs and OD are 
highlighted with dashed lines. (b) SPP1 LT nuclease domain (PDB 2WBN). The β-strands in the core and 
β-hairpin are numbered. (c) SPP1 portal protein (13-mer, left) and monomer (right) (PDB 2JES). 
Domains are indicated by dashed ovals. All the structures, except the inset are to scale. 
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It has been showed that G2P FL is a monomer in solution (13). The X-ray structure of the C-
terminal nuclease domain of SPP1 LT was determined at 1.9 Å resolution, showing that the 
G2P_ΔN construct comprises seven β-strands with a set of α-helices at each side of the β-sheet 
and a short β-hairpin at the C-terminus (Figure 3b) (22). The fold of the RNase H endonucleases 
family (26) was identified suggesting that SPP1 LT might possess a similar catalytic 
mechanism.  
Furthermore, several acidic residues and His400 were shown to be important for the cleavage of 
DNA and the C-terminal β-hairpin movements were implicated in switching the nuclease 
activity on and off (22).  
1.3.3 Portal protein 
The portal protein is a 12-subunit homo-oligomer embedded in the capsid, replacing one of the 
12 pentamers of the capsid icosahedron (27,28). Besides providing the passage of DNA from 
the protoplasm to the interior of the capsid during the assembly and in the reverse direction 
during host infection, the portal protein is believed to provide the site for the scaffolding 
protein, SPP1 G11P, to associate and thus to begin polymerising the assembly of the major 
capsid protein, G13P (29,30). The cryo-EM structure showed that the functional oligomerisation 
state of the portal protein is a 12-subunit ring-like structure that forms a central channel through 
which the DNA is translocated. However, subsequent determination of the X-ray crystal 
structure of recombinantly expressed G6P in E. coli showed that a 13-subunit assembly is 
formed which is also shown to exist in solution (11,28,31). The G6P X-ray structure provided 
information about the interaction of the portal protein with DNA, highlighting the potentially 
key role of the portal protein’s tunnel loops in DNA translocation (11).  
G6P is a mixed α/β structure composed of four domains, named from top to bottom, crown, 
wing, stem and clip (Figure 3). The stem and wing make contact with the capsid protein, while 
the clip interacts with the terminase complex. The tunnel loop, mentioned above, comprises 21 
residues connecting the twisted helices α6 with α5. Its movement is likely to accompany DNA 
translocation through the portal (11). 
The 13-mer has an inner diameter at its most constricted portion, defined by tunnel loops, of 
27.7 Ǻ (vdW diameter). In the functional 12-mer assembly, however, the internal diameter of 
this ring is reduced to 18.1 Ǻ. The position of the loop in the 13- and 12-mer structures differs 
by ~ 3 Å shift along the tunnel axis, demonstrating potential movement of these loops in the 
protein. (11) 
The translocation model proposed by Lebedev et al overcomes the reduced diameter of the 
tunnel that would imply clashes between DNA sugar phosphates and the tunnel loops by 
introducing two structural rearrangements. First, it was proposed that the DNA is shifted so that 
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it is no longer coaxial with the portal protein, in this way the major groove can be 
accommodated by approximately three loops at one time. The second rearrangement occurs 
when loops slide relative to each other in a sequential mode, as a “Mexican wave”, allowing two 
base pairs to be translocated while one ATP molecule is hydrolysed by the viral ATPase (11). 
 
1.4 Icosahedral capsid architecture 
Capsids, also known as heads or shells, are protein assemblies designed not only to contain and 
protect the viral genome, but also to transport it from one host cell to another (32).  
1.4.1 Quasiequivalence 
In many viruses, the capsid is built by the aggregation of a high number of copies of a single 
protein, but in more complex viruses two or more proteins can be involved. Such behaviour is a 
perfect example of viral efficiency; for a virus it is more economical to store the genetic 
information using only a single gene rather than two or more. In addition, when within the host 
cell, it is easier to direct the production of multiple copies of a single (or few) protein(s) rather 
than many different ones (32).  
Based on Watson and Crick’s observations about the structure of small plant viruses (33), 
Caspar and Klug postulated that only a limited number of designs for a biological container 
made up of a high number of the same protein was possible, the helical tubes and icosahedral 
particles (32).   
In helical tubes, the protein subunits are packed in helical array and every subunit lies in 
identical structural and chemical environments, except by the subunits at the top and bottom of 
the rod. As the same contacts are used by the subunits over and over through the helical array, it 
is reasonable to say that they are all in the same environment and are equivalent (32). 
The architecture of flexible filamentous viruses can be explained if some of the bonds that hold 
the helical array together are slightly distorted. Since all the bonds are no longer the same but 
the overall bonding pattern has not changed considerably, the subunits remain quasi-
equivalently related (32).  
Caspar and Klug first introduced the concept of quasi-equivalence in 1962 to argue that the 
same principles that governed the construction of helical viruses applied for virus particles with 
icosahedral symmetry (32).  
Icosahedral symmetry permits the highest number, that is 60, of identical proteins to cluster in 
spherical arrangement where they are identically accommodated, a situation that is only valid 
for small viruses (Figure 4a). To construct larger viruses, which have a higher number of 
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subunits, it is necessary to deviate from the equivalence and adopt quasi-equivalence; Individual 
subunits can be packed with slightly distorted bonds so they will lie in similar, but not exactly 
identical environments. In this way the capsid is essentially still held together by the same type 
of inter-subunit interactions, but they differ slightly for subunits in different environments (32).  
 
Figure 4. Icosahedral symmetry in capsids  
(a) Symmetry axes in a T=1 icosahedral capsid. The 2-, 3- and 5-fold axes are indicated by ovals, 
triangles and pentagons. At the most left figure the subunits on each triangular facet are represented by 
black commas. The smallest icosahedron fits three individual subunits on each triangular facet, designated 
as one unit triangle. (b) Drawing of triangular facets on a hexagonal lattice. Calculation of the T number 
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is done by selecting an origin, O, for the initial pentamer and then finding the closest pentamer centre. 
The coordinates (H,K) describe, in unit triangles, how far the pentamers are to each other in the capsid. 
One icosahedron with T=7, has either (2,1) (blue) or (1,2) (red) values. For the facet with (1,2) values, the 
closest pentamer to the origin is at position one unit triangle along the H axis and two unit triangles along 
the K axis. Facet triangles belonging to icosahedra with numbers T=1 (pink), 3 (brown), 4 (cyan), 13 
(black) and 25 (yellow) are also plotted. (c) Icosahedral asymmetric unit in a T=4 capsid. One triangular 
facet extracted from the icosahedron shows the four unit triangles and twelve subunits that form it 
(centre). One third of the triangular facet is shown at the right to highlight only one asymmetric unit 
(shadowed in purple), formed by four copies of the capsid protein. Figure adapted from Prasad & Schmid, 
2012 (34). 
 
The quasi-equivalence is clearer to understand if it is emphasised that the same subunit can form 
pentamers and hexamers (Section1.4.2). The subunits and contacts at the pentamers are different 
from those at the hexamers, however not significantly, as the environment at the five- and three-
fold axes (centre of hexamer or six-fold axis) cannot be too different because of the intrinsic 
properties of the individual subunits that forbid extreme variances.  
1.4.2 Icosahedral symmetry 
Two general shapes are commonly observed in viral capsids, helical tubes or isometric particles 
with cubic symmetry. Three types of cubic symmetry are found in isometric capsids: 
tetrahedral, octahedral and the one that is preferred by viruses, the icosahedral symmetry 
(32,34).  
One icosahedron has 20 identical facets, each defined by an equilateral triangle formed by three 
copies of the capsid protein, making it possible for the icosahedral container to accommodate 60 
copies of capsid protein, the maximum number of copies among particles with cubic symmetry, 
as there are only 12 for the tetrahedron and 28 for the octahedron (Figure 4a) (32,34).  
The icosahedrons are characterised by exhibiting 2-, 3- and 5-fold rotational symmetry axes. 
Application of these rotational symmetries to the icosahedral asymmetric unit (Section1.4.4) is 
enough to determine the complete capsid structure (Figure 4.a,c).  
Every icosahedral capsid is composed of 10T+2 morphological units (pentamers and hexamers) 
built by the same type of capsid protein (See section 1.4.3 to read more about the triangulation 
number T). The smallest viruses are formed by pentamers only, distributed symmetrically at the 
vertices of the icosahedron, making a total of twelve pentamers. Larger virus design incorporate 
hexamers, distributed on the triangular facets, that allow the architecture of the capsid to enlarge 
when required. Even though pentamers and hexamers form the shells, the assembly into 
pentamers and hexamers is not necessary before capsid formation. The number of 
morphological units can be calculated by the formula 10(T-1) hexamers + 12 pentamers (32,34). 
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1.4.3 Triangulation number 
It was mentioned earlier that the smallest icosahedral capsid can accommodate 60 subunits in 20 
triangular facets, that is 3 subunits per facet, all in identical environments (Figure 4.a). If more 
subunits are incorporated, for example in larger viruses, the triangular facet needs to be enlarged 
by the equation T=H
2
 + HK + K
2
, where T is the triangulation number and H and K are 0 or 
positive integers that represent coordinates along the H and K axes that cross at a 60° angle in 
the hexagonal lattice (Figure 4.b) (32,34-36).  
Icosahedron with T=1 has (H,K) values of (1,0) and its facet is defined as unit triangle. To find 
the T value for larger icosahedra, one origin, O, is chosen at any pentamer centre. Next, a vector 
is drawn from the origin to the closest neighbouring pentamer centre, that has certain (H,K) 
values. The triangular facet is enclosed by drawing a second vector from the point (H,K) to the 
centre of a third pentamer (Figure 4.b). Thus, the T number indicates the distance between 
pentamers and the number of unit triangles on each facet. Two capsids with (2,0) and (2,1) 
(H,K) values have numbers T=4 and T=7 with 4 and 7 unit triangles per facet, respectively 
(Figure 4.c). The number of subunits is calculated by 60T, derived from the condition that all 
icosahedra have 20 triangular facets, with T unit triangles formed by 3 subunits each: 20 x 4(or 
7) x 3 = 240 or 420 respectively (32,34-36). 
1.4.4 Icosahedral asymmetric unit  
The icosahedral asymmetric unit is defined as one third of the icosahedral triangular facet, 
which results from dividing the triangular facet into three identical parts at the three-fold axis 
(Figure 4.a,c). Producing the 60T subunits of the capsid is possible by applying 5-3-2 rotational 
symmetry to the asymmetric unit. A capsid with T=1 has one copy of the capsid protein in the 
asymmetric unit, while a capsid with T=4, has four. Thus, the triangulation number also 
describes how many copies of the capsid protein are fitted in the asymmetric unit (34).  
1.4.5 Prolate icosahedra 
Icosahedral morphologies different to the isometric version are observed in phages T4 and φ29 
(37,38), where capsids are assembled as prolate icosahedra. Prolate is the name given to 
icosahedra that present with the main cylindrical body elongated (Figure 5). Thus, these 
icosahedra are formed by two types of triangular facets, equilateral triangles at the top and 
bottom, defined by the T number, and larger triangles in the cylindrical body. The larger facets 
are defined by two different vectors, the base vector of the triangle is still determined by T= H
2
 
+ HK + K
2
, whereas the elongated sides are determined by the elongation number, Q, calculated 
by Q=H1H2 + H1K2+ K1K2. 
Figure 5 shows the pair of triangular facets for prolate capsids of both φ29 (T=3, Q=5) and T4 
(T=13l, Q=20) phages. The equilateral facets have coordinates φ29 (1,1) and T4 (3,1) while the 
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elongated sides’ coordinates are φ29 (1,2) and T4 (4,2). To draw the elongated facet, the K1 
axis becomes the H2 axis and a new K2 axis, at 60° with respect to the H2/K1 is sketched.  
 
 
Figure 5. Prolate Icosahedron 
Equilateral and elongated facets of phage φ29 are shown in blue and cyan, and those of T4 in yellow and 
red. Coordinates for each phage, the origin and axes are indicated. Figure adapted from Prasad & Schmid, 
2012 (34). 
 
1.5 HK97 capsid protein  
In 2000, the X-ray structure of the complete capsid from the dsDNA phage HK97 was 
determined at 3.6 Å resolution (Figure 6. (39). The HK97 capsid, with T=7, exhibits icosahedral 
symmetry with 12 pentamers at the vertexes and hexamers at the rest of the triangular facets. 
Through the capsid, three different levels of organisation are observed. First, residues K169 and 
N356 (shown as black balls in the asymmetric unit in Figure 6.b and in ball and stick 
representation in Figure 6.c) create isopeptide bonds between neighbouring subunits. The 
second level corresponds to the pentamers and hexamers formed by the capsid protein and the 
third one to the catenated links that create the “chainmail” all over the capsid (39). As of 2014, 
the isopeptide bond has only been observed in the capsid of HK97 but not in other capsids. 
The asymmetric unit from HK97 has seven slightly differently folded copies of gp5, six from a 
hexamer and the seventh from a pentamer (Figure 6.b). Every monomer is an α/β structure 
organised into peripheral (P-) and axial (A-) domains. The P-domain spans the quasi-three and 
two-fold axes of the capsid (Figure 6.). The main features of the peripheral domain are the 
extended loop (E-loop), helix α3’, and residues K169 and N356, responsible of holding the 
capsid together. Whereas the P-domains interact with P-domains both from the same or 
different morphological units, the A-domains are only in close contact with A-domains from the 
same morphological unit, at the 5-fold and 6-fold symmetry axes (39). 
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Figure 6. Structure of the HK97 capsid 
(a) In the HK97 phage capsid, pentamers are shown in purple and hexamers in cyan. (b) Asymmetric unit 
extracted from the capsid. Residues are shown as black balls to illustrate their distribution in the 
asymmetric unit. (c) Individual subunit organisation. A- and P-domains are circled by dashed lines. The 
N-arm is shown in green and helix α3’ in cyan. Residues K169 and N356 are shown in ball and stick 
representation. Part a was extracted from Wikoff, et al, 2000 and used with permission of the editor (39). 
Parts b and c were made using the PDB code 1OGH.  
 
Initially, residues 1-103 facilitate and guide the assembly of the immature form of the viral 
capsid, called prohead I (procapsid I). At a later stage, residues 1-103 are cleaved off by the 
serine protease encoded by HK97 (39,40). The 29 N-terminal residues of the 104-385 protein 
construct comprise the N-arm, which within the capsid, lies beneath adjacent monomers. The 
flexibility of the N-arm and the E-loop is thought to be critical for allowing gp5 to oligomerise 
into pentamers and hexamers (39).  
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1.5.1 Structural conservation of capsid proteins 
Tailed dsDNA bacteriophages are at first glance very distant from each other since they adopt 
different morphologies and contain tails of varying length. Phages T4 and φ29 present prolate 
icosahedra (37,38), while HK97 and SPP1 adopt isometric forms (39,41). They can have 
different T/Q numbers, for example, φ29 has T=3, Q=5, T4, T=13l, Q=20 and P22, HK97, SPP1 
have T=7l numbers. In addition dsDNA bacteriophages can have somewhat different assembly 
pathways, belong to different families and infect different hosts, which can be both Gram-
positive and Gram-negative bacteria (Table 1) 
Despite all these significant differences, it has been proposed that all tailed dsDNA 
bacteriophages have evolved from a common ancestor (42). This hypothesis is supported by the 
common HK97-fold of the capsid protein, named so because the first X-ray structural data were 
obtained for the capsid of this phage (Figure 7) (39). 
Table 1. Capsid proteins in dsDNA bacteriophages 
--- Information not available. 
For particles with isometric icosahedral shape only T is shown. 
1Z1U is a theoretical model for T4 hexameric protein, gp23. 
 
Phage HK97 SPP1 T4 P22 φ29 PfV Bb_PhRP Ec_Pcp 
Family Siphoviridae Siphoviridae Myoviridae Podoviridae Podoviridae Domain 
Archaea 
--- --- 
Host E.coli B.subtilis E coli Salmonella s. 
typhimurium 
B.subtilis Pyrococcus 
furiosus 
Bordetella 
bronchiseptica 
E. coli 
 
Diameter 
(Å) 
 
660 
 
610 
 
850 width 
1150 height 
 
 
628 
Prolate: 
450 
Isometric: 
425 width 
x 540 height 
 
 
--- 
 
 
--- 
 
 
--- 
T 7l 7l T=13l 
Q=20 
7l T=3 
Q=5 
T=3 --- --- 
Protein  
gp5 
 
G13P 
gp24 
Pentamers 
gp23 
Hexamers 
 
gp5 
 
gp8 
 
--- 
 
--- 
 
--- 
Size 
(kDa) 
30.7 35 56 
48.7 
~47 49.8 38.8 34.1 39.6 
Aa’s 282cleaved 324 521 
422 
430 488 345 316 351 
Technique X-ray 
 
Cryo-EM X-ray 
Cryo-EM 
Cryo-EM 
 
Cryo -EM X-ray X-ray X-ray 
 
 
Resolutio
n (Å) 
 
 
 
3.6 
 
 
8.8 
(Full particle) 
 
gp24 
2.9 
Capsid 
22 
 
 
ExH-8.2 
Shell-9.1 
 
Isometric 
fibreless 7.9 
Isometric 
fibered 8.7 
Prolate  
fibreless 12.7 
 
 
3.6 
 
 
2.05 
 
 
2.2 
 
 
 
Special 
features 
Protease: 
gp4 
 
Inter-subunit 
crosslinking 
between 
K169 and 
N356  
 
Scaffolding: 
G11P 
 
Decoration 
protein: 
G12P 
 
Insertion 
domain  
 
Decoration  
proteins: 
gp hoc,gp soc 
Scaffolding: 
gp22- 
Assembly 
protease: 
gp21 
Telokin-like 
domain  
 
Scaffolding: 
gp8- 
 
BIG2 domain  
 
174b pRNA 
 
Scaffolding: 
gp7  
 
Head fibres 
gp8.5  
 
 
 
 
 
--- 
 
 
 
 
--- 
 
 
 
 
--- 
PDB 1OHG 4AN5 1YUE 
1Z1U 
3IYH 
3IYI 
1YXN 2E0Z 3BJQ 3BQW 
Reference (39) (41) (37) (43) (38)  (44) (45) (46) 
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Likewise, protein folds observed in capsid proteins of other groups of viruses are also suggested 
to be shared, like the PRD1 phage-like fold and the blue-tongue virus-fold (BTV), that are 
found in viruses that infect mainly Eukarya (42). 
To date there are X-ray structures available for the already described HK97 gp5, for the vertex 
protein gp24 from T4 (38), for the putative capsid protein of prophage of Escherichia coli 
CFT073 (Ec_Pcp) (46), for a phage-related protein BB3626 from Bordetella bronchiseptica 
(Bb_PhRP) (45), for a viral capsid-like particle found in Pyrococcus furiosus (PfV) (44) and the 
shell-forming encapsulins, from bacteria Thermotoga maritima (47) and Myxococcus xanthus 
(48) (Table 1, Figure 7). Cryo-EM structures, deposited as poly-Ala models, have been solved 
for the capsid proteins from P22 (gp5) (43,49), φ29 (gp8) (38) and for SPP1 (G13P) phages 
(41). In T4, proteins gp23 forms hexamers and gp24, pentamers. The structure of gp23 was 
determined by building a homology model using the gp24’s X-ray structure (37). The HK97-
fold has also been identified in the cryo-EM reconstructions of Sf6 (50), T5 (51), T7 (52), λ 
(53), P-SSP7 (54) and ε15 phage capsids (55). 
Structures of all these capsid proteins are homologous to the HK97 capsid protein, gp5, to some 
extent (Figure 7) and are hence described as HK97-like. All the head proteins appear to be 
organised into A- and P-domains. For bacteriophage P22, poly-Ala models for the expanded 
head (ExH) and empty shells were determined. While in the ExH particle that includes no 
pentamers, the A-domain is easy to identify, in the shell particle the A-domain lies in a “hidden” 
location, suggesting that it can adjust its position in the different maturation stages (43).  
A-domains establish contacts with A-domains from neighbouring subunits at the five- or six-
fold axis. Helices α5 and α6 and the apical loop that connects them are partly responsible of 
keeping the subunits of one morphological unit in place. Helices α5 and α6 from the same 
subunit are packed next to helices α6 and α5, respectively, from different subunits at each side.  
The P-domains from all the capsid proteins make extensive contacts with their counterpart in 
the same or adjacent capsomers. Specifically the long β strands at the bottom of the P-domain 
are the source of such interactions at the two-fold symmetry axes. In T4 it was observed that the 
distance between the closest Cα atoms between hexamers is around 16 Å in particles without 
decoration proteins. Such a long distance was attributed to variation in the structure of the loops 
at the P-domain in gp24 and gp23 or calibration errors in the amplification of the electron 
microscope (38). 
More specific features are observed in the analysed set of capsid proteins, for example, the long 
helix spanning most of the P-domain has proved to be one of the most remarkable structural 
characteristics of the HK97-fold. Helices α3, α5 and α6 (shaded) have served a reference in 
cryo-EM 3D reconstructions because they are easily recognisable and have been used as a 
starting point for building models (41,43). 
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Figure 7. Capsid proteins with HK97 fold 
Side views of the structures mentioned in the text and Table 1 are shown as ribbon diagrams (X-ray 
structures) or worm representations (Poly-Ala models from cryo-EM reconstructions). The N-arm from 
HK97 is shown in lime colour and so is a segment from φ29. Insertion domains are shown in green 
(delimited by dashed ovals). Helix α3 (following numbering in HK97) is shown in cyan and the E-loop is 
shown in salmon. Conserved helices (α3, α5 and α6) are highlighted with grey background. 
Corresponding PDB entries and references are found in Table 1. 
 
The E-loop has been identified in other capsid proteins, however its conformation is less 
conserved than the long helix spanning the P-domain. In T4 and Bb_PhRP, it was not possible 
to trace it as it is highly disordered, probably due to its intrinsic flexibility (38,41). In P22, a 
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putative capsid protein from an E. coli prophage, and in the viral capsid-like particle from P. 
furiosus, the E-loop is considerably shorter than that in HK97 capsid protein (43,44). 
One more difference between HK97 gp5 and other capsid proteins is the presence of one 
additional globular domain (shown in green) at the distant end of the E-loop in T4 (37), P22 
(43,56) and φ29 (38). This domain is called the insertion domain in T4 (it presents topological 
similarity to the chitin-binding domain of chitiquinase), the telokin-like domain (or 
immunoglobulin-like) in P22 and group 2 bacterial immunoglobulin-like domain (BIG2) in φ29. 
The additional insertion domain is thought to play an analogous role to the crosslinking and glue 
proteins in HK97 and T4 since it is involved in intra- and inter-capsomer contacts. 
The finding of a virus-like particle in P. furiosus was intriguing because it proved that viruses 
with HK97-fold are also present in the Archaea domain (44). The purified particle does not 
carry DNA nor is it able to infect P. furiosus. Little is known about the origin of the 
corresponding gene though it is speculated that it is an immature or aberrant form of another 
capsid. (The evidence is that mutants of φ29 capsid proteins fail to assemble into prolate 
icosahedra but form isometric particles instead). A similar change could have occurred to this 
capsid-like individual subunit since its shape is almost spherical, which is supported by the 
absence of encapsidated DNA, known to contribute to shape the final icosahedral morphology 
in other phages. Other essential proteins involved in the assembly or DNA-packaging process 
are also likely to be missing (44).  
As a result of the accumulation of structural information about the capsid protein in viruses, it is 
conceivable that viruses use a limited range of capsid protein folds to preserve their DNA since 
the HK97-fold is conserved across bacteria and in the evolutionarily related archaeal and 
eukaryotic viruses (42). 
 
1.6 SPP1 phage capsid protein 
1.6.1 Morphogenesis 
The assembly of the SPP1 capsid is initiated when the scaffolding protein, G11P (23.4 kDa) 
promotes polymerisation of 415 protomers of the major capsid protein, G13P (35.3 kDa), 
around the portal protein (12 copies of G6P, 63kDa each) into icosahedral lattices with T=7l 
(Figure 8) (29). To form a viable procapsid, all the listed components were shown to be 
necessary, for instance removal of G6P leads to populations of capsids with T=7 and T=4 
geometries (30). Removal of G11P produces immature proheads and aberrant heads tubes. As 
expected, removal of G13P produces no capsids, while its overexpression in E.coli leads to 
formation of big aggregates that elute in the void volume of gel filtration columns, evidence of 
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its intrinsic capability to polymerise. Individually purified G11P and G13P polymerise into 
filament like-structures and empty or open coiled capsid-like structures, as revealed by 
negative-stain EM. Co-expression of both G11P and G13P leads to the immature/aberrant 
structures described earlier (29,30).  
The scaffolding protein’s secondary structure was predicted to consist of long α-helices and two 
heptad ((I/L)X(E/D)LXXX) sequences that might confer amphipatic character to G11P which 
then would be able to form dimers. It has been demonstrated that G11P forms tetramers 
although dimers of refolded protein were found to bind more efficiently to G13P than the native 
His-tagged tetramers (57).   
 
Figure 8. Assembly of SPP1 phage 
All elements that are known to be involved in the process are shown. G6P, G7P, G11P and G13P form 
the procapsid. Once completed, the procapsid serves to dock the G1P-G2P-DNA complex. As the DNA 
fills the procapsid, G11P exits through gaps between G13P protomers. Full procapsids change from the 
initial spherical to the characteristic icosahedral shape. After a complete genome is translocated the G1P-
G2P complex leaves and the portal is free to attach the completion proteins and tail. G12P is then also 
added to the final capsid. The number of shown components does not reflect the real stoichiometry at any 
step. The location of G7P during assembly is not clear. Figure adapted from Lebedev et al, 2008 (11) and 
Becker et al, 1997 (29). 
 
Early research found that the minor protein, G7P (34K kDa), is present during the complete 
assembly process, however it was not possible to identify its function (29). Further experiments 
demonstrated clear interactions with G6P. One or two copies of G7P are found in the SPP1 
capsid and it is possible that these are associated with the portal (30). The most recent findings 
about G7P indicated that mutants lacking gene 7 produced less infectious progeny than when 
G7P was supplied. However, the less infectious phages showed the same efficiency of DNA 
packaging and processivity of translocation cycles as the wild-type (WT) phages. If G7P does 
not participate in the capsid assembly or in the DNA-translocation process, then it is likely to 
play a role in the efficient delivery of DNA to the host as phages missing G7P detach from the 
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ejected DNA but the ones with G7P remain attached to one end of the viral DNA. G7P might 
act as a clamp that slows down the ejection rate to a level that allows efficient passage to the 
protoplasm, which is compatible with the fact that removal of this gene produces faster ejection 
of DNA than in the WT, although the G7P is not co-ejected to the cell host (58). Two copies of 
G7P per phage strongly interact with G6P via the C-terminus of the latter protein (59).  
The function of G8P and G9P remains unclear, but it is known that removal of these genes 
produced no heads or tailless heads, respectively (29). 
After DNA packaging, the decoration protein, G12P (6.6 kDa) is attached to the outer surface of 
the capsid, whilst completion or “stopper” proteins G15P and G16P are docked to the portal to 
avoid leakage of DNA and at the same time provide the site for attachment of the tail (29,60).  
NMR structures have been solved for G15P (11.6 kDa) and G16P (12.5 kDa) monomers (Figure 
9). G15P consists of four helices and a short β-strand. G16P is organized into seven β-strands 
that form a β-barrel with four sheets at every side. β1-β2 and β2’-β3 pairs are connected by long 
loops. Docking of G15P structure onto the Cryo-EM density maps (11) was only possible by 
dissecting the structure. Twelve subunits were fitted in different ways in a ring-like 
conformation, suggesting that G15P reorganises itself during the assembly with G6P and G16P 
(hence called the adaptor protein).  
 
Figure 9. Completion proteins of SPP1 phage 
Ribbon diagrams of the main models from the NMR structures of the adaptor (G15P) and stopper (G16P) 
proteins. The numbering is the same as in the original reference. The long β2-strand is present at both 
sides of the barrel, thus is indicated as β2 and β2’. G15P PDB 2KBZ, G16P PDB 2KCA.  
 
On the other hand, Twelve G16P subunits were fitted as rigid bodies in a way that one long loop 
from every subunit projects toward the centre of the cylinder to prevent DNA leakage. G16P 
does not undergo major structural rearrangements to interact with other phage proteins nor to 
oligomerise as G15P does. G16P provides the interface to attach the tail (61). 
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1.6.2 Cryo-EM structure of the SPP1 capsid 
Pseudo-atomic structures of SPP1 capsid, determined by Cryo-EM, at late stages of assembly 
showed icosahedral arrangements with T=7l geometry. Interestingly, the shape and thickness of 
the protein layer (~ 27 Å) of tailless, DNA-filled, decorated and non-decorated capsids, and 
tailed, empty and DNA-filled capsids were essentially the same, making it apparent that no large 
changes occur to the capsid when the tail or decoration proteins are attached or when the DNA 
is ejected (41).  
 
Figure 10. Cryo-EM structure of the SPP1 capsid protein.  
(a) Pseudoatomic model of G13P. HK97 gp5 is shown in red while identified α-helices in SPP1 are 
shown in green. (b)(c) Asymmetric unit that features seven copies of G13P, six forming the hexamer and 
one forming a pentamer. The density of G12P is shown in orange in (c). (d) Superposition of hexamers 
from decorated and non-decorated capsid. Density corresponding to G12P is coloured in purple. Figure 
extracted from White et al, 2012 and used with permission of the editor. 
 
Helices α3, α5 and α6 were identified in the EM density maps at the same position they are in 
HK97 (Figure 10a), therefore a model for SPP1 G13P using alignments of secondary structure 
predictions of proteins which exhibit a similar fold could be constructed. G13P displays the 
HK97-fold, being organised in A- and P-domains that are involved in inter-subunit contacts. 
The E-loop could not be traced in SPP1 but the G13P model fitted into the extracted asymmetric 
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unit shows some unassigned density that might indicate either an interaction between the E-loop 
of one subunit with the adjacent P-domain or a different conformation of G13P in the region 
where the E-loop is in HK97 (Figure 10b,c) (41).  
Superposition of hexamers extracted from decorated and non-decorated capsids exposed the 
location of G12P (Figure 10d). Three copies of G12P bind to each of the sixty flat hexameric 
centres. However the spike density observed is not long enough to account for three G12P 
subunits implying a degree of flexibility in the most distal subunit. The function of G12P 
remains elusive since decorated and non-decorated capsids exhibited the same morphology, 
released packed DNA and underwent protein denaturation at the same temperature when 
thermostability was tested, ruling out a potential role in defining the capsid shape or conferring 
stability (41,62). 
 
1.7 Example of protein-engineering to facilitate crystallisation 
A clear example of how altering some characteristics in wild type (WT) proteins allows the 
study of key functional details in protein structure is presented by the human β2-adrenergic 
receptor (β2-AR), which was engineered to solve its X-ray structure (63,64). The β2-adrenergic 
receptor, a membrane protein that belongs to the G protein-coupled receptors, is located 
principally in the smooth muscle, and changes at the genetic level lead to diseases like asthma, 
hypertension and heart failure.  
The inherent flexibility and complexity of the WT receptor’s flexible intracellular loop (ICL3) 
and its C-terminus hampered the growing of diffraction quality crystals. This obstacle was 
overcome by replacing the ICL3 that links transmembrane α-helices V and VI with T4-
lysozyme (T4L) (65) and by truncating the C-terminal portion (residues 366-413) that was 
shown to present an extended conformation (66). T4L was chosen due to its solubility, 
propensity to crystallise and the proximity between the N- and C-termini (10.7 Å), which is 
similar to the distance predicted between α-helices V and VI. Residues 2-164 in T4L replaced 
region 234-259 in the β2-AR. C54T and C97A mutations were introduced in the T4L protein 
(63,64).  
The X-ray crystal structure of the β2-AR-T4L engineered protein in complex with the agonist 
carazolol was solved at 2.4 Å resolution (Figure 11). The β2-AR comprises seven 
transmembrane long α-helices, one short intracellular α-helix and one short extracellular loop 
(ECL2) that is folded in α-helical arrangement. The N- and C-termini from T4L are linked to α-
helices V and VI respectively (63,64). The fold of T4L in complex with β2-AR remains 
unchanged in comparison to the crystallised T4L monomer while the overall fold of the α-
helices from the β2-AR are likely to be very similar to the WT one as it has been shown that the 
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two regions connected by the ICL3 (helices I-V and VI-VII) can be expressed separately and 
still assemble into functional receptors (67).  
Investigation of the functional properties of the β2-AR-T4L protein revealed an active 
phenotype that exhibits higher affinity for the agonists used in the study than the WT. The 
affinity for the antagonist was normal. β2-AR-T4L did not bind to G proteins as could be 
predicted because of the removal of the ICL3. 
 
Figure 11. Human β2-AT-T4 lysozyme engineered protein 
The β2-AR is shown in white and T4L in grey. α-helices V and VI are highlighted in dark blue. Carazolol 
is shown in red. WT T4L is shown in light blue. The N- and C-termini from the engineered protein and 
WT T4L are shown in black and blue respectively. PDB entries: β2-AR-T4L: 2RH1, T4L: 2LZM 
 
1.8 Structural diversity of small terminases 
Several high resolution crystal structures of STs from mesophilic phages including SPP1-like 
phage SF6 (16), P22-like Sf6 (68), P22 (14) and T4-like phage 44RR (69), are available ( 
Table 2, Figure 12). A fifth X-ray structure is available for the putative ST from Bacillus cereus 
ATCC 14579 prophage phBC6A51 (70). The ST has also been identified in the Pseudomonas 
aeuroginosa phage PaP3 (15) for which functional studies are available and in the Lactococcus 
lactis bacteriophage ASCC454 (71) whose ST has been crystallised but no X-ray structure has 
been published.  
All the elucidated structures exhibit a ring-like organisation enclosing a central channel of 
varying diameter. The number of subunits varies from eight to twelve, nevertheless, the general 
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architecture and the overall outer diameter are similar. P22 (14,72), Sf6 (68) and prophage 
phBC6A51 oligomerise with a fixed number of subunits while 44RR (69) and SF6 (16) can 
crystallise in two different forms: 11-mers or 12-mers (44RR), and 9-mer or 10-mers (SF6). 
 
Table 2. Small terminases in dsDNA phages 
 SF6  
(SPP1-like) 
Sf6  
(P22-like) 
P22 44RR  
(T4-like) 
Prophage 
phBC6A51 
Family Siphoviridae Podoviridae Podoviridae Myoviridae --- 
Host Bacillus subtilis Shigella flexneri Salmonella s. 
typhimurium 
Aeromonas 
salmonicida 
Bacillus cereus 
ATCC 14579 
Technique X-ray X-ray X-ray X-ray X-ray 
 
Resolution 
(Å) 
1.85/2.19 
1.68 
3.0 
4 
 
1.65 
 
1.75 
3.35 
 
2.8 
1.8 
 
1.9 
 
Oligomeric state 
10-mers 
9-mer 
9-mer 
9-mer 
 
8-mer 
 
9-mer 
 
11-mer 
12-mer 
 
9-mer 
 
Protein and 
truncations 
G1P-53-120  
G1P-53-120 
G1P-65-141 
G1P- FL (1-164) 
(only 1-141 in 
crystal) 
 
gp1-FL (140 
residues), crystallised 
from 10-139 or 10-
132 
gp3 cleaved: (1-
140) 
 
gp3-FL(1-162), 
last 23 aa’s are 
disordered. 
gp16-FL 1-154 
26-112, 11-mer 
25-114, 12-mer 
 
 
---- 
Overall diameter 
(reported) Å 
65 (53-120) 
DBDs flexible 
 
99 
 
95 
75.5 
80.6 
 
~100 
 
Height 
(reported) 
 
~88  
 
66 
70 (in both 
crystals) 
100 (plus modelled 
α-helix barrel 
 
~40 
 
~45 
Channel diameter 
(most constricted 
part)ª 
 
14.3, 9-mer 
 
 
~15.5 
 
19.4 
 
24.2 
27.8 
 
~9 
 
PDB 
3ZQM/3ZQN 
3ZQO 
3ZQP 
3ZQQ 
 
3HEF 
 
3P9A 
 
3TXQ 
3TQS 
 
2AO9 
Reference (16) (68) (14) (69) To be published 
(70) 
--- Information not available 
ª The presented diameters correspond to the most constricted section of the channel, which might be not 
the top part of the assembly. 
 
Interestingly, in the case of 44RR, the subunits that constitute both oligomeric forms are 
identical (69), whereas in SF6, constructs missing the C-terminus assemble into both 10-mer 
and 9-mers, but the full length protein only forms 9-mers, suggesting that the C-terminus is 
important in defining the oligomerisation state (16).  
For P22, Sf6 and prophage phBC6A51 the overall diameter is comparable, however, for SF6 
and 44RR, that have flexible or disordered NTDs, it is not possible to accurately measure the 
outer diameter since it is likely that the NTDs occupy different positions (Figure 12). The 
overall heights vary to a greater extent as the assemblies have distinctive C-terminal domains: 
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β-stranded barrels in SF6, Sf6 and prophage phBC6A51, or an α-helical barrel in P22. 
Moreover, in most cases portions of the C-terminus are disordered in the crystal. 
 
Figure 12. Small terminases in dsDNA phages 
Ribbon diagrams for the oligomer (top view, left) and monomer (side view, right) of every ST with 
published X-ray structure. Diameter for the most constricted part of the channel is indicated (atom-to-tom 
distance). The highlighted subunit is shown in the side view with the NTDs in red, ODs in blue and C-
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terminal β-strand in purple. The numbering of the secondary structure elements is the same as in the 
original publications. Table 2 lists corresponding PDB entries and references. 
With the exception of P22, the terminases present defined ODs that pack closely in a circular 
array and establish contacts with adjacent subunits to form a central channel. The helical N-
terminal domains (NTD), identified as the DBD in SF6 (16) and Sf6 (68), hang at the periphery 
of the structure surrounding the oligomer. Helix-turn-helix in the DBDs motifs of SF6 and Sf6 
are formed by α-helices 2 and 3 and their connecting loop. Superposition of SF6 and Sf6 DBDs 
show an almost identical fold (shown in section 8.3). Other shared features between some STs 
are a β-hairpin barrel at the bottom of the SF6 and P22 structures and a β-stranded barrel on top 
of SF6, Sf6, P22 and phBC6A51 STs. A structural comparison will be presented in chapter 8. 
 
1.9 Proposed models for the small terminase-DNA interaction 
The currently available structures provide insights about the oligomerisation state of the ST, the 
general organisation of the assembly and domain organisation of individual subunits, however, 
the structures in isolation are still a limited source of information when addressing how the ST 
interacts with DNA. Two major models that take into account distinct properties of the ST have 
been proposed to describe such interaction (Figure 13) (16,69,73). The first model posits that 
the dsDNA wraps around the circular assembly to establish contacts with the HTH motifs 
present in the DBD from every subunit (Figure 13a). This model is supported by the finding that 
multiple DNase-protected sites were found in the pac recognition site of SPP1 (19) separated by 
~10 bp stretches (full turn of B-form DNA), in good agreement with the predicted distance of 
~35 Å between adjacent DBDs in SF6 (16). The spacing of DBDs in SF6 is similar to that 
observed experimentally between DBD in Sf6 (68) or between the traces of NTD (including a 
predicted HTH motif) in 44RR (17) even though the number of subunits per oligomer differs.  
In contrast, the second model considers the central channel as the binding site for DNA (Figure 
13b), proposing that DNA could pass through the channel, on its way to the procapsid, during 
mechanical translocation by the LT. Although this model assigns function to the channel, it has 
several vulnerable points. For instance, only the channel from phage 44RR (69) is wide enough 
to accommodate DNA (~23 Å van der Waals diameter) since the rest of the channels have 
portions that would lead to clashes with DNA (Table 2). Moreover, threading DNA through the 
channel would imply one free end before interaction with the ST, which is not likely to occur as 
the ST needs to present the DNA to the LT to generate the free end. The possibility of the 
disassembly of the ST to embrace DNA is unlikely due to the high stability of the oligomer 
(Discussed on reference (69)).  
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Figure 13. Small terminase:dsDNA models 
Molecular surface representations of SF6 ST with dsDNA bound around the outside (a) and passing 
through the assembly (b). Top and side views are presented for clarity. DNA is indicated by orange 
arrowheads. The models for this figure (including nine DBD and circular DNA) were derived from the X-
ray structure of SF6 ST (16) (PDB 3ZQQ). Figure adapted from Buttner et al, 2012 (16). 
 
To date, little evidence exists to support the ST channel-dsDNA model. Little or no interaction 
was observed between the DNA and SF6 ST missing the DBD by SPR and EPR experiments, 
strongly suggesting the DNA binding around the outside. The truncated versions of SF6 ST (53-
120 and 53-145) exhibited only residual binding to the tested DNA fragments in SPR 
experiments, in comparison with the full-length (FL) protein. The labelled version of the second 
construct, with only one spin label (facing the channel) introduced in one subunit to avoid 
coupling between adjacent subunits, failed to show any interaction with DNA in EPR 
experiments, when a 22-bp dsDNA extracted from the SPP1 pac sequence was added to the 
reaction (16).  
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1.10 Small terminase interaction with DNA: recognition sites and 
bent DNA 
1.10.1 Bent DNA 
Bending of DNA is a recurrent theme in the discussion of protein-DNA interactions as it is 
often involved in increasing the specificity of the protein towards DNA. The selectivity for 
DNA introduced by the bending is achieved because this allows the nucleic acid to adopt a 
conformation required for protein binding. In some cases, bending is induced by the bound 
protein, however most of the time, it is an inherent characteristic of the DNA sequence (74).  
Two hypotheses to explain the mechanism of bending were initially put forward based on 
anomalously migrating DNA fragments in acrylamide gels (reviewed in (75)): the junction and 
wedge models (Figure 14).  
 
Figure 14. Models for bent DNA 
(a) The junction model. Segments that represent B-form and non-B-form DNA are indicated by cylinders. 
(b) The wedge model. Consecutive bends caused by an AA dinucleotide are indicated by a blue triangle. 
(c) Tilt and roll wedges. Figure adapted from Sindens, 1994 (75). 
 
The junction model assumes that bending occurs at a B- and A-form DNA junction associated 
with A-tracts. The position of bending could be either at the 3’, 5’-end or both ends of the A-
tract (76).  
The wedge model suggests that there is a “wedge” angle at an AA dinucleotide that causes 
deviation from the axis of the double helix. Bending is observed when consecutive wedge 
angles add on. Two different wedge angles are observed according to their location: tilt angle, 
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opening in the direction of the phosphate backbone and the roll angle, which opens in the 
direction of either the minor or major groove (77,78).  
In both models the phasing of A-tracts or AA dinucleotides is stated as the optimal condition to 
lead to bending, as for the sequence, tracts of A4-9 were shown to be bent, however sequences 
without A-clusters also can be bent (75). Likewise, AT-rich segments, exposing the minor 
groove to a protein, have been pointed out as a source of bending. Removal of the water 
molecules from this site decreases the rigidity associated with the minor groove, making the 
DNA capable of adopting the conformation imposed by the binding protein (79). According to 
the literature 8.7° or 18° bends can be generated by each AA dinucleotide (77) or A-tracts, 
respectively (74).  
 
1.10.2 Recognition sites: SPP1 pac site  
The ST from SPP1 phage recognises a specific site on the viral genome to start packaging, the 
pac site (Figure 15a). The pac site is further divided into three segments with no apparent 
sequence similarity, pacL (left), pacC (centre) and pacR (right). G1P binds only to pacL and 
pacR as was evident by the presence of DNase protected segments. One of the protected 
regions, at pacL, is surrounded by poly-A sequences separated by approximately 10 bp that may 
induce bending upon binding to G1P (19). 
Based on the observations that G1P is an oligomer in solution with several HTH motifs at the 
NTDs and that G1P binds to both the encapsidated and non-encapsidated ends, pacR and pacL, 
respectively, a model was proposed to explain how the SPP1 ST interacts with DNA and how it 
makes DNA accessible to the LT (G2P) (Figure 15b). Briefly, two different G1P oligomers bind 
separately to the pacL and pacR sites. Protein-protein interactions between the oligomers bring 
the two sites together and at the same time the pacC site is exposed so G2P can bind to G1P and 
make a cut in the DNA producing a free end. In Figure 15b, G2P monomers are represented by 
small spheres that interact with DNA and with G1P, but it is unknown whether the G2P contacts 
the same or different G1P molecule (19). 
This model, proposed in 1995, was the first wrap-around model published and to date some of 
its key points are largely accepted by the community. 
Besides SPP1, other packaging initiation regions have been identified in phages λ (site cosB, 
120 bp long) (80), P1 (pac site, 161 bp long) (81) and P22 (pac site, 120bp long) (82). 
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Figure 15. Model for ST complex with LT and pac DNA 
(a) Scheme of the pac site DNA of the SPP1 phage (not to scale). The length and position of each 
fragment in the genome is indicated. Box b, where G2P is expected to bind and cut is shown. Distances 
between the end and start of pacL-pacC and pacL-pacR are indicated by double-headed arrows. The 
centre-to-centre distance of pacL-pacR is also shown. (b) Model of the G1P nucleoprotein complex with 
the pac site DNA. Two different G1P assemblies recognise the pacL and pacR sites, while G2P 
establishes contact with G1P and recognises box B. The site of cut is pointed out with a black arrowhead. 
The direction of packaging is signalled by the horizontal arrow. Figure adapted from Chai et al, 1995 
(19). 
43 
 
 
1.11 Objectives 
There is enough evidence to conclude that dsDNA phages make a huge impact on the biosphere 
of our planet. Evolutionary related animal viruses, such as members of the herpes family of 
viruses, lead to several health problems resulting in huge economic costs (42,44). The dsDNA 
bacteriophages are the focus of extensive research for several reasons. First, they serve as 
excellent model systems for understanding how similar animal viruses function (9). Secondly, 
their hosts include bacteria of industrial or clinical relevance, such as Lactococcus lactis (71), a 
fermentative organism in the dairy industry or Escherichia coli and Salmonella, both foodborne 
pathogenic bacteria (83,84). Therefore we can benefit from learning how bacterial viruses 
assemble and how they function. 
In dsDNA phages, the icosahedral capsid is the container that viruses use to store and protect 
their nucleic acid molecule. At one of the twelve vertexes, the portal protein is embedded to 
provide the gate of entry for DNA and the surface for the DNA-terminase complex docking (9). 
The aim of this thesis is to elucidate X-ray structures of the capsid protein G13P from 
mesophilic phage SPP1, and that of the ST from thermophilic phage G20C.  
The X-ray structure of the SPP1 capsid protein could then be fitted into the available Cryo-EM 
maps (41) to reconstruct the complete capsid. Fitting the X-ray structure of the portal protein 
will make possible to study the nature of the capsid-portal interaction. One long term goal of 
this project is to introduce mutations in G13P to disrupt interactions between other G13P 
protomers to leave the portal surrounded by a single layer of capsid. These complexes could 
potentially be attached to any surface to deliver DNA after the assembly of the molecular motor. 
The possible uses of these devices include gene therapy or other areas of biotechnology. The 
capsid structure will allow the understanding of the mechanism SPP1 uses to stabilise its capsid 
during maturation.  A comparison with other capsid proteins would be useful for elucidating 
segments that remain most conserved across evolution. 
Solving the structure for the G20C ST will provide further knowledge about the oligomerisation 
state, domain organisation and characteristic features. One additional aim is to address the ST-
DNA interaction by investigating binding activity towards viral and non-viral DNA. Several 
constructs will be tested to determine which domain(s) are responsible for DNA-binding. A 
comparison with available ST X-ray structures will be carried out to identify common features. 
Finally, the X-ray structure and experimental data will be used to propose a model for a 
functional complex of the G20C ST with DNA. 
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Chapter 2 
2. Materials and methods 
The chapter two of this thesis concisely describes how the constructs were handled during 
cloning, purification, crystallisation and biochemical investigation. Each subsection offers a 
general description of the protocol, and the additional details about every construct are 
presented in the appendices or results sections. Those approaches that were developed 
specifically for this project are described in the results section 3.4 (production of engineered 
proteins) and chapter 9 (cloning of DNA for probing DNA-binding activity). 
 
2.1 Cloning 
The full-length genes G13P, coding for the SPP1 capsid protein, and the one coding for the 
putative ST in G20C, were amplified from the genomic DNA of SPP1 and G20C phages by 
PCR. The pairs of primers for each construct used in this project are listed in appendix 1. Inserts 
were then cloned into vector pET28a (Novagen) by ligation with T4 ligase according to 
manufacturer instructions (New England BioLabs) (Figure 17, section 2.3). The cells were 
transformed (Section 2.2) with the recombinant DNA and incubated overnight at 37°C. The 
following morning, the presence of the insert in the vector was tested by colony PCR using the 
pair of primers specific to every construct but using the colony as source of DNA. From a single 
positive colony, overnight cultures were prepared. Plasmid DNA was extracted according to 
manufacturer’s instructions from the cell pellet. Purified recombinant DNA was sent for 
sequencing (GATC-BIOTECH, Germany) to confirm the sequence of the vector insert. The 
positive plasmids were used to transform cells for overexpression of the protein of interest 
(POI).  
Details about the types of modifications that were made to the wild type proteins, in addition to 
the affinity purification tag and vector used are listed on appendix 1.  
In general, all the inserts were produced by one amplification reaction, with the exception of the 
G13P-Anti-TRAP constructs, for which two reactions were set up in order to clone the 
engineered proteins. A detailed explanation about the design and production of both constructs 
is given in the results section 3.4. 
Two types of cloning were used in subsequent constructs. The first one consisted in using T4 
ligase to create phosphodiester bonds between the insert and vector, both with complementary 
sticky ends generated by endonucleases in specific restriction sites (Figure 16). The second 
approach takes advantage of the DNA-recombination activity of the In-Fusion® enzyme (85). 
Briefly, both insert and vector are amplified so they have 15-bp complementary regions at the 5’ 
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and 3’ ends. During the incubation period, the poxvirus DNA polymerase uses its 3’-5’ 
exonuclease activity to generate sticky ends at the provided substrates by removing nucleotides 
at the 3’ end, producing complementary ends that can then anneal. Nicks present within the 
recombinant DNA are repaired by bacterial enzymes following transfection (86).  
 
 
Figure 16. Production of recombinant DNA 
Schematic representation of approaches used for production of large amounts of recombinant DNA. 
 
Table 3. Settings of PCR, ligation and In-fusion reactions 
PCR reaction Ligation In-fusion 
 
 
 
Component 
 
0.2-1 μM  Primers A /B  
0.4 μL      10 mM dNTPs 
  x ng        DNA template 
4 μL         5X Phusion HF buffer    
0.4 μL     Phusion DNA polymerase 
               H2O 
20 μL  20 μL 
- Incubation at RT during 2h 
 
Component 
 
50 ng     Vector DNA (4 kb) 
37.5 ng  Insert DNA (1 kb) 
2 μL     10X T4 DNA Ligase         
              Buffer 
              H2O 
1 μL T4 DNA Ligase 
    10 μL 
- Incubation at 50°C during 15  
   min 
Component 
 
50-100 ng  Vector DNA (5.5  
                   kb) 
50-100 ng  Insert DNA (1 kb) 
2 μL 5X     In-Fusion HD  
                   Enzyme Premix 
                   H2O 
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PCR program for G13P_FL_D194W 
98 °C 2 min 
98 °C 15 s 
48 °C 20 s 
72 °C 3 min 
72 °C 5 min 
2.2 Cell transformation 
Several E. coli modified strains were used to produce multiple copies of plasmids or 
recombinant proteins. The type of competent cell was selected according to the experimental 
requirements; one particular example will be described below. The manufacturer’s instructions 
for every cell strain were followed. Most of the cells used in this study required 30 minutes of 
incubation on ice with the DNA (5-10 ng) after cell thawing. Heat shock at 42 °C during 45 s-1 
min followed. The cells were again incubated on ice for 2 min followed by addition of ~ 200 µL 
of Luria-Bertani medium (LB). After 1 h incubation at 37 °C in the shaker at 180 rpm, the 
samples were plated on LB agar plates with antibiotics suitable for selecting for the cells 
harbouring the desired plasmid, and incubated overnight at 37 °C. B834 cells were used to 
produce native protein when the protein was expressed in a higher amount than when using 
other cells. The type of cell used in the solubility screen is mentioned in the legend of the 
figures. 
BL21 Star
TM
 DE3 cells were used to express G13P-AT full length constructs because these cells 
carry a truncated version of the RNase E enzyme gen (rne) of which the C-terminal portion is 
involved in mRNA degradation. The truncated gene only lacks the C-terminal portion of the 
RNase E enzyme but keeps the N-terminal portion that is involved in rRNA processing and cell 
growth, making the expressed mRNAs more stable (87).  
The pLysS plasmid was incorporated in Rossetta 2 or BL21 cells used for this study as is 
compatible with the pET system. The pLysS plasmid encodes the T7 lysozyme to lower the 
basal expression of the gene of interest under the control of the T7 promoter since it inhibits the 
T7 RNA polymerase (88,89). 
2.3 Cell growth and protein overexpression: pET system 
Cultures (Luria-Bertani medium) started from single colonies were grown to optical density of 
0.6 (O.D 600 nm) at 37 °C. When cultures were ready, protein expression was induced with 1 mM 
Isopropyl β-D-1-thiogalactopyranosid (IPTG).  
All of the recombinant DNAs used the pET expression system to produce large quantities of 
POI.  
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The pET system is a bacterial plasmid that contains the gene for the lac repressor protein (lacI), 
the T7 promoter, specific to T7 RNA polymerase, a lac operator to block transcription, origins 
of replication f1 and genes for antibiotic resistance (Figure 17). The gene that codes for the POI 
is situated at the poly-linker region that includes several restriction sites, the region coding for 
the tag is situated at the 5’ end of the poly-linker region. Moreover, the host’s genome is 
modified to incorporate the T7 RNA polymerase and the lac promoter and operator. 
The addition of IPTG, an analogue of lactose, displaces the lac repressor from the lac operators 
both on the pET plasmid and host’s chromosome so the T7 RNA polymerase is expressed to 
then express the gene that encodes the POI. 
 
Figure 17. pET28a (+) vector 
(a) Features of the pET system. (b) The squared area, part of the poly-linker is magnified for detail. Only 
some of the restriction sites used in this project from the polylinker area are shown. 
 
For solubility screens, the induction time was for 3 h at 37 °C to an optical density at 600 nm 
(OD600) of ~0.6 or overnight at 16 °C. 1 mL culture aliquots were prepared and centrifuged to 
keep only the pellet.  
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For large scale production, 1:100 dilutions were prepared with 7.5 mL of overnight culture (37 
°C) and 750 mL of autoclaved LB medium. The baffled flasks were grown up to 0.6-0.8 O.D600 
at 37 °C, 180 rpm. Protein overexpression was induced with addition of 1 mM IPTG at the 
temperature where the higher solubility was observed in the solubility screens. 
2.4 Production of Seleno-Methionine (Se-Met) proteins 
An overnight culture of B834 cells expressing the POI in LB medium was used to inoculate 500 
mL of 40 μg mL-1 Se-Met medium [including 1μg mL-1 vitamins, 40 μg mL-1 amino acids and 
0.4% (w/v) glucose, 2 mM MgS04, 25 μg mL
-1
 and 2X M9 salts] and incubated at 37°C until 
O.D0600 nm ~ 0.8 1 mM IPTG was added to induce protein overexpression at 16 °C overnight.  
B834 cells are methionine auxotrophs, which means they cannot synthesise their own 
methionine, being forced to incorporate the Se-Met supplied from the medium. Tryptone is 
absent in the medium as it contains sulphur-based Met. 
2.5 Solubility tests in SDS-PAGE 
1 mL aliquots of cultured bacteria were centrifuged after protein induction to produce pellets 
that were resuspended in 200 μL of buffer (Figure 18). The resuspended bacteria were sonicated 
to obtain the total lysate sample (soluble and insoluble). A sample of 12 μL mixed with 4X 
loading dye was loaded on the SDS-PAGE gel. Lysates were clarified by centrifugation at 
13,300 rpm for 1 min at room temperature (RT). A further 12 μL of the supernatant was loaded 
in the gel to estimate the fraction of protein remaining in solution, which is the soluble protein. 
The same procedure was followed with aliquots taken immediately before induction. 
 
Figure 18. Solubility screen 
 
12 or 15 % polyacrylamide gels (stock: 30 % (w/v) polyacrylamide, 0.8 % (w/v) Bis-
acrylamide, ratio 37.5:1) were prepared and run in 25 mM Tris-HCl, 192 mM glycine, 0.1 % 
SDS for 50 min at 200 V. The gel was stained with Coomassie blue.  
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2.6 His-Tag stain 
The InVision™ His-tag in-gel stain (Life technologies) was used to specifically stain His-tagged 
proteins. The protocol described by the manufacturer consists in fixing the gel (carefully washed 
with ultrapure water immediately after the run,) during 1 hour in 100 mL of 40 % (v/v) ethanol 
and 10 % (v/v) acetic acid, followed by 10 min washes with ultrapure water. The gel was 
incubated with the InVision™ His-tag In-gel stain for 1 hour to later be washed 2 times with 20 
mM NaH2PO4 pH 7.8. The gel was visualised at 560-590 nm immediately after. 
2.7 Nickel-affinity chromatography 
Nickel-affinity chromatography (NAC) was used to purify most of the protein constructs in this 
study. By adding a poly-Histidine tag (poly-(His)6 or His-tag) to the POI, it was possible to 
separate it from the bacterial cell debris and endogenous E.coli proteins as the poly-His segment 
binds to nickel ions, which are chelated by the immobilised group from the cross-linked agarose 
beads (Sepharose
TM
) of the His-Trap
TM
 column (GE healthcare) (Figure 19a). Subsection 2.7 is 
based on protocols described in references (90,91). 
Prior to the chromatography, the crude lysate was prepared by resuspending the pelleted 
bacteria in buffer containing  25 mM Tris pH 7.5, 200 mM NaCl, 20 mM Imidazole, 100 μg 
mL
-1
 lysozyme, 0.7 μg mL-1 pepstatin A, 0.5 μg mL-1 leupeptin and 100 mM 4-(2-Aminoethyl)-
benzenesulfonyl fluoride hydrochloride (AEBSF). To see the buffers used for every construct 
see appendix 2. The sonicated solution was spun down at 15,000-17,500 rpm to produce a clear 
supernatant. 
The clear supernatant was loaded onto a His-trap high performance column (His-trap HP, bead 
size: 30 μm) attached to the ÄKTA purifier (GE Healthcare). The His-tagged protein was eluted 
over a gradient mixture of loading buffer with buffer containing 0.5 M free imidazole that has 
higher affinity towards the Ni
+2
 in the matrix than the His residues and hence disrupts the His-
Ni
+2
 coordination bonds (Figure 19a). 
Samples from the lysate, supernatant and fractions were loaded onto 12 % or 15 % (w/v) 
polyacrylamide gels (37.5:1) to estimate the presence and purity of the POI. Those fractions that 
contained the POI were pooled together to undergo thrombin digestion followed by size-
exclusion chromatography (SEC) 
When the His-tag was cleaved by thrombin protease (BD Biosciences), digestion was carried 
out at the same time that the sample was dialysed against the binding buffer (no imidazole) 
using 1 unit of thrombin to digest 1 mg of protein overnight at 4 ºC. A second NAC was 
performed to separate the cleaved protein from non-cleaved. The cleaved protein was further 
purified by SEC.   
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The His-tag was replaced by the glutathione S-Transferase-tag (GST) in three constructs 
because of its bigger size than the His-tag and its propensity to form dimers that in theory could 
help stop G13P from aggregating. Beads with immobilised glutathione were used to bind the 
POI. Elution was achieved by adding reduced glutathione to the buffer. GST fusion proteins 
featured a 3C protease cleavage site between GST and the G13P construct to facilitate further 
removal.  
One of the G13P-Anti-TRAP (G13P) constructs was cloned into the H-MBP vector that encodes 
both the His-tag and the maltose-binding protein (MBP) that is usually included because it can 
increase the solubility of overexpressed proteins in bacteria. It is then possible to purify MBP 
fusion proteins by chromatography on cross-linked amylose and then elute with 10 mM 
amylose, however it was decided to make use of the His-tag and purify the construct by NAC 
There was also some variation regarding the type of columns used to purify the constructs. His-
trap fast flow crude columns (His-trap FF) (GE Healthcare) were chosen when constructs 
precipitated after centrifugation at high speed. The bead size in His-trap FF crude columns is ~ 
90μm, making it possible to load clear lysate at relatively fast flow rates without blocking the 
column. The principles of binding and elution from the Ni-beads are the same as for His-trap 
HP columns. 
The Hi-trap Q fast flow columns (or only FF Q, bead size: 45-165 μm) are anion exchange 
columns that contain quaternary ammonium (-N
+
(CH3)3) as the anion exchanger (GE 
Healthcare) (Figure 19c). This column was used to isolate the untagged G13P constructs. The 
bacterial pellet was resuspended in binding buffer (low NaCl concentration), sonicated, 
centrifuged and loaded onto the column. The POI was then eluted with buffer containing high 
concentration of anion (Cl
-1
). 
2.8 Size-exclusion chromatography 
Samples from NAC were concentrated and filtered through a 0.45 μm filter to remove big 
aggregates and rubbish from the sample that could block the SEC column filter. 500 μL or 5 mL 
were loaded manually in appropriate loops onto Superdex
TM
 200 10/30 or Hi load 16/60 
columns (GE Healthcare), respectively. The buffers used for all the constructs are listed in 
appendix 2. When no S200 column was available, S75 16/60 columns were used. 
The three type of columns listed contain a matrix of cross-linked agarose and dextran with 
particles of mean size of 34 μm that contain pores in their surface. As the sample goes through 
the column, smaller components will be delayed by passage through the pores while bigger 
particles will elute faster as they are unable to insert into the pores and instead pass through the 
void volume between the particles (Figure 19b). 
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Figure 19. Protein purification techniques 
(a) Nickel–affinity chromatography. One coordination bond between a His-tagged protein and the 
nitriloacetic acid (NTA) resin is shown. The Ni
+2
 atom is highlighted in cyan. Adapted from (90) (b) Size-
exclusion chromatography. The separation of three protein molecules in a SEC matrix is illustrated. (c) 
Anion exchange chromatography. The matrix from a Q column binds to negatively charged molecules 
which are eluted with Cl
-
. Protein or matrix components are not to scale. Figures b,c adapted from (92). 
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Those particles that are too big to fit into the bead pores will elute at the early stages of the run 
in the void volume. S200 and S75 columns can resolve particles that range in size from 3-10
3
-
7x10
4
 and 1x10
4
-6x10
5
 (Mr), respectively. The manufacturer’s instructions where followed to 
complete the protein separation.  
2.9 Anion exchange Chromatography  
Anion exchange chromatography (AEC) was included during the optimisation of the 
purification process of untagged G13P double mutants and during the purification of G20C ST. 
Buffer with low NaCl concentration was used to resuspend bacterial pellets and a clear 
supernatant was obtained as described above. The supernatant was loaded onto a Mono Q 
column 5/50 (GE Healthcare) that is packed with polystyrene/divinyl benzene beads that have 
immobilised quaternary ammonium as the anion exchanger. The -N+(CH3)3 in the beads adsorb 
molecules with opposite charge. As the counter-anion Cl
-1
 is added to higher concentrations, the 
POI is desorbed from the matrix according to its charge (Figure 19c). 
2.10 On-column refolding  
Fast expression of recombinant protein often leads to the formation of insoluble aggregates 
called inclusion bodies. Even though the inclusion bodies are formed by insoluble protein they 
have the advantage of producing the protein in high yield, this protein is protected from 
proteolysis and can be solubilized into folded active species (93).  
The on-column refolding method used to purify one His-tagged protein from this study 
consisted of refolding the denatured protein while it was bound to the Ni-beads. One important 
aspect of this protocol is that it allows lowering of the denaturing agent concentration at a rate 
that prevents aggregation but allows folding. It also avoids exposure of the protein to 
intermediate denaturant agent concentrations for a long time period, like in dialysis, in which 
the POI is prone to aggregation since it is neither entirely folded nor denatured (93). 
The pelleted bacteria were resuspended in cold denaturing solution (Table 4) and incubated on 
ice for 45 min. Quick sonication of the sample to disrupt DNA was followed by manual loading 
onto a His-Trap FF (GE Healthcare) column previously equilibrated with denaturing solution. 
Once the column was reconnected to the ÄKTA purifier, denaturing solution 2 was flowed over 
to remove any non-specifically bound protein. The denaturing agent was washed off with 
solution III that contained the detergent triton X-100 to prevent aggregation and 0.5 M NaCl to 
remove contaminating protein molecules bound to the target protein or column. β-cyclodextrin 
was included in solution IV to remove the triton X-100 from the protein-detergent complex and 
to promote folding. Before detaching the protein with elution buffer, solution V was flowed 
through the column to wash β-cyclodextrin off.   
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Table 4. On-column refolding solutions 
Solution Components: 
I.  Denaturing solution 6 M Guanidine hydrochloride 
50 mM Tris pH 7.5 
10 mM β-Mercaptoethanol 
II.  Denaturing solution 2 (2 CV) Solution I + 20 mM Imidazole 
III. Detergent buffer (4 CV) 50 mM Tris pH 7.5, 0.5 M NaCl, 0.1 % 
Triton X-100 
IV. Buffer for detergent removal (15 
CV) 
50 mM Tris pH 7.5, 0.1 M NaCl, 5 mM β-
Cyclodextrin 
V.  Basic Buffer (5 CV) 50 mM Tris pH 7.5, 0.1 M NaCl 
VI. Elution Buffer (20-25 CV) 50 mM Tris pH 7.5, 0.1 M NaCl, 0.5 M 
Imidazole 
 
2.11 Pull-down assays 
Pull-down assays were used to determine where the spontaneous truncation in G13P-AT 
engineered proteins was taking place. 30 µL of nickel-beads (from His-TRAP columns) were 
washed two times with 25 mM Tris pH 7.5, 250 mM NaCl to remove the storage solution. 100 
µL of soluble fraction from the BL21 Star cultures (section 2.2) were added to the beads. The 
mix was incubated at room temperature with continuous shaking for 15 min. 12 µL were kept to 
load later on SDS-PAGE as the total sample. The mix was centrifuged at 13,300 rpm for 1 min, 
and the supernatant was discarded. The beads were washed two times with buffer. 12 µL of 
supernatant (SND) and beads were loaded onto SDS-PAGE. Finally, the bound protein was 
eluted with the binding buffer plus 0.5 M imidazole. Two dilutions of the eluted protein were 
loaded. 
 
2.12 Size Exclusion Chromatography coupled with Multi-Angle 
Laser Light Scattering (SEC-MALLS) 
SEC-MALLS is a technique used to measure molecular weight based on how molecules scatter 
laser light. SEC-MALLS was used to estimate the molecular weight of G13P or the oligomeric 
state of G20C ST. Scattering of light is dependent of the POI concentration, refractive index, 
molecular weight and scattering angle. 
His-tagged or non-tagged samples were diluted to a fixed concentration in 20 mM Tris pH 7.5, 
250 mM NaCl, and loaded onto a BioSep SEC-s3000 gel filtration column (Phenomenex) which 
was equilibrated with 20 mM Tris pH 7.5, 250 mM NaCl. Size-exclusion chromatography was 
carried out on a Shimadzu HPLC system with flow rate of 0.5 mL/min. The elution was 
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monitored at 280 nm by a SPD20A UV/Vis detector. Light scattering data were recorded by a 
Dawn HELEOS-II 18-angle light scattering detector and the concentration of the eluting protein 
was measured by an in-line Optilab rEX refractive index monitor (Wyatt Technology). Data 
were analysed using the ASTRA V software package (Wyatt Technology). 
 
2.13 Protein crystallisation experiments  
Only when protein molecules precipitate in an ordered manner can crystals form. Variables 
influencing crystallisation include the nature of the protein, the nature of the precipitating agent, 
the protein or crystallising agent concentrations, pH, temperature, time, etc. The dynamic 
representation of the interaction of several variables and resulting solubility with respect to the 
crystallisation outcome is known as phase diagram (Figure 20a).  
The phase diagram is organised into several zones that describe how the phase of the protein 
behaves as the variables change, for example, protein and crystallising agent concentrations 
(Figure 20a). In the undersaturated zone the protein will remain in liquid solution. When a 
crystallisation experiment is set up it is expected that the protein concentration will increase 
until the labile zone is reached, which is where the formation of the nuclei occurs. Protein 
molecules will aggregate around the nuclei so the protein concentration will decrease until 
nucleation will no longer occur and a new zone, the metastable zone, will be reached. In this 
zone, the crystal growth is supported only while the protein concentration is high enough. 
Liquid-liquid phase separation, visible as protein rich droplets under the microscope, happens at 
the metastable zone, where the protein concentration is high. At some point, the crystal will get 
to the saturation zone, indicated by the solubility curve, where the crystals, if present, will be in 
equilibrium with the solution. The crystal would dissolve if the solution changes to the 
undersaturated zone. In cases where the protein concentration is too high to sustain ordered 
aggregation, precipitates will form. The supersaturated precipitation zone is characterised by the 
formation of microcrystalline or amorphous precipitates, with the former being able to 
redissolve, keep their native conformation and sometimes act as good seeds for crystallisation.  
2.13.1 Sitting drop vapour diffusion  
The POIs were utilised to set up crystallisation trays using commercial screens: INDEX 
(Hampton Research), PACT (QIAGEN), MPD (QIAGEN), ammonium sulphate screen 
(QIAGEN), MORPHEUS (Molecular Dimensions) and Clear Strategy Screens I and II (CSS 
1&2). All were selected as initial screens because of the variety of salts, precipitants, pH value 
and additives they incorporate in order to cover an extremely diverse variety of chemical 
conditions. Sitting drop vapour diffusion experiments were set up in 96-well MRC 
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crystallisation plates with a Mosquito nanolitre pipetting robot (TTP lab-tech). The program 
carried the instructions to aliquot 54 μL of each screen solution into each well and then to 
aliquot 150 and 300 nL of sample to the top and bottom drop, respectively plus 150 nL of 
reservoir solution to each drop. 
In this kind of experiment, the protein-reservoir solution drop is placed in vapour equilibrium 
with the reservoir. Since the concentration of reagents is lower in the drop, water will diffuse 
from the drop to the reservoir, producing an increase in the protein and reagent concentrations, a 
fact that could take the drop solution into the labile zone for crystal nucleation (Figure 20b). The 
trays were stored in a temperature-controlled room at 18°C unless otherwise stated. 
 
 
 Figure 20. Protein crystallisation experiments 
(a) Phase diagram describing the crystal input as the concentrations of protein and crystallising 
agent increase. Adapted from Luft, et al, 2011 (94) .(b), (c) Sitting and hanging drop vapour 
diffusion settings. Adapted from reference (95). 
 
2.13.2 Manual optimisation: hanging drop vapour diffusion experiments 
When hits (formation of crystalline material) were observed in the 96-well trays, the original 
conditions were occasionally manually reproduced and optimised, varying the protein and 
reagent concentrations or additives. Optimisation was carried out with hanging drops 
equilibrated with 500 μL of reservoir in previously grease-sealed 24-well trays. Wells were 
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covered with siliconised glass coverslips and incubated at room temperature. Usually 1 μL of 
protein was mixed with 1 μL of reservoir, when indicated, 0.5 μL of seed stock were added.  
The principle of the hanging drop and sitting drop are the same, with differences lying in the 
speed of setup or easiness to fish the crystals (Figure 20c), and theoretical maximum dimensions 
of crystals grown due to the size of the drop and equilibration times. 
  
2.13.3 Seeding 
Seeding is a technique where already formed crystals are used as nuclei that are introduced into 
new reservoir-drop condition in a lower level of supersaturation to nucleate crystal formation 
(96). 
Two types of seeding were used: macroseeding and microseeding. Macroseeding implicated the 
transfer of macro seeds or crystal (5-50 µm in diameter) to the new drop. For this type of 
seeding, the seed stock preparation consisted of mixing drops that contained crystals (under 
similar conditions) and then streaking drops prepared as described for manual optimisation with 
a needle previously soaked in the seed stock.  
The preparation of the seed stock was more elaborate for the microseeding. Crystals from single 
drops were collected separately and then resuspended in 50 - 100 µL of ice-cold stabilising 
solution placed in a seed bead (Hampton research). The conditions on the stabilising solution 
were essentially the same as in the original reservoir solution but either the concentration of the 
main precipitant was slightly increased or glycerol was added to prevent the crystals from 
dissolving. The seed bead was vortexed for 1 min and then centrifuged at 14, 000 rpm at 4°C for 
1 min. The vortexing and centrifugation were repeated once. To use the seed stock, a final 
vortexing was implemented. The seed stock was added directly to the optimisation drop (0.5 
µL) or aliquot by the Mosquito robot into each of the 96 conditions from the commercial 
screens (50 nL). 
2.13.4 Crystal testing 
The fished crystals were flash-cooled in liquid nitrogen to be tested in-house using a MSC-
RUH3R X-ray generator (Rigaku) with rotating anode and MAR345 detector (Marresearch). 
When the diffraction was about 3.5 Å resolution, the crystals were kept in liquid nitrogen and 
sent to the Diamond Light Source, UK, facility to collect data at the I04 beamline. When some 
of the crystals were fished out, cryo-protectant solution was used to keep the crystal in optimal 
condition. 
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2.14 Bioinformatics, molecular graphics and modelling software 
The following online software was utilised to investigate SPP1’s G13P or G20C ST’s sequences 
or to create figures of proteins relevant to this thesis from the published PDB files published in 
the RCSB PDB (97). 
2.14.1 Bioinformatics 
• The Position-Specific iterated Basic Local Alignment Search Tool (PSI-BLAST) was 
used to align sequences of capsid proteins with published X-RAY structure to G13P (98). 
• The secondary structure of G13P was predicted with the JPred server (99). 
• Multiple sequence alignment and multiple secondary structure prediction were carried 
out using PRALINE using DSSP (100) and PSIPRED (101). 
• Nucleotide sequences were aligned using ClustalW (102). 
• Disorder prediction for G13P was done with DisEMBLTM (103). 
 
2.14.2 Molecular graphics 
• All molecular representations like ribbon diagrams or electrostatic surface 
representation were created using CCP4mg (18).  
 
2.14.3 Analysis of X-ray crystal structures 
• The protein topology was sketched using the Pro-origami server (104). 
• PDBePISA was used to identify H-bonds and buried/exposed surface (105). 
 
2.14.4 Modelling  
• PDBefold was used to identify crystallised protein-DNA complexes that could be 
superposed to G20C ST. Scores will be explained in section 8.4 (106). 
 
2.15 Elucidation of X-ray crystal structures 
The following subsection provides the reader with a list of software used to solve X-ray 
structures. All the references are included for more details about the calculations and details of 
each program. 
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2.15.1 Data processing  
The set of diffraction patterns collected for crystals of native or Se-Met SPP1 G13P or G20C ST 
were processed to deduce crystal symmetry and cell dimensions, and to produce integrated 
intensities of the reflections present in every diffraction image using the program XDS (X-Ray 
Detector Software) (107) .  
The previously integrated reflections were merged by the program Aimless (108,109). Merging 
of reflections consists in averaging reflections equivalent by symmetry and of similar intensity.  
 
2.15.2 Phasing by single anomalous diffraction (SAD) 
The SHELXC and SHELXD (110) programs provided the location of the Selenium atoms 
present in SPP1 G13P and G20C ST.  
The phases of the data set were calculated using the software Phaser SAD (111,112) providing 
the integrated intensities, the substructure from SHELXD and the amino acid sequence. To 
investigate the structure of the crystallised G20C ST and SPP1 G13P double mutant in the 
lower-resolution native data sets, molecular replacement (MR) was carried out. The Phaser MR 
option was used to determine the phases inputting the refined Se-Met protein models of both 
proteins and the processed native data sets.  
 
2.15.3 Density modification and automated model building 
The program Parrot (113) was run to perform density modification on the phases determined by 
Phaser SAD in order to obtain an electron-density map to submit for automated model-building.  
The modified electron-density map, the sequence of G13P and the coordinates of the heavy 
atoms were fed to the program Buccaneer (114) to perform automatic model building.  
 
2.15.4 Refinement and validation 
The refinement, which is the process to improve the agreement of the model and the X-ray data 
was performed using the REFMAC software (115).  
Coot (116) was used for validation of the model. 
Additional miscellaneous data processing was carried out using diverse programs clustered in 
the CCP4 interface (117). 
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2.16 DNA-binding tests using electrophoretic mobility shift assays 
(EMSA) 
To test the capability of the G20C ST WT to bind DNA, the DNA concentration, either 
G20C_F1 or pUC18 (Chapter 9), was adjusted to 0.015 µM in a 20 µL total volume containing 
25 mM Tris pH 7.5, 100 mM NaCl, 20 mM Mg
+2
 and 1 mM ATP (a master mix was prepared to 
transfer the same volume to all the reaction tubes). The ST WT concentration was adjusted to 
3.75, 7, 15 and 30 µM to have molar ratios of 9-mers to 1 kbp DNA fragment of 250:1, 500:1, 
1000:1 and 2000:1, respectively. DNA controls included no protein to test the migration of 
DNA alone. Reactions were incubated at 37°C during 45 min and then loaded on 0.75 % (w/v) 
agarose gel. The gel was run at 60 V, 45 mA at room temperature for 1 h 20 min. SYBR  safe
®
 
was added during the preparation of the agarose gels.  
To test the capability of the ΔC, ΔN and DBD G20C constructs to bind dsDNA, the 
concentration of ΔC, ΔN constructs was adjusted to 30 µM while the concentration of DBD was 
270 µM. DNA concentration was kept at 0.015 µM for all the constructs so the final construct to 
1 kbp DNA fragment molar ratio was 2,000:1 for ΔC and ΔN, and 18,000:1 for the DBD. 
Solution conditions were the same as stated above, as was the procedure followed to run the 
agarose gel. 
 
Figure 21: DNA-binding experiment settings 
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Chapter 3 
3. Production of SPP1 capsid protein crystals 
 
The current chapter summarises approaches carried out to produce homogeneous SPP1 capsid 
protein to use in crystallisation experiments. The outcome of this investigation is arranged in 
subsections that describe the main results for the different types of modification that G13P 
underwent. Such modifications include truncations at the N- or C-termini, single and double 
point mutagenesis, and protein engineering by fusion. The information presented flows in a 
logical and chronological ordering. The design and purification of every modified construct are 
presented in the same subsection while the crystallisation work performed on every construct 
found to be suitable for crystallisation trials is summarised in section 3.5. Most of the 
experimental details are described in Chapter 2. Whenever appropriate, protocols and/or 
protocol modification are briefly described.  
3.1 Purification of G13P wild type 
The full length gene coding for G13P_WT was cloned into pET28a vector between the NdeI 
and XhoI restriction sites. The pET28a vector contains a Hexa-Histidine tag (His-tag) at the 5’ 
end of the NdeI restriction site, separated by a flexible linker that includes one thrombin-
cleavage site. Information about the cloning design for the WT protein and subsequent 
constructs can be found in appendix 1.  
The recombinant DNA was used to transform BL21 and Rossetta 2 pLysS cells. Overnight 
cultures of 5 mL medium were set up to perform a solubility screen from which it was observed 
that G13P_WT is expressed in a higher amount and in soluble form when induced in BL21 cells 
at 37 °C than in Rossetta 2 pLysS or at 16 ºC. Expression was scaled up to cultures of 750 mL 
medium to purify G13P_WT by NAC. 
 
3.1.1 Nickel Affinity Chromatography and Size exclusion chromatography  
The protocol for purification commenced with NAC and continued as described next. It was 
observed that the lysate had a cloudy aspect due to the presence of small granular white 
precipitate, indicating the formation of protein aggregates. Cell lysate containing G13P_WT, 
purified in 25 mM Tris pH 7.5, 150 mM NaCl using an imidazole gradient (Figure 22), eluted in 
four peaks which indicated four species with different affinity towards nickel ions. The peaks 
were analysed separately. SDS-PAGE confirmed that the SPP1 capsid protein was present in all 
peaks and that the migrating size corresponded to the expected size, ~35 kDa.  
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Figure 22. Purification of G13P_WT 
(a) NAC profile. Peaks and fractions are numbered 1-4 according to the peak numbering. The yellow 
arrowhead points to G13P. The lysate, flow through (FT) and eluted fractions were loaded onto the SDS-
PAGE. (b) SEC for the four peaks from NAC. The elution volume of the main species is indicated. The 
gel in the inset represents fractions from SEC runs. (c) 2% Uranyl acetate stain for cryo-EM. The 
diameter of one structure is indicated by light blue numbers and a single capsid wall is indicated by a red 
star.  
 
The same volume from each peak was run through a S200 10/30 SEC column to further 
separate species in the samples by size. Even though protein concentration is different in the 
four samples, it is observed that G13P_WT elutes in the void volume of the column, which is 
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the volume confined to species that are too big to migrate through the gel pores due to its 
aggregated form. Peaks 1, 2, 3 and 4 eluted at ~7.5 mL. By running commercial SEC markers, it 
was estimated that monomeric species would be expected to have an elution volume of around 
14.4 mL, as an example, ovalbumin (44 kDa), eluted at 14.4 mL under the same conditions 
G13P_WT was run. 
To rule out the His-tag playing a role in the aggregation process, one thrombin-digested sample 
was analysed by SEC. The digested sample showed the same elution volume as the undigested 
samples, confirming that both samples form aggregates, and thus indicated that aggregation is 
probably mediated by G13P-G13P contacts.  
SEC fractions of non-digested sample were analysed by cryo-EM by collaborators at the 
Birkbeck College, London (Figure 22c). Deformed capsid-like structures of ~ 560 Å in diameter 
and ~ 35 Å-thick walls were visible. The capsid-like structures were shown to pack against each 
other, as had been observed with the overexpression of G13P_WT in the absence of scaffold 
protein G11P which also led to the formation of aberrant capsids (29).  
The discovery that the size of the capsid-like structure is smaller than that of the mature capsid 
(~610 Å (41)) determined by cryo-EM but the wall is thicker (~27 Å thick in the mature capsid) 
can be explained by the absence of G11P or G6P that when present, lead G13P to organise into 
a proper icosahedral shell. Also, the absence of the molecular motor to pack DNA leads to the 
immature versions of the capsid that do not undergo expansion when full with DNA. Thickness 
of the presented capsid-like structure is also bigger than that of the mature HK97 capsid (~18 Å) 
(39), supporting the idea that reorganisation of the capsid protein is needed to produce thinner 
but more stable walls.  
3.1.2 Solubility test 
To overcome the G13P_WT polymerisation property in pursuit of obtaining stable and soluble 
monomer, a more thorough solubility screen was carried out (Figure 23a). New overnight 
cultures were resuspended in buffers containing 50-500 mM NaCl and 50 mM of buffer (Na 
acetate pH 4, Tris pH 7.5 or Ches pH 10). Different additives like glycerol, sucrose or metals 
were also added. After sonication, total samples were taken to use as reference and the 
remaining solution was centrifuged at the start time (To) and incubated at RT during thirty 
minutes or two hours. After this time, samples that would make a new total sample were taken 
(2h) and the rest of the solution was spun down at 13.3 krpm to obtain the soluble fraction 
(S2h). Where indicated by a star (*), samples were spun down at 17.5 krpm, the same speed that 
is used to obtain a clear lysate for NAC.  
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Figure 23. Screening of conditions to disrupt aggregation  
(a) Solubility screen at pH 4 (top), 7.5 (centre) and 10 (bottom). The time (T0 or 2 h) at which total 
samples were taken is indicated at the top part of the lanes and the NaCl concentration or included 
additives are indicated at the bottom part. “S2h” and a star (*) denote the final soluble fractions after the 2 
h of incubation and after centrifugation at high speed (17.5 krpm), respectively. (b) SEC of thrombin-
digested and digested G13P _WT at varying pH and NaCl concentration. The elution volume of the main 
specie is indicated. 
64 
 
None of the conditions tried had a significant effect in stopping aggregation as can be seen in 
samples after centrifugation. For example, when pH 7.5 was used the amount of protein at To 
was reduced to about 50%, of the original amount in the three tested NaCl concentrations.  
After two hours, the same amount of protein remained in solution (2h), however, subsequent 
centrifugation decreased the amount of protein (S2h). When the sample in 150 mM NaCl was 
centrifuged at fast speed (17.5 krpm), most of the protein precipitated (Figure 23). 
In experiments including additives, samples were only incubated during 30 min but the 
behaviour observed is the same as explained above for samples with no additives.  
In the case of acidic pH, samples precipitated when SDS was added to the mix, forming solid 
aggregates that did not migrate through the polyacrylamide gel.  
3.1.3 Size exclusion chromatography with variable NaCl concentration 
To confirm whether changes in the pH or NaCl concentration had any effect in leading 
G13P_WT towards the formation of smaller or monomeric species more suitable for 
crystallisation, thrombin-digested samples from NAC were run onto a SEC column using 
conditions different to the originally tested (Figure 23b). The logic behind this screen is to find 
those conditions where solvent-protein contacts are preferred over protein-protein contacts. This 
approach demonstrated that the size of the aggregates does not vary upon change in pH or NaCl 
concentration as all the samples eluted at 7.5mL, corresponding to the void volume.  
 
3.2 Purification of truncated G13P 
3.2.1 Secondary structure prediction  
Considering that the WT protein was not suitable for crystallographic studies, truncations at the 
N- and C-termini were introduced based on the secondary structure and disorder predictions 
(Figure 24) in an attempt to produce more ordered monomers by removal of disordered regions. 
Often, short regions at both ends do not have a defined secondary structure and their flexibility 
prevents the whole protein from establishing regular contacts with other subunits to form a 
crystal. It is not unusual that removal of a few residues at either end results in more soluble or 
non-aggregating proteins. Ten truncated versions of G13P were designed (appendix 1) and 
cloned: only one construct lacked a C-terminal portion while the other nine lacked several 
lengths of the N-terminus. Moreover, three of these constructs were GST-tagged and the rest 
had an N-terminal His-tag, removable with thrombin protease.  
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Figure 24. Design of truncations in G13P_WT 
(a) Scheme of the secondary structure prediction by JPred (not to scale). α-helices, β-sheets and loops are 
represented by cylinders, thick arrows and a black line, respectively. Numbering is included. Positions 
where truncations where introduced are indicated by green arrowheads. The residue showed on top of 
each arrowhead is the first residue after the start methionine. (b) Disorder prediction was carried out using 
the DisEMBL server (103). The disorder probability is plotted versus the amino acid number. The blue 
line represents the propensity to form loops, the green line the disordered regions and the red line the 
floppy loops that have high temperature factors.  
 
3.2.2 Solubility test 
The designed constructs were cloned and expressed (see appendices 1-3) in two bacterial strains 
at 16 and 37 °C. The solubility tests showed that constructs expressed at 16 °C and 37 °C 
G13P_ΔC, ΔN15 His-tagged, ΔN15 GST-tagged, ΔN21 His-tagged, ΔN21 GST-tagged and 
ΔN27 were insoluble in both strains in spite of being expressed in high amount (Figure 25a). 
Only results from one strain, one temperature or a small number of buffers are shown. Unless 
otherwise mentioned, similar findings were observed in all conditions.   
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When the protein was soluble, variations in pH or NaCl concentration did not seem to make a 
difference since the amount of protein found in solution was similar between the samples. For 
construct G13P_ΔN10 it was observed that expression at 16 °C produced soluble protein in 
contrast to expression at 37 °C, where even though the POI was expressed, it was not soluble.  
The introduction of the GST-tag in constructs G13P_ΔN15 and ΔN21 did not improve 
solubility. The GST-tag was chosen due to its high solubility and large size that would impede 
G13P aggregation. One version of the G13P_WT with GST tag was cloned, expressed and 
purified, but it did not produce a high yield (not shown). G13P_ΔN6 exhibited high solubility in 
all the tested conditions. 
The truncated constructs were designed and expressed at different times, therefore the 
conditions tried varied based on experience with previously characterised constructs.  
 
3.2.3 Nickel Affinity Chromatography and Size exclusion chromatography  
The two truncated versions that were soluble were expressed on a large scale followed by NAC. 
It was observed in repeated experiments that centrifugation at high speed of the lysate of cells 
containing G13P_ΔN10 led to precipitation. New crude lysate was loaded onto a His-Trap FF 
crude column that allows loading crude lysate without further centrifugation. Using this 
approach made it possible to obtain enough G13P_ΔN10 to perform SEC to characterise its 
oligomeric state (Figure 25b). Both thrombin-digested and non-digested samples were analysed, 
demonstrating that G13P_ΔN10 still forms big aggregates that elute in the void volume.  
G13P_ΔN6 was purified by standard NAC, however its behaviour in SEC was the same as 
G13P_ΔN10 as it also eluted in the void volume.  
Only G13P_ΔC included truncation at the C-terminus and it was the first construct characterised 
after the WT. A thorough solubility screen that involved testing the conditions tried with the ΔN 
constructs was carried out. In addition, protein auto-induction was also included. After several 
efforts to make it soluble it was abandoned in favour of the ΔN constructs (Figure 25a). 
Truncating the G13P_WT protein proved not to be an effective approach to stop aggregation. 
Nevertheless, it established the extent to which the protein could be truncated. This information 
was useful when designing new modifications that will be described later in this chapter. 
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Figure 25. Production and purification of the G13P truncated constructs 
(a) Solubility screen of truncated constructs. Only results from BL21 cells induced at 16°C are shown. 
The pH and NaCl concentration are indicated at the top part of the gel. The gels are not to scale to each 
other, for that reason the protein markers are included in every gel. Φ corresponds to samples before 
protein induction. Total samples correspond to the sonicated sample after induction and the rest of the 
lanes to the soluble fractions. (b) SEC profile of G13P_ΔN6 and G13P_ΔN10. The elution volume is 
indicated at the top of the peaks.  
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3.3 Design and purification of single and double mutants 
3.3.1 Design of single mutants 
From section 1.5.1 it is evident that in spite of the low sequence homology between the known 
capsid proteins from dsDNA bacteriophages, they all have the HK97-fold. Position-specific 
iterated Basic Local Alignment Search Tool (PSI-BLAST) was used to find proteins with 
published structure that would guide us in the design of mutations that stop interactions between 
G13P_WT (No cryo-EM model of G13P was available during the early years of this project). 
The mutations were expected to disrupt the formation of the capsid-like structures promoting 
the formation of hexamers, pentamers or monomers in isolation. The PSI-BLAST was used to 
produce a multiple protein sequence alignment with HK97 gp5 that showed 28 identical 
residues (11%) and 70 conservative substitutions (27%) introducing 10 gaps (Figure 26a). Once 
HK97 gp5 was predicted to have structural homology to G13P, the analysis of the PDB file was 
carried out using the PDBePISA server. 
3.3.2 PDBePISA Analysis 
Residues participating in inter-subunit contacts in the HK97 icosahedral asymmetric unit were 
identified with PDBePISA, which lists the H-bonds created at the different interfaces between 
the seven subunits (Figure 26). Table 5 and Table 6 list some of the residues that establish H-
bonds between subunits F & A, both from the hexamer, and between subunits G & F, with G 
being part of the pentamer (complete tables can be found in appendices 4 and 5).  
Six residues were selected in HK97 gp5 based on their likely significance in forming positive 
interactions with neighbouring subunits because of their positioning or H-bonding ability. The 
aligned residues in SPP1 G13P, based on PSI-BLAST were mutated to facilitate 
crystallographic studies (Figure 26). 
Residue N291 from HK97 gp5 is situated at the top of the A-domain and it creates a circular 
network of H-bonds with the same residue in the adjacent subunits in both pentamers and 
hexamers. In SPP1, the same position identified by the iterated BLAST sequence alignment is 
occupied by residue D194. This residue was mutated to tryptophan by single point mutagenesis, 
due to the tryptophan’s size and steric bulk that would be expected to disrupt the H-bonding 
network at the subunit-subunit interface, and at the same time keep A-domains of other subunits 
further from each other (Figure 26 and Figure 27).  
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Figure 26. Design of mutations in SPP1 G13P_WT 
(a) Alignment of SPP1 G13P and HK97 gp5 sequences obtained by iterated PSI-BLAST procedure. Key 
residues from HK97 gp5 that were identified to be important for inter-subunit contacts are shown in 
yellow boxes, while the corresponding residues, that were mutated in SPP1, are shown in blue boxes. 
Residues that covalently link HK97 capsid are shown in red boxes. Helix α3 sequence is squared in a 
cyan box. Identical residues and conservative substitutions are indicated by the one-letter code or plus 
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signs (+), respectively. (b) Location of residues in HK97, expected to be important in the SPP1 capsid 
(thick bond representation). Only subunit G was labelled.  
 
Table 5. H-bonds at subunits F-A subunits interface 
## Structure 1 Dist. 
[Å] 
Structure 2 
20 F:MET 119[SD] 3.3  A:THR 143[OG1]  
21 F:ILE 125[O] 3.5  A:GLU 153[N]  
22 F:MET 126[O] 3.1  A:ARG 372[NH2]  
23 F:THR 185[O] 2.7  A:VAL 163[N]  
24 F:ALA 187[O] 3.3  A:ASP 161[N]  
25 F:TRP 189[O] 2.9  A:SER 172[N]  
26 F:GLY 214[O] 3.5  A:ASN 158[ND2]  
27 F:ASN 291[O] 3.2  A:ASN 291[ND2]  
28 F:GLU 292[O] 3.1  A:ASN 291[N]  
29 F:PRO 300[O] 2.7  A:TRP 309[N]  
30 F:GLN 301[O] 2.7  A:GLY 310[N] 
The complete table is shown in appendix 4. Residues of interest are presented with grey background. 
Table 6. H-bonds at the F-G subunits interface 
 
 
 
 
 
 
The complete table is shown in appendix 5. Residues of interest are presented with grey background. 
 
Residue N158 from gp5 is located in the E-loop and it is H-bonded to residue G214 from helix 
α3 in the right-hand adjacent subunit (Figure 26 and Figure 27). Residue G64 from SPP1 aligns 
with N158 and it was substituted by another tryptophan, following the same logic that with 
D194W mutation. 
In HK97 gp5 pairs R194-D198 and F353-V354 are located at the P-loop and helix α2 (Figure 
27). R194 and D198 form H-bonds with E344 and R338 from the adjacent subunit of a 
neighbouring morphological unit. Mutations D100R, T104Y, A261W and L262W were 
introduced in G13P since these residues align with residues R194, D198, F353 and V354 in 
gp5, respectively. All mutations consist of bulky amino acids that would keep subunits from 
other morphological units distant. While mutation D194W is aimed to disrupt interactions at the 
## Structure 1 Dist. [Å] Structure 2 
3  G:ARG 338[NH2]   3.0  F:ASP 198[O]  
4  G:ARG 338[NH2]   3.1  F:ASP 199[OD1]  
5  G:ARG 365[NH1]   3.0  F:ASP 199[OD1]  
7  G:ARG 350[N]   3.8  F:GLU 348[O]  
8  G:SER 346[OG]   2.5  F:GLU 348[OE1]  
9  G:ARG 347[N]   3.5  F:GLU 348[OE1]  
10  G:GLU 348[N]   3.3  F:GLU 348[OE1]  
11  G:ARG 350[N]   3.2  F:ARG 350[O]  
12  G:ASP 173[OD2]   3.1  F:SER 104[N]  
13  G:GLU 171[OE2]   3.5  F:SER 104[N]  
14  G:GLU 344[OE2]   2.5  F:ARG 194[NH2]  
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centre of the morphological units and theoretically produce monomers, the rest of the mutations 
aimed to keep hexamers or pentamers in solution.  
 
 
Figure 27. Scheme of H-bonding of key residues in HK97 gp5 
Ball and stick representation of several residues that establish H-bonds in HK97 gp5. Counterparts of 
these residues in SPP1 were targeted for mutagenesis. Carbons atoms are coloured according to the chain 
they belong to. Oxygen and nitrogen atoms are shown in red and blue. The corresponding chain is 
labelled and so are some secondary structure elements (representations not to scale). 
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3.3.3 Solubility test 
All mutants were cloned by site directed mutagenesis using the G13P_WT DNA as template. 
Briefly, forward and reverse primers included the desired mutation at the centre of the primer 
permitting the complementary regions at each end to anneal to the template whilst the modified 
codon created a bubble that in subsequent cycles allows the annealing of the complete primer. 
The recombinant DNA was then used to transform two types of bacterial strains and induce 
expression at two different temperatures. Samples were resuspended in several buffers to screen 
their solubility (Figure 28) following the described protocol. All mutants showed solubility at 
some extent in at least one of the expression conditions tested. The buffer or NaCl concentration 
did not make a significant difference as approximately the same amount of protein was observed 
in SDS-PAGE. 
 
 
Figure 28. Solubility screen for G13P mutants 
Only results from BL21 cells induced at 16°C are shown. The pH and NaCl concentration are indicated. 
The gels are not to scale with each other. For G13P_FL_L262W results from BL21 pLysS cells cultured 
at 37°C are shown as these conditions showed the highest solubility. FL refers to full length constructs. 
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3.3.4 Purification of single mutants 
Production of mutants was scaled up to cultures of 750 mL of LB medium and NAC and SEC 
were performed as a way of testing which of the mutations prevented aggregation. Because of 
previous experiences with the truncations and other modifications that were made on G13P, it 
was decided to keep on characterising different constructs in the case a particular one did not 
show optimal solubility or yield. Even though in theory all mutations were expected to affect 
aggregation, the low percent of homology with HK97 gp5 gave a degree of unpredictability to 
the mutations in G13P.  
G13P_FL_D100R and G13P_FL_D194W did not give a high yield from NAC, which could be 
explained by the difference in the amount of protein between the lysate and the loaded 
supernatant (Figure 29a). Even when the lanes with the lysate are overloaded with protein it is 
possible to see that the mutants were expressed in high amount, but centrifugation at high speed 
led to the precipitation of most of it. In the case of G13P_FL_D100R, the lane containing the 
lysate shows a broad protein band of ~40 kDa that likely contains G13P but with retarded 
migration. A dilution of the lysate included at the left side of the lysate confirms that G13P was 
in solution before centrifugation. No further work was made with these mutants.  
The rest of the mutants were soluble and subsequently purified by NAC and SEC. The amount 
of G13P_FL_A261W, T104Y and L262W after SEC was too low to setup crystal trays, 
nevertheless, it was observed that also G13P_FL_A261W and T104Y aggregated but a fraction 
of the sample eluted where a monomer or a similarly sized impurity would elute. 
G13P_FL_L262W did not exhibit aggregation but the yield from SEC was low (Figure 29b). 
G13P_FL_G64W was produced in high amount after SEC. Aggregation was observed, although 
most of the protein remained as low MW species. Fractions from this peak were pooled together 
and concentrated using a 10 kDa cut-off centrifugal concentrator, where the formation of 
proteinaceous white threads was observed when the protein concentration started to rise. Non-
concentrated samples were run onto a SEC-MALLS instrument and the estimated molecular 
size was 1x10
6
 Da (Not shown). Such observation is attributed to aggregation. The G64W 
mutation, located at the E-loop, was expected to weaken interactions between the capsid 
proteins, but other residues for example at the P-loop or A-domain still promoted the formation 
of aggregates. From a protein that establishes multiple contacts using diverse surfaces, it is not 
surprising that a single mutation is not sufficient to stop its aggregation.  
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Figure 29. Purification of G13P single mutants 
(a) NAC for G13P_FL_D100R and G13P_FL_D194W. The corresponding gels are included at the right 
side and every lane is labelled to show the most important samples. (b) SEC profile for G13P_FL_ 
G64W, T104Y, A261W and L262W. The elution volume of both species is indicated.  
 
3.3.5 Tagged and untagged double mutants 
As none of the single mutations were suitable for isolating stable monomer, the three most 
successful single-point mutations were combined in pairs to generate three double mutants to 
investigate whether their joint effects were sufficient to produce protein that could exist stably 
in solution without aggregation.   
The selected double mutants were: G13P_FL_G64W;A261W, G13P_FL_T104Y;A261W and 
G13P_FL_G64W;T104Y. The second mutation was introduced by site directed mutagenesis 
using either single mutant DNA as template and primers for the desired second mutation. As 
done with the truncated and mutant constructs, bacterial cells were transformed with 
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recombinant DNA and protein expression was induced at 16 and 37 °C (Figure 30a). 
G13P_FL_G64W;T104Y was produced in a higher amount when cultured at 37 °C in 
comparison with G13P_FL_T104Y;A261W and G13P_FL_G64W;A261W where the major 
amount of expressed protein was obtained at 16 °C. 
Figure 30b shows the NAC profile of G13P_FL_G64W;A261W using a His-trap FF crude 
column. During the standard NAC it was observed that most of the POI precipitated after 
centrifugation at high speed (not shown). A new crude lysate was loaded onto the FF crude 
column however no binding to the Ni-beads was observed. Characterisation of the rest of the 
mutants followed and no further work was performed with this particular double mutant.   
G13P_FL_G64W;T104Y and G13P_FL_T104Y;A261W were soluble and purified successfully 
by NAC and SEC (Figure 30c). The SEC profile shows that both double mutants eluted like 
homogenous species where a monomer would be expected. A reasonable amount of protein was 
produced out of subsequent SEC runs with the rest of the purified protein by NAC. SEC 
fractions were concentrated and no aggregates were visible. Crystallisation work for these 
constructs will be described in section 3.5. 
The molecular weights of G13P_FL_G64W;T104Y and G13P_FL_T104Y;A261W, determined 
by SEC-MALLS were 35.0 and 34.9 kDa, respectively, both corresponding to monomers of 
G13P within experimental error of the technique.   
Interestingly, the double mutant which did not include the T104Y mutation was the only 
construct that precipitated, suggesting that T104 is establishing contacts with adjacent subunits. 
It is possible that the replacement by tyrosine kept apart residues proximal to T104 that make 
inter-subunit contacts.  
The individual effects of G64W or A261W mutations did not lead to the production of 
monomers, but both did when combined with the T104Y mutation. The mechanism for this 
disruption by T104Y mutation might be due to the relatively bigger gap that the new tyrosine 
creates between the area above the P-loop and the P-domain (Figure 27). Introducing such a 
mutation would disrupt H-bonds between R338-D198 and R194-D100 (in HK97 gp5) at the 
same time. Although the single T104Y mutant protein was monomeric to some extent, the 
presence of a second mutation is likely to further separate subunits from each other (Figure 29, 
individual SEC for T104Y).  
Untagged versions of the double mutants that were monomers in solution were the last 
constructs to be explored during this project. They are included in this section to keep constructs 
classified by the type of alteration that was introduced. It was decided to continue working with 
the double mutants after the lack of successful results with the engineered protein (To be 
discussed in section 3.4). 
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Figure 30. Production of G13P double mutants  
(a) Solubility screens for G13P_FL_G64W;A261W (in B834 cells) and G13P_FL_T104Y;A261W (in 
BL21 PLysS cells).(b) Solubility screen and NAC profile (FF crude column) for 
G13P_FL_G64W;A261W. (c) SEC profile of G13P_FL_G64W;T104Y and G13P_FL_T104Y;A261W. 
 
The cloning protocol consisted in amplifying the full length double mutants with primers that 
had fifteen bases from the insert and fifteen bases from pET22b expression vector, specifically, 
between the restriction sites NdeI and XhoI. The start methionine encoded by one of the codons 
of the NdeI restriction site was used as the start codon and one stop codon was introduced after 
G13P’s last residue codon to avoid including the His-tag at the 3’ end that is part of pET22b 
vector.  
Only one strain of bacterial cells were transformed and protein expression was carried out at 
16°C as it was known that these double mutants are generally well expressed and soluble. Both 
untagged-G13P_FL_G64W;T104Y and untagged- G13P_FL_T104Y;A261W (abbreviated as u-
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construct from here on) were soluble under the conditions used that include pHs 6, 7.5 and 9 
and NaCl concentration from 10 mM to 1 M (Figure 31a). 
 
 
Figure 31. Production of G13P untagged double mutants 
(a) Solubility screen for u-G13P_FL_G64W;T104Y and u-G13P_FL_T104Y;A261W (in B843 cells). (b) 
SEC profile in a S200 16 60 column (absorbance at 280 nm). Fractions from each run are shown in the 
gels at the right side. 
 
Production was scaled up and the u-G13P_FL_G64W;T104Y was purified from the bacterial 
pellet by (NH4)2SO4 precipitation and a variety of chromatographic techniques (not shown). 
Briefly, the final optimised protocol used to purify both constructs included getting a clear 
supernatant by spinning down the cell lysate. The supernatant was then loaded onto a FF Q 
column without previous (NH4)2SO4 as it was observed that after centrifugation the supernatant 
was relatively pure. Protein was then eluted using a NaCl gradient. SEC followed the anion 
exchange chromatography. 
Both constructs, plus Se-Met u- G13P_FL_T104Y;A261W were produced in high amount and 
concentrated for crystallographic studies (Sections 3.5). Constructs eluted as monomers in the 
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S200 16/60 column used for the large scale production (86 mL). Difference in the elution 
volume of the Se-Met construct might be due to flow rate, AKTA purifier used, or degree of 
cleanness of the column as this particular purification was performed weeks after the native 
constructs. The gels at the right of the graph show that the purified protein was pure enough to 
set up crystal trays. 
One truncated version of G13P_FL_T104Y;A261W was cloned to test if the removal of the N-
terminal portion in addition to the double mutation led to crystallisable protein. 
G13P_ΔN6_T104Y;A261W was soluble when expressed in B834 cells at 16°C. SEC analysis 
showed that it existed mainly as monomer in solution; however a fraction of the sample also 
aggregated. When the monomeric sample was run again in SEC the aggregate was generated 
again, suggesting that existed equilibrium between the aggregate form and the monomer (not 
shown). No further work was performed on this construct. 
 
3.4 Design and purification of G13P-Anti-TRAP constructs  
Following the example of protein-engineering that was presented in section 1.7 where a flexible 
ICL3 loop was replaced by T4 lysozyme to regions contributing to the movement of 
transmembrane α-helices in the β2-AR, a similar approach was followed with G13P by 
introducing the Zinc-binding domain from anti-TRAP into the region in G13P that aligns with 
the P-loop from HK97 gp5 (Figure 32).  
Anti-TRAP (AT) is an antagonist of TRAP, a common protein in Gram-positive bacteria 
involved in tryptophan metabolism regulation. The AT crystal structure was solved at 2.8 Å 
resolution by the Antson Laboratory. In the crystal, AT exists as a dodecamer formed by four 
AT trimers. Each L-shaped monomer displays two wings separated by a 100º angle (Figure 
32e). One of the wings contains two pairs of small antiparallel β-strands and one zinc-binding 
domain that consists of four Cys residues coordinating one ion of Zn
+2
. The second wing 
consists of one short α-helix (118).  
AT was selected as fusion partner to G13P for several practical reasons. The first one concerns 
the presence of the coordinated Zn
+2
 atom that once integrated into the engineered protein 
would facilitate structure solving by anomalous scattering. Secondly, the ordered fold of the Zn-
binding domain correctly integrated into the G13P monomer would be expected to disrupt inter-
P-domain contacts as well as replacing a loop that might be flexible and be contributing to 
disorder in the G13P structure. Finally, the distance between the residues at the ends of the AT 
portion that was inserted in G13P sequence is similar to that predicted in G13P based on 
homology modelling against the HK97 gp5, thus it is more likely to yield a structure resembling 
the native fold.  
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Two segments from AT, both comprising the Zn-binding domain, were included in the fusion 
construct: V10-I35 and A11-V34 (Figure 32a,b). In HK95 gp5 such segment from AT would 
feasibly replace residues E347-M357 (Figure 32c), however in the ten aligned residues in G13P 
this would likely disrupt some secondary structure elements, predicted from homology 
modelling, and thus the range in G13P that was substituted for AT segments was A257-Q265, 
which was predicted to connect strands β9-β10 in G13P. 
The distance between AT residue pairs V10-I35 and A11-V34 (which are allocated at the ends 
of the two AT segments) are 3.9 and 5.4 Å respectively, comparable to the distance between 
pair E347-M357 in HK97 gp5, which is 7.8 Å. 
A model using AT and gp5 PDB entries was created with Coot by merging the desired 
fragments from each protein (Figure 32e), using gp5 as a model for G13P. In theory, all G13P 
domains would be expected to exhibit their native folds in the designed fusion constructs since 
the β-hairpin from the Zn-binding domain would bring the C-terminal portion of G13P to 
proximity with the rest of G13P to complete the P- and A-domains as is predicted in the wild 
type structure.  
3.4.1 Design of primers 
The recombinant DNA for constructs G13P-V10-I35AT and G13P-A11-V34AT (two residues 
shorter) was produced in two rounds of PCR using G13P_WT and AT as templates. Both G13P 
and AT DNA sequences were combined to sketch the engineered proteins’ sequences and 
design primers that included both sequences (Figure 33, Table 7). The logic to design primers 
for both constructs was the same and hence it will be explained in detail only for G13P-V10-
I35AT, more information about G13P-A11-V34AT can be found in appendices 6 and 7.  
Three pairs of primers were used to generate three DNA fragments that contained overlapping 
G13P or AT sequences for construction of the complete construct coding sequence (Figure 34). 
For instance, single DNA chains of fragment A generated during the first PCR had a short 
segment of AT at the 3’ end in addition to the large segment of G13P at the 5’ end encoding the 
N terminal portion. Chains from fragment B consisted of the complete introduced AT sequence 
plus additional G13P sequences at each end. Fragment B included the 3’ segment of G13P plus 
a short sequence of AT at the 5’ end. More information about the sequence of the primers and 
the templates they amplify is given in Table 7. 
Separate PCR rounds produced fragments A (789 bp), B (114 bp) and C (198 bp) that served as 
a template in the second PCR stage, where only primers to amplify G13P_WT, identical in the 
G13P-AT constructs were included. This PCR product, containing copies of full length G13P-
V10-I35AT construct, was digested with NdeI and XhoI and then ligated into pET28 vector for 
subsequent sequencing and expression. 
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Figure 32. Engineered G13P protein containing  the Zn-binding domain from Anti-TRAP 
(a), (b) Anti-TRAP amino acid and DNA sequences. Sequences highlighted in yellow and brown 
correspond to the portions of AT that constructs G13P-V10-I35AT and G13P-A11-V34AT incorporate, 
respectively. (c), (d) Partial amino acid sequence of gp5 and G13P, respectively. Substituted sequences 
are highlighted in black/grey background. (e) Model for G13P-V10-I35AT. The Zn-binding domain is 
coloured in yellow and gp5 is coloured following the scheme used in Figure 6. PDB entries: AT: 2BX9, 
gp5: 1OHG.   
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Figure 33. Engineered protein G13P-V10-I35AT 
(a), (b) Nucleotide and amino acid sequence of G13P-V10-I35AT. The region corresponding to AT is 
highlighted in yellow. Areas in red correspond to the annealing sites for the primers.  
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Table 7. Primers for G13P-V10-I35AT 
Template Fragment  
Amplified 
Designed Primers  
 
G13P_FL 
A: 
1-789 (G13P) 
1_F   5’   GG AAT TCT CAT ATG GCA TAC ACA AAA ATT TCA G  3’ 
 
II-R   5` GCA TTT CGG GCA AGC AAC TGT TTC TGT TGG TAC TTC 3` 
 
 
Anti-TRAP 
B: 
754-867 (G13P -AT- G13P) 
III-F   5`  GAA GTA CCA ACA GAA ACA GTT GCT TGC CCG AAA TGC 3` 
 
IV-R   5` ACG GTT GAT AAG AAT ATC GAT AAC ACC TTT ACC GGA  3` 
 
G13P_FL 
C: 
832-1029 (G13P) 
V-F   5` TCC GGT AAA GGT GTT ATC GAT ATT CTT ATC AAC CGT  3` 
 
1_R   5’   CCA GAA CTC GAG TTA TGC TTG TAG TCT GTG TT  3’ 
Areas highlighted in yellow correspond to the AT sequence. NdeI and XhoI restriction sites are 
highlighted in cyan and salmon, respectively. 
 
 
 
Figure 34. Generation of G13P-V10-I35AT by PCR 
(a) Fragments A-C. Scheme of possible fragments generated on the first PCR when using the designed 
primers (not to scale). It is important to note that after several cycles all fragments would have blunt ends 
and both sequences would be incorporated on them. We are interested in any fragment that could have 
complementarity with other fragments. The arrows indicate the primers that generated that chain, not the 
one to which they anneal to. (b) PCR scheme of the predicted DNA fragments for the first (left) and 
second PCR (right). Length is indicated at the right of each gel.  
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3.4.2 Solubility test 
Both engineered proteins were successfully cloned as described above (Figure 35a). Sequencing 
results showed that the AT fragment was properly incorporated into G13P and so were the 
resulting full length G13P-AT constructs into pET28 (appendix 8 and 9). Sequencing was 
performed by synthesis, with T7 promoter and terminator primers by GATC-BIOTECH 
(Germany) 
BL21 pLysS and B834 cells were transformed with the recombinant DNA to be further used to 
induce protein at 16 and 37°C. Proteins were expressed in high amounts only at 16°C in B834 
cells (Figure 35b). In spite of being soluble under most of the conditions used in the experiment, 
two bands on SDS-PAGE of slightly different size were present where the FL constructs were 
expected (G13P-V10-I35AT: 39.19 KDa, G13P-A11-V34AT: 38.98 kDa). At this early stage, 
large scale production of protein was started. 
 
Figure 35. Production of G13P-V10-I35AT and G13P-A11-V34AT 
(a) PCR reactions. The left gel (2% agarose) shows fragments A-C from the first PCR. The right gel 
presents the 2nd PCR, in order, - control (no template), + ctrl (G13P_WT), G13P-V10-I35AT. The 2-log 
ladder is at the first lane in every gel. (b) Solubility screen in B834 cells. 
84 
 
3.4.3 Purification of G13P-AT constructs 
NAC and SEC followed large scale production in B834 cells at 16°C. Taking the 
aforementioned double mutants of G13P as a reference point it is possible to say that both 
G13P-AT constructs exist predominantly as monomers or at least low-molecular weight species 
in solution since they elute at ~13.5 mL without the formation of significantly bigger species 
(Figure 36). Even though only one peak is observed for the monomer in each run, two protein 
bands are still visible in the SDS-PAGE in fractions taken from the SEC eluent.  
 
 
Figure 36. SEC of G13P-V10-I35AT and G13P-A11-V34AT 
 
To determine where the possible degradation giving rise to these two distinct bands was taking 
place, several approaches including Ni-affinity pull-down assays, thrombin-digestion, and His-
tag stain were carried out (Figure 37). The two constructs were cloned into pET28a that include 
the His-tag at the N-terminus. If degradation was taking place at the C-terminus, all of the 
sample would still bind to the Ni-beads. On the contrary, with the absence of His-tag at the N-
terminus, the sample would not bind to the Ni-beads. It was confirmed that the N-terminus is 
intact as both constructs were shown to be present in the samples containing washed beads 
when run on SDS-PAGE, and in the eluted sample (as it was initially observed in NAC) (Figure 
37a).  
When digested with thrombin, G13P-V10-I35AT showed a discreet shift in size, the same shift 
observed when the His-tag is removed from the N terminus in other samples (Figure 37b). The 
His-tag stain that selectively dyes His-tagged protein also confirmed that the His-tag is present 
in the two constructs. This suggested that degradation was occurring at the C-terminus, as 
evident by the presence of the two species both possessing His-tags (Figure 37c). 
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Figure 37. Detecting the His-tag in G13P-AT constructs. 
(a) Pull-down assays. Total fraction, supernatants from the second wash (SN2), concentrated beads and 
two dilutions of the eluted sample are shown for every construct. Samples expressed in BL21 Star
TM
 
cells. (b) G13P-V10-I35AT before and after thrombin-digestion. (c) His-Tag stain of samples from NAC 
and SEC from both constructs. The green arrow points towards the POI.  
 
Attempts to stop degradation consisted of expressing protein in BL21 Star
TM
 pLysS cells. BL21 
Star
TM
 pLysS cells carry a mutated rne gene that results in a phenotype which does not degrade 
mRNA and hence is expected to continue translating mRNAs without interruptions until the 
product is finished. This would rule out premature termination as the reason for two species 
with two different sizes appearing in samples. The protein was expressed as routine at 16°C to 
be used in solubility screens. No change from the behaviour in BL21 pLysS or B834 cells was 
observed. The constructs were expressed in high amount and were soluble but two bands were 
still visible on SDS-PAGE. It is clear from the SDS-PAGE that the truncation happens early on 
in the purification, possibly in the cell or during cell lysis.  
Versions of both constructs with the His-tag at the C-terminus were subsequently cloned into 
the pET22b vector. Their analysis demonstrated that degradation still occurs (Not shown). 
Concentrated samples of C-tagged G13P-V10-I35AT and G13P-A11-V34AT were used to set 
up INDEX and PACT crystal screens. 
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SEC samples from previous runs to purify G13P-V10-I35AT and G13P-A11-V34AT were 
concentrated to be used in crystallographic studies as the spontaneous degradation might signify 
the removal of naturally unstable portions (See section 3.4.4). 
The determined molecular weight of G13P-V10-I35AT and G13P-A11-V34AT determined by 
SEC-MALLS were 30.8 and 29.78 kDa respectively (Not shown). Both are lower than the 
expected theoretical molecular weight presumably due to degradation. Electrospray ionisation 
(EI) was performed as a more accurate technique to measure molecular weight.  
Because G13P-A11-V34AT is essentially identical to G13P-V10-I35AT, only the second one 
was used for EI. Two species of 35,755 and 37,563 Da were detected, representing the two 
species observed by SDS-PAGE. These molecular weights can be explained if 29 or 14 residues 
were removed from the C-terminus, respectively (Figure 38), indicating that both species 
observed by SDS-PAGE were potentially missing C-terminal segments. 
 
Figure 38. Truncations at G13P-V10-I35AT 
(a) Electrospray ionisation for G13P-V10-I35AT. The molecular weight for the two main species is 
indicated (b) partial G13P-V10-I35AT amino acid sequence. The missing segments and resulting 
constructs are indicated by purple arrows. Sequence highlighted in yellow corresponds to AT. Sequences 
in red correspond to the annealing points for the primers to produces fragments ABC.  
 
The residues E314 and K329 were identified as the point of the truncations by relating the 
missing mass with the amount of residues that would account for that loss. In an attempt to 
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produce more stable constructs, truncated versions were designed based on this information. 
Two reverse primers were designed to produce the truncations in G13P-V10-I35AT and G13P-
A11-V34AT that signifies four new constructs: G13P_V10-I35AT_ΔC330, G13P_V10-
I35AT_ΔC314, G13P_A11-V34AT_ΔC328 and G13P_A11-V34AT_ΔC312. 
 
3.4.4 Production of truncated G13P-AT constructs and on-column refolding 
The four new truncations were successfully cloned into a modified version of vector pET28a 
using the full length G13P-AT DNAs as templates. B834 and BL21 PLysS cells were 
transformed to express the protein at 16 and 37 °C. Even though constructs were produced in 
high amount, none of them were soluble under the tested conditions (See Figure 39a for the 
solubility test of G13P_V10-I35AT_ΔC330). Nevertheless, constructs with these truncations 
produced only one visible band in SDS-PAGE, demonstrating that no degradation exists when 
expressed in the cell and thus validating this approach. The previous experience with G13P_ΔC, 
for which a thorough solubility screen was carried out, suggested that the C-terminus of G13P is 
essential for solubility and therefore it was likely that further efforts with the truncated G13P-
AT truncated constructs would make no improvements to solubility despite difference in amino 
acid sequence.  
Often recombinant proteins that are overproduced in E. coli cluster in insoluble aggregates 
known as inclusion bodies (93). It was decided to implement an alternative, on-column 
refolding, to take advantage of the availability of the four cloned constructs for G13P-AT which 
exhibited insolubility, and to continue the extensive work made on the SPP1 capsid protein.  
The on-column protein refolding protocol consisted of the denaturation of the inclusion bodies 
and then refolding the protein whilst still bound to the Ni-beads in the column (93).   
G13P_V10-I35AT_ΔC330 was used as a pilot test to perform this technique. Briefly, the 
bacterial pellet of B834 cells induced at 16°C was resuspended in cold denaturing buffer (6M 
guanidine hydrochloride) to be manually loaded to the His-trap column. The column was 
washed with denaturing buffer plus 20 mM imidazole to remove all non-specifically bound 
proteins. Next, 0.1% Triton X-100 detergent buffer was flowed through the column to prevent 
aggregation. The remaining detergent was removed with 5mM β-cyclodextrin and the attached 
protein was eluted with an imidazole gradient (Figure 39b).  
G13P_V10-I35AT_ΔC330 eluted in two peaks that were kept separately to perform SEC with 
each one. A small volume from peak 2 was centrifuged and then loaded on SDS-PAGE. It was 
observed that most of the protein remains in solution after centrifugation in comparison with a 
non-centrifuged sample, indicating that the on-column refolding was successful in producing 
soluble protein (not shown). 
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Figure 39. Production of G13P_V10-I35AT_ΔC330 
(a) Solubility screen in B834 cells at 16 and 37°C. (b) On-column refolding. The solutions used at each 
stage are indicated. Samples in the gel are numbered according to the solutions flowed over. (c) SEC 
profile of samples from refolding. Elution volumes of P2A and P2B are shown. The chromatograms at the 
left and right correspond to runs in S200 10 60 and S200 10 30 columns, respectively.  
 
The SEC profile for peaks 1 and 2 showed that the protein present in both of them eluted close 
to the void volume, suggesting that G13P_V10-I35AT_ΔC330 forms two types of aggregates. 
Both chromatograms consisted of one main peak and a second one, visible as a shoulder on the 
major peak. Therefore, these two different species might have very similar molecular weights or 
hydrodynamic radii. Peaks observed in the SEC for peak 2 from NAC are classified as P2A 
(elution volume 49 mL) and P2B (elution volume 56 mL) from here on. Both of them have 
89 
 
elution volumes considerably higher than that observed for the full length G13P_V10-I35AT in 
the S200 16 60 column (~87 mL), confirming that they are not monomers.  
Samples from P2A and P2B were loaded onto a SEC S200 10 30 column to investigate their 
individual behaviour (Figure 39c). One sample of peak 2 from NAC was included as control. 
The three samples eluted close to the void volume, at ~8.1mL, in comparison with the full 
length G13P_V10-I35AT that in S200 10 30 columns elutes at 13.4 mL, as monomer. Sample 
2A exists as single species while sample 2B is present as two different species.  
 
3.5 Crystallisation of G13P 
3.5.1 Crystallisation of native G13P 
Protein constructs that behaved like stable homogeneous monomers and those that could be 
concentrated to >10 mg mL-1 were used for crystallisation. Crystallisation experiments were 
performed by sitting drop vapour diffusion using commercial screens with 96 conditions in 
each. The protein sample was kept in the original SEC buffer or buffer-exchanged to new 
conditions. When a condition was observed to yield crystals, hanging drop vapour diffusion 
optimisation experiments were set up manually in 24-well plates, by varying the concentration 
of the main precipitant in small steps by probing the influence of various additives.  
Table 8 lists the crystallisation experiments set up for eight of the constructs produced during 
this project. Single mutant G13P_FL_G64W, G13P-AT engineered proteins or 
G13P_FL_G64W; T104Y did not yield any crystals, even though the latter two were monomers. 
G13P_FL_T104Y; A261W was the only double mutant that initially formed crystalline material 
(Figure 40). Clusters of small needles were observed in condition C11 from PACT screen. 
Condition C11 contained 0.1 M Hepes pH 7, 0.2 M CaCl2, 20 % (w/v) PEG 6K. Manual 
optimisation experiments did not yield larger crystals (Figure 40a).  
Low-quality crystals were also grown in the INDEX screen, condition H5: 0.1 M succinic acid 
pH 7, 20 % (w/v) PEG 3.35 K (Figure 40b). These crystals represented triangular clusters of 
smaller single crystals, however, their borders were not well defined. Subsequent optimisation 
produced similar crystals, which quickly dissolved when fished by a nylon loop for subsequent 
freezing and X-ray diffraction testing.  
One example of a crystal of G13P_FL_T104Y; A261W is shown in Figure 40c. Small triangular 
and rhomboidal crystals were grown in condition D10 of the Morpheus screen: 0.1 M MES pH 
6.5, 12% (w/v) PEG 20K. Although the crystal edges were more well-defined than those 
described previously, they were too small to test and instead a seed stock was made out of them 
for optimisation experiments by crystal seeding.  
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After working with the G13P-AT constructs, untagged versions of the monomeric double 
mutants were cloned, purified and crystallised. Approximately three weeks later several screens 
were set up for u-G13P_FL_T104Y; A261W no crystals were observed and the trays were 
transferred to 10°C. Three days later octahedral crystals were grown in a drop where only 
microcrystalline precipitate was observed before the transfer to the lower temperature. The 
microcrystalline precipitate formed at higher temperature, probably served as the nucleation 
points for growing larger crystals (Figure 40d,e). These crystals grew from G12 PACT 
condition: 0.1 M bis-tris propane pH 7.5, 0.2 M Sodium malonate, 20% (w/v) PEG 3350, with 
10 mg mL
-1
 protein concentration. Three of these crystals were fished at 4°C, cryo-cooled and 
tested using the in-house diffractometer. No cryo-protectant was added as original conditions 
served well to prevent ice formation. Crystals exhibiting diffraction using the in-house MSC 
Micromax 007HF X-ray generator (Rigaku) with rotating anode and MAR345 detector (Mar 
Research) were sent to the I04 beamline at the Diamond Light Source, UK, for collection of a 
high resolution data set for structure determination. 
Further work consisted of optimising condition PACT G12, but this did not produce any 
crystals. However, long rectangular crystals grew in 0.1 M PCB (propionic acid, cacodylate, 
bis-tris propane), 20 % (w/v) PEG 1.5 K at room temperature with 10 mg mL
-1
 protein 
concentration (Figure 40f). This condition was derived from C5 PACT screen: 0.1 M PCB, 20 
% (w/v) PEG 1.5 K. When fishing was attempted, crystals dissolved upon contact with the loop 
and exposure to air. 
A Se-Met version of u-G13P_FL_T104Y; A261W was purified to set up crystal trays in parallel 
with the native protein. Additives like Zn
+2
, crystals seeds and TCEP were included.  
 
3.5.2 Crystallisation of Se-Methionine labelled G13P 
Se-Met labelled u-G13P_FL_T104Y; A261W was buffer-exchanged to 10 mM Hepes pH 7.5, 
100 mM (NH4)2SO4  and concentrated to 10 mg mL
-1
 to setup sitting drop vapour diffusion 
experiments at RT using the crystal screen PACT. After seven weeks of incubation, small 
crystals appeared in conditions D12 (0.1 M Tris pH 8, 10 mM ZnCl2, 20 % PEG 6K) and E9 
(0.2 M Na/K Tartrate, 20 % PEG 3.35 K) (Figure 40g,h). Since crystals from both conditions 
were too small to be tested, they were mixed together in 100 μL of solution containing 0.1 M 
Tris pH 8, 10 mM ZnCl2, 20 % PEG 6K, to create a seed stock. This seed stock was used to set 
up the INDEX and PACT screens for Se-Met u-G13P_FL_T104Y; A261W diluted to 11 mg 
mL
-1
 protein in 10 mM Tris pH 7.5, 200 mM NaCl at RT. Crystals grew after seven weeks of 
incubation (Figure 40i,j) in the INDEX screen in conditions A3 (0.1 M Bis-Tris pH 5.5, 2.0 M 
(NH4)2SO4) and A5 (0.1 M Hepes pH 7.5, 2.0 M (NH4)2SO4). The cryo-cooled crystals on 
Figure 40i,j, diffracted to ~ 5.0 and 8.2 Å, respectively, when tested using in-house equipment. 
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Both crystals were sent to the I04 beamline at the Diamond Light Source, UK, for collection of 
a high resolution data set for structure solution. 
 
Table 8. Cristallisation of G13P 
Protein Concentration 
mg mL-1 
Buffer Crystal screen Observations 
 G13P_FL_G64W 3 / 5 25mM Tris pH 7.5 
10mM NaCl 
INDEX, PACT No crystals 
 
 
 
 
 
 
 
 
G13P_FL_T104Y; 
A261W  
5.9 25mM Tris pH 7.5 
10mM NaCl 
INDEX, PACT Small needles in PACT 
7.7 INDEX, PACT  
5.8 25mM Tris pH 8, 
100mM NaCl  
INDEX, PACT  
6.4  
 
25mM Tris pH 7.5 
10mM NaCl 
 
INDEX, PACT  
10.7 CSS 1&2, MPD, 
Hampton 
 
11.7 INDEX, PACT Small needles in PACT 
10 / 7 (NH4)2SO4  
7.5 24-Well tray Micro and macro seeding  
9.7 10mM Tris pH 7.5 
50mM NaCl 
CSS 1&2* *Bis-Tris pH 5.5 and 6.5 
used 
9.7 INDEX Seeding in 96-well plate 
7 25mM Tris pH 7.5 
500mM NaCl 
INDEX  
His-Tag removed 
 
 
10.9 INDEX, PACT 
 
15 
10mM Tris pH 7.5, 
150mM NaCl,  
MPD, CSS 1&2*,  
Hampton 
15 150mM NaCl, 10mM 
Tris pH 7.5 
CSS 1&2* *Tris pH 6.5 and 8.5 
used. 
G13P_FL_G64W; 
T104Y 
Similar experimental setting as for G13P_FL_T104Y; A261W, no crystals were grown. 
 
G13P_V10-I35AT 
8.95 10mM NaCl, 25mM 
Tris pH 7.5 
INDEX, PACT  
30 50mM NaCl, 10mM 
Tris pH 7.5 
INDEX  
13.5 150mM NaCl, 10mM 
Tris pH 7.5 
MPD, CSS 1&2*, 
Hampton 
Tris pH 6.5 and 8.5 used 
A) G13P_V10-
I35AT-C’_tag 
B) G13P_A11-
V34AT-C’_tag 
 
25 
12.5 
 
25mM Tris pH 7.5 
500mM NaCl 
 
 
INDEX, PACT 
 
No crystals grown 
 
 
u-
G13P_FL_T104Y; 
A261W 
10 
15 
 
 
 
10 mM Tris pH 7.5 
200 mM NaCl 
 
INDEX, PACT Optimisation of PACT 
A4, A5, A6. C4, C5, C6, 
F8, G12 at RT and 10°C 
15 MPD, Hampton, 
CSS 1&2, Morpheus 
 
10 PACT Set up in parallel at RT 
and 10°C 
11 INDEX, PACT Plus: Zn+2, seeds, NA 
u- 
G13P_FL_G64W; 
T104Y 
 
15 
10 mM Tris pH 7.5 
200 mM NaCl 
INDEX, PACT, 
MPD, Hampton, 
CSS ½, Morpheus 
Optimisation of PACT 
A4, A5, A6. C4, C5, C6, 
F8, G12 at RT and 10°C 
 
 
Se-Met u-
G13P_FL_T104Y; 
A261W 
 
10 
10 mM Tris pH 7.5 
200 mM NaCl 
 
(NH4)2SO4 
 
Optimisation at  
Optimisation PACT G12, 
F8 at RT and 10°C 
10 10 mM Tris pH 7.5 
100 mM NaCl 
PACT  
11 10 mM Tris pH 7.5 
200 mM NaCl 
INDEX, PACT Plus: Zn+2, seeds, TCEP, 
NA 
RT- room temperature 
NA- no additive 
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Figure 40. Crystallisation of G13P_FL_T104Y; A261W 
(a-c) Low quality crystals of tagged G13P_FL_T104Y;A261W. (d-f) Crystals of native u-
G13P_FL_T104Y;A261W. (g-h) Crystals of Se-Met u-G13P_FL_T104Y;A261W used as seeds. (i-j) 
Crystals of Se-Met u-G13P_FL_T104Y;A261W used for structure solution. Pictures not to scale. See text 
for screen conditions.  
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3.6 Conclusions 
In total, efforts to crystallise the major capsid protein G13P, comprised the cloning and 
expression of thirty-two different constructs that include truncations at the N- or C-terminus, 
single or double mutants and engineered fusion proteins. Out of these, only six constructs were 
monomers. These six constructs and the G13P_G64W mutant protein were subjected to 
crystallisation experiments. The rest of the produced constructs were insoluble from the cell 
pellet, formed insoluble aggregates during purification or produced soluble protein in very low 
yield unfit for the purpose of crystallography.  
All six monomeric constructs, including double mutants (G13P_FL_G64W;T104Y, 
G13P_FL_T104Y;A261W) and G13P-AT chimeras (full length N- or C-terminally tagged), 
have in common the alteration of the P-loop (Figure 27 and Figure 32e). Alteration of the P-
loop consisted in the introduction of two bulky amino acids or the AT Zn-binding domain, 
suggesting that this area of the capsid protein features residues essential in establishing contacts 
with other subunits.  
To date, from the references reviewed, SPP1’s G13P from this study is the second protein, 
besides T4’s gp24 in being crystallised from the overexpression of the encoding gene alone 
(37). The rest of capsid proteins are available from the crystallisation or cryo-EM reconstruction 
of assembled purified capsids (section1.5.1). SPP1 G13P is the first major capsid protein 
characterised by X-ray crystallography in the monomeric state since T4 gp24 self-assembles 
into pentamers. No information about gp24’s oligomeric state is provided in the original 
reference, but analysis of the corresponding PDB entry shows that it does not appear to form 
oligomers.  
The identification of the double mutant of G13P for which diffraction quality crystals could be 
obtained and X-ray data could be collected (see Chapter 4) signified an important step forward, 
enabling determination of the X-ray structure of this protein in a stand-alone monomeric form.  
Although modification of two residues abolished G13P’s propensity to aggregate, we do not 
expect this to affect protein’s conformation as the side chains of these two residues are exposed 
and not involved in intra-subunit interactions stabilising capsid assemblies of other viruses. 
Thus the crystallised species is likely to be truly representative of the WT protein, although 
influence of G6P, G7P, G11P or G12P if any, might not be reflected in the recombinantly 
produced protein. 
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Chapter 4 
4. Elucidation of structure of SPP1 capsid protein  
 
4.1 Native protein crystals 
4.1.1 Data collection 
A complete data set was collected from a cryo-cooled crystal of uG13P_FL_T104Y;A261W at 
the I04 beamline at the Diamond light Source UK at a wavelength of 0.97950 Å. The distance 
crystal-to-detector was 533 mm. 1,100 images were collected, each one at a 0.2° rotation of the 
crystal, to cover a 220° overall rotation range. The highest diffraction where weak reflections 
were observed was ~ 3.8 Å (Figure 41).  
 
Figure 41.- Data collection from SPP1 uG13P_FL_T104Y;A261W native crystals 
 
4.1.2 Structure determination  
Images were processed with XDS (107) software using the resolution range 50-3.6 Å. Images 
were indexed in the space group P 41212 with the cell dimensions of a=b= 79.8 Å and c= 134.8 
Å, α=β=γ= 90° (See Table 9). The relevant parameters of the collected data set can be found in 
Table 9, in summary, the R-factors Rmerge and Rmeas (all I
+
 & I
-
) had values of 17.8 % (118 %) 
and 18.4 % (122.1 %), respectively. The completeness and multiplicity values of the data set 
were 99.6 % (96.1 %) and 12.3  (12.0), respectively (108,109).  
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The calculated solvent content was 59.6 % (Matthew’s coefficient 3.0 Å3/Da) (119), 
corresponding to one subunit per asymmetric part. 
Molecular replacement was performed to determine phases using both the cryo-EM model of 
SPP1 G13P (PDB 4AN5), and a poly-Ala version of HK97 gp5 (PDB 1OHG) as search models. 
None of the models could successfully be used as source of phases. The solutions obtained 
showed that with the SPP1 EM model as search model, the long helix at the P-domain matches 
well the electron density; however, for the rest of the structure, there is no agreement between 
the provided model and the electron density. A similar case resulted when HK97 gp5 poly-Ala 
model was fed onto Phaser (112). Some features (e.g. a few β-strands at the A-domain and helix 
α3’) were found in SPP1 G13P, but the rest of the structure could not be traced.  
Indexing the reflections in the enantiomorph space group P 43212 did not yield reliable results 
when the SPP1 EM model was used to recover the phases. Subsequent efforts focused on the 
production of Se-Met labelled uG13P_FL_T104Y;A261W to solve the phase problem 
experimentally (Section 4.2.3).  
 
4.2 Se-Met protein crystals 
4.2.1 Data collection 
Se-met crystals of uG13P_FL_T104Y;A261W were sent to the I04 beamline at the Diamond 
Light Source, UK, to collect a data set at the wavelength of 0.97934 Å. This wavelength was 
established from the X-ray fluorescence scan, which found a peak at ~ 12,660 eV (Figure 42a). 
The crystal’s total rotation range was 180°, with data collected at a 542 mm crystal-to-detector 
distance and 0.2° crystal rotation per image. Diffraction spots were observed up to ~3.2 Å 
(Figure 42b). 
4.2.1 Structure determination 
Using XDS for data reduction led to the determination of the space group and cell dimensions 
(Table 9). The used reflections were in the resolution range 49.28-3.00 Å. The protein 
crystallised in the space group R 32 with cell dimensions a, b = 176.2 Å; c = 356.7 Å and angles 
α, β = 90° , γ = 120° (hexagonal setting). Data processing statistics are in Table 9. 
For the heavy atom detection and the subsequent phasing of the structure, the SHELXCDE suite 
was used. 
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Figure 42.- Data collection from SPP1 uG13P_FL_T104Y;A261W Se-Met crystals 
(a) X-ray fluorescence scan showing the characteristic peak of absorption for Selenium atoms. (b) 
Diffraction image. The resolution at the edge of the plate is ~ 3.5 Å. 
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Table 9. X-ray data statistics for SPP1 G13P 
 Native crystal Se-Met crystal 
X-ray source Beamline I04,  
Diamond  LS, UK 
Beamline I04,  
Diamond  LS, UK 
Detector Pilatus 6M-F Pilatus 6M-F 
Wavelength (Å) 0.97950 0.97936 
Space group P 41 21 2 R 32 (hexagonal setting) 
Cell dimensions (Å) a,b = 79.8; c = 134.8  
α, β, γ = 90° 
a, b = 176.2; c = 356.7 
α, β = 90, γ = 120° 
Resolution range (Å) 45.01-3.60 (3.94-3.60) 49.28-3.00 (3.11-3.00) 
No. of unique reflections 5477 (1254) 42732 (4265) 
Rmerge
†
 (%) 17.8 (118.0) 18.1 (207.8) 
Rmeas (%) 18.4 (122.1) 18.9 (217) 
Average I/σ(I) 14.6 (2.9) 12.4 (1.3) 
Completeness (%) 99.7 (99.1) 99.6 (96.1) 
Multiplicity 14.9 (15.4) 12.3 (12.0) 
CC (1/2) * 0.998 (0.898) 0.990 (0.503) 
CC (1/2) DelAnom NA 0.620 (0.027) 
Wilson B-factor (Truncate) (Å
2
) 84.9 70.2  
Number of atoms 2319 (1 chain x 308 
residues) 
12097 (4 chains x 323 
residues, 1 x 308 
residues)  
Solvent content (%) 59.6 59.2 
Number of reflections used in 
refinement 
 40571 
R-factor (%)  24.4 (37.1) 
Number of reflections used for 
Rfree 
 2097 
Rfree (%)  26.5 (37.6) 
Average atomic B-factor (Å
2
)  56.1 
Rms BondLength (Å)  0.007 
Rms BondAngle (°)  1.27 
 
Values in parentheses are for the highest resolution shell. 
 
† Rmerge =Σhkl Σi |Ii(h) - ‹I(h)›|/ ΣhklΣiIi(h), where I(h) is the intensity of reflection h, ‹I(h)› is the average 
value of the intensity, the sum Σhkl is over all measured reflections and the sum Σi is over i measurements 
of a reflection. 
* CC1/2 - Correlation coefficient between the average intensities of random unmerged half-data sets. The 
value of CC1/2 is closer to +1 when there is a good correlation between the half-data sets and 0 when 
there is no correlation. At low resolution CC 1/2 is generally close to 1 at low resolution and tends to get 
closer to zero at higher resolution since the intensities are weaker (109). 
 
 
The integrated intensities were merged in a .HKL file that was used as input file by SHELXC 
(110). SHELXC created the run files for SHELXD, which uses the merged intensities to 
identify and locate the heavy atoms (Figure 43). SHELXD identified 47 heavy atoms, indicating 
that the asymmetric unit would contain a pentamer or hexamer of subunits (there are ten Se-
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methionine residues per monomer). Figure 43b shows the solutions found for the substructure of 
uG13P_FL_G64W;T104Y. The heavy atom positions were then used to determine the phases of 
the protein using Phaser option SAD (111,112). Inspection of the heavy atoms coordinates 
showed a symmetrical arrangement, where a possible pentamer was observed (Figure 43c,d).  
 
 
 
Figure 43.- Location of heavy atoms by SHELXC/D 
(a) Occupancy graph for the heavy atoms. (b) Substructures of heavy atoms located by SHELXD. (c), (d) 
visualization of the heavy atoms in Coot. Figures in this chapter featuring initial versions of G13P’s 
structure were prepared by Coot (116). 
 
Only the inverted hand output map from Phaser had discernible features (Figure 44a, left) and it 
was therefore the choice to continue with the structure solution process. After density 
modification was performed, the electron density map was interpretable to an extent that α-
helices and loops were in continuous arrangement (Figure 44b, right).  
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Figure 44. Solvent flattening, model-building and crystal arrangement 
(a) Same view of the electron density maps before (left) and after (right) density modification. Contoured 
at 2 σ. (b) Automatic model-building. Initial (left) and final (centre and right) models built by Buccaneer. 
The unit cell is drawn with yellow lines and the 3- and 2-fold crystallographic axes are indicated with a 
triangle and an oval. (c) Views along the Z and Y axis of the crystal.  
Automatic model building was performed with Buccaneer (114). The first generated .pdb file in 
the first cycle of building, displayed several subunits with no apparent symmetrical 
arrangement, although some of them resembled the fold of HK97 gp5 (Figure 44b, left). By the 
end of the final cycle, Buccaneer built 1,562 residues (out of 1,620 for a pentamer) in 39 
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fragments arranged in 5 chains in the asymmetric unit. The completeness of every chain was 
86.4 % (Figure 44b, centre and right). The final model involved five copies of G13P arranged in 
a circular structure.  
Interestingly, every pentamer is tightly surrounded by six pentamers, as it was a hexamer, 
producing a hexagonal lattice when viewed along the Z axis (Figure 44c and Figure 46c). This 
observation points out that the subunits from the pentamer establish different contacts with the 
neighbouring pentamers in order to be packaged as a hexamer.  
Pentamers exhibited a head-to-head and tail-to-tail packaging in the unit cell since the top of 
each pentamer (tower loops from the A-domain) face the top region of another pentamer. 
Likewise, the tail (bottom of the P-domains) faces the tail of another pentamer (Figure 44c).  
4.2.2 Refinement and validation 
Several modifications of the model built by Buccaneer involving the removal of inserted 
residues or random fragments, merging fragments from the main chain and sequence 
renumbering were carried out in Coot (Figure 45a,b). The side chain rotamers and 
Ramachandran outliers were adjusted using the validation tools from Coot followed by 
refinement in reciprocal space with Refmac5 (115). The final value of the R was 24.4 (37.1) % 
(Rfree =  26.5 (37.6) %). The complete refinement statistics can be found in Table 9. At the 
current resolution of 3.0 Å, some side chains atoms, especially the loops residues, were not 
clearly defined in the electron density maps (Figure 45c-e). 
The extended loop (E-loop) represented the most difficult part to conform with the 
Ramachandran plot (Figure 45 c-e). Electron density was observed for most of the E-loop Cα-
backbone but not all the side chains were defined. This portion was removed from the initial 
model and manually rebuilt using omit maps to improve the fit. After a few cycles of 
refinement, some positive density buds indicated where some side chains could be positioned.  
Using NCS during model building, the sequence of the loop could be assigned and most of the 
loops were completed. Electron density for a large fraction of the E-loop from subunit E was not 
observed (details on Chapter 5). Subunit E differs from the rest of the subunits only at this 
region. There was only electron density for the start and end of the E-loop. 
The final model showed good stereochemistry with 96.32 % of the residues located in the 
preferred regions of the Ramachandran plot, 2.86 % in the additionally allowed regions and 0.82 
% were outliers (Figure 45a).  
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Figure 45. Model validation 
(a) Ramachandran plot. The blue triangles correspond to glycine residues. (b) Rotamer analysis. The 
purple bars indicate residues with truncated side chains. (c-e) E-loops from the pentamer assembly. The 
E-loop in (c) belongs to subunit E. The electron density maps from the 3.0 Å resolution G13P Se-Met 
structure are contoured at 1 σ. 
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4.2.3 Structure determination of the native protein by Molecular replacement  
The refined structure of Se-Met G13P was used to determine the structure of the “native” 
protein by MR (Figure 46). Electron density was visible for the A- and P-domains but not for 
the E-loop (Figure 46a).  
A remarkable difference between native and Se-Met crystals is the arrangement of molecules 
(Figure 46). While in the Se-Met crystals, subunits are organised in symmetric pentamers, in the 
native crystals no hexameric or pentameric arrangement is detected. Instead, every subunit uses 
different surfaces to interact with several neighbours. Part of one P-domain rests in the cavity 
formed by the A- and P-domains from another subunit, whilst other area at the bottom of the 
same P-domain faces another P-domain.  
 
 
 
Figure 46. Molecular replacement on native crystals 
(a) MR performed with subunit E as search model. (b) Representations of the crystal contacts for the 
subunit in red. Circles and stars indicate subunits at the back and front of the subunit in red, respectively. 
 
Refinement of the native structure was in progress at the time when this chapter was written, a 
finished version of it will be available in a corresponding publication. 
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4.3 Conclusions 
The structure of SPP1 u-G13P_FL_T104Y;A261W was solved at 3.0 Å resolution by SAD. 
Crystals belonged to the space group R 32.  
The Se-Met model enabled structure determination of the lower-resolution native crystals using 
MR. The structure of the native protein was solved at 3.6 Å resolution. The proteins differ in the 
conditions and space group they crystallised in. There appear to be differences in the structures, 
with the most significant being the absence of interpretable electron density corresponding to 
the E-loop in the native crystals. 
The conditions where both crystal forms grew suggested that high salt could shift the 
oligomerisation state of u-G13P_FL_T104Y;A261W from monomer (crystals grown in 0.2 M 
Sodium malonate) to pentamer (crystal grown in 2.0 M (NH4)2SO4). No additional X-ray data 
sets for Se-Met or native crystals were collected to establish an oligomerisation pattern, 
although several crystals of Se-Met protein grew in very similar conditions. Based on visual 
inspection, it is expected that these crystals are ordered in a similar way to those from which the 
X-ray structure was determined.  
At the time this thesis was submitted, X-ray structures of the capsid proteins were available only 
for bacteriophages HK97 (39) and T4 (37), while cryo-EM studies identified the HK97-fold in a 
number of viral capsids. Until now, no X-ray structure of a stand-alone native capsid protein 
was reported. The limited X-ray structural information on capsid proteins is most probably due 
to difficulties associated with the crystallisation. The resolution of the SPP1 G13P X-ray 
structure (this study) is comparable to the resolution achieved during structural studies of HK97 
and T4 capsid proteins (Table 10) and other capsid-like structures.  
 
Table 10. Comparison of X-ray statistics of capsid/capsid-like proteins structures 
 SPP1
¥
 HK97
*
 T4 Bb_PhRP PfV Encapsulin 
T. maritima* 
Resolution (Å) 3.0 3.45 2.90 2.05 3.6 3.1 
Mean ((I)/sd(I)) 2.9 1.9 8.42 1.91 1.85 1.32 
R-factor 0.247 0.373 0.27 0.186 0.268 0.22 
Rfree 0.265 0.374 0.3 0.227 0.267 0.239 
Ramachandran  
outliers (%) 
0.82 2.8 3.6 0.1 2.2 2.2 
Rms BondLength 
(Å) 
0.007 0.010 NA 0.013 0.010 0.009 
Rms BondAngle 
(°) 
1.27 1.40 NA 1.40 1.37 1.33 
PDB Pending 1OHG 1YUE 3BJQ 2E0Z 3DKT 
¥ Latest model version. * Values for the complete capsid or capsid-like structure. 
The mean ((I)/sd(I)) corresponds to the outershell values. 
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Chapter 5 
5. Structure of SPP1 capsid protein 
Chapter 5 describes in detail the 3.0 Å resolution X-ray structure of the SPP1 capsid protein 
uG13P_FL_T104Y;A261W construct (referred to as G13P henceforth). G13P was compared 
with (i) capsid proteins from phages HK97 and T4 and (ii) capsid-related proteins, e.g., PfV and 
encapsulins.  
 
5.1 SPP1 G13P monomer and crystallographic oligomer 
5.1.1 Monomer 
The G13P monomer has a mixed α/β structure that comprises nine α-helices, one 310 helix, 
eighteen β-strands and several loops of varying length (Figure 47 and Figure 48a). G13P folds 
into three spatially distinct regions: the axial (A-) and peripheral (P-) domains and the extended 
loop (E-loop), all named following the same convention as for the HK97 phage.  
The main core of the globular A-domain comprises seven clustered antiparallel β-strands with 
helices α7 and α8 at each side of the cluster. The principal features of the elongated P-domain 
are the N-terminus which makes up helix α1, the long helix α5, and the antiparallel strands β5 
and β15, which span half of the P-domain length. The E-loop is a 28 residues-long curved 
polypeptide chain that accounts for half of the P-domain length. The E-loop can be considered 
as extension of the P-domain that connects strands β2 and β4. Both domains are connected by 
three short linkers (Figure 47 and Figure 48).  
The introduced mutations T104Y and A261W were located exactly where predicted by the PSI-
BLAST alignment, validating the use of the HK97 structure for initial analysis of possible 
mutations. The T104Y mutation is located on helix α4 in P-loop 1 (PL-1), while A261W is 
located at the PL-2, which connects strands β14 and β15. 
 
5.1.2 Oligomer and inter-subunit contacts 
Although the G13P double mutant exists as monomer in solution (Figure 31b), in the crystal, 
five copies of G13P form pentameric assemblies (Figure 48b,d). The overall atom-to-atom 
diameter of the pentamer is 110 Å. The diameter of the internal tunnel is ~ 8 Å.  
Within the pentamer, five A-domains are in close proximity, positioned at the centre of the 
pentamer. Helices α7 and α9, enclose the antiparallel β-strands forming a ring of intercalating 
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helices. The P-domains are situated at the periphery of the structure, defining the sides of the 
pentamer. The E-loop of one monomer sits over the P-domain of the right-hand neighbouring 
subunit. Specifically, every E-loop covers the PL-1 and part of helix α5 and strands β5 and β15. 
Other characteristics of the assembly are the tower of loops on top of the pentamer formed by 
the loops connecting β6- α7 and β11- β12 (Figure 48b,d). 
 
 
Figure 47. G13P topology 
Structure cartoon of G13P generated with the Pro-origami server (104). The α-helices are coloured in red, 
310 helices in magenta, β-strands in blue and N- and C-termini in yellow. The A- and P-domains are 
contoured with cyan dashed lines. The E-loop and PL-1&PL-2 are squared using pink and purple lines, 
respectively. The introduced mutations are indicated with green triangles. Helices α5, α7 and α9 are 
labelled with a star (*).The length of α-helices and β-strands drawn approximately to scale.  
 
106 
 
 
Figure 48. SPP1 G13P X-ray crystal structure 
(a) Ribbon diagram of G13P. Domains and main secondary structure elements are labelled. The area 
where mutations were introduced is enlarged in (c). Mutations are shown in ball and stick representation. 
Top (b) and side (d) views of the crystallographic pentamer with every subunit in a different colour. 
Diameters of the pentamer and tunnel are indicated (atom-to-atom distance). The location of the missing 
E-loop in subunit E is shaded in grey. (e-f) Flexible loops in G13P. 
 
The position and length of the secondary structure elements is the same in the five subunits of 
the pentamer. Conversely to the folded regions, loops PL-2, E-loop, loops β11-β12, β8-β9 and 
β6-α7 are highly flexible (Figure 48e,f). 
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The extent of flexibility of PL-2 confirmed that the adopted approach to substitute it with a 
folded Zn-binding domain from AT was in theory feasible, although it proved to be 
unsuccessful, presumably due to affecting the fold of the protein. 
One unexpected difference in fold between subunits, was observed in subunit E (between A and 
D), which lacks most of the E-loop. As aforementioned in section 4.2.2, electron density for 
residues 60-80 was missing. The portion left of the E-loop, superimposes perfectly with its 
counterparts in other subunits. Since only one subunit lacks the E-loop, it is proposed that fitting 
a fifth subunit in the pentamer results in the increased flexibility of the E-loop of this subunit. 
Furthermore, the loop’s flexibility suggests that during capsid assembly, in each copy of G13P 
the loop adjusts its conformation to fulfil the required roles of both pentamers and hexamers. 
The intrinsic flexibility is reflected in the missing density in subunit E in the Se-Met structure 
and in the G13P monomer present in crystals of the native construct. Since in the Se-Met 
structure, loop’s flexibility (lack of electron density) is observed only for one subunit, 
proteolytic cleavage or degradation are unlikely.   
The pentamer is held together by combination of H-bonds and salt bridges (SB) that repeat in 
every inter-subunit interface (Table 11,Table 12, Figure 49). On average, every subunit-subunit 
interface buries 1,379.4 Å
2
 of surface and contains nineteen H-bonds and seven salt bridges 
(SB). G13P contains not Cys residues hence there are no disulphide bridges to stabilise the 
pentamer. It is deduced that every subunit establishes 38 H-bonds with its two neighbours. In 
comparison, subunits from the hexamer in the HK97 asymmetric unit, establish 64 H-bonds.  
 
Table 11. Pentameric G13P interfaces* 
Structure 1 Structure 2 Interface 
area Å2 
Δ
i
G 
Kcal/mol 
NHB NSB NDS 
Subunit iNat 
i
Nres Surface Å
2 Subunit iNat 
i
Nres Surface Å
2 
A 174 52 16,808 B 153 44 16,701 1,469.3 -7.2 20 7 0 
B 169 48 16,701 C 150 43 16,610 1,499.3 -10.1 20 7 0 
C 171 50 16,610 D 142 39 16,560 1,476.8 -8.6 15 5 0 
D 127 36 16,560 E 100 28 15,253 1,027.0 -2.1 19 10 0 
E 172 53 15,253 A 136 35 16,808 1,424.7 -12.0 21 7 0 
       Average 1,379.4 -8.0 19 7 0 
*. Table calculated with the PDBePISA server (105). All definitions were extracted from the output file.  
i
Nat - Number of interfacing atoms in the corresponding structure.  
i
Nres - Number of interfacing residues in the corresponding structure. 
Surface Å2 - Total solvent accessible surface area in square Angstroms. 
Interface area Å
2 
- Difference in total accessible surface areas of isolated and interfacing structures divided by two. 
ΔiG - Solvation free energy gain upon formation of the interface, in Kcal/M. Negative ΔiG corresponds to 
hydrophobic interfaces, or positive protein affinity. 
NHB - Number of potential H-bonds across the interface. 
NSB - Number of potential salt bridges across the interface. 
NDS - Number of potential disulphide bonds across the interface. 
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Table 12 lists the H-bonds established by chain B at the AB and BC interfaces (Figure 49). 
Twenty H-bonds are formed in both interfaces mainly where the A-domains converge and 
where the E-loop sits over the adjacent P-domain.  
At the A-domain interface, helices α7-α9 and strands β8-β9 from different subunits are 
responsible for ~35 % of the H-bonds, however the area of extensive interaction occurs at the E-
loop-P-domain region. In both areas, several charged and polar residues, predominantly Arg, 
Asp and Ser, create a network of H-bonds that stabilises the pentamer and is reproduced in 
every interface. On Table 12 it is shown that the residues forming H-bonds from chain A at the 
interface AB are mostly the same that chains B uses to form H-bonds with chain C at the 
interface BC, with slight variation.  
In the HK97 asymmetric unit (head II), the same areas of contact are observed though the 
number of H-bonds is larger due to the presence of the N-arm, which slides below the start of 
the E-loop of the left-hand adjacent subunit (39). In G13P no N-arm is present (See section 5.2).  
 
Table 12. H-bonds established by subunit B* 
 Interface AB  Interface BC 
##     Subunit A     Dist. [Å]   Subunit B ##     Subunit B    Dist. [Å]   Subunit C    
 1   ARG 117[ NH1]    2.4    ASN  60[ O  ]   1    ASP 100[ O ]  3.5   ASN  60[ ND2]   
 2   ARG 117[ NH2]    2.9    LEU  62[ O  ]   2    GLU 125[ OE2]   2.7   SER  66[ N  ]   
 3   TRP  96[ NE1]    2.7    ASP  63[ OD1]   3    GLY  93[ O  ]   3.3   GLN  67[ N  ]   
 4   ARG 117[ NE ]    3.3    ASP  63[ OD1]   4    LEU  91[ O  ]   2.9   LEU  69[ N  ]   
 5   ARG 117[ NH2]    3.0    ASP  63[ OD1]   5    THR 291[ OG1]   2.2   ASN  70[ ND2]   
 6   TYR 121[ OH ]    2.6    GLY  64[ O  ]   6    ARG 207[ O  ]   3.7   ASN 213[ ND2]   
 7   ARG  92[ NH1]    3.5    SER  66[ OG ]   7    SER 106[ OG ]   3.5   ASP  39[ OD2]   
 8   E:ARG  92[ NH1]    3.4    SER  66[ O  ]   8    ARG 117[ NH1]   2.8   ASN  60[ O  ]   
 9   GLY  93[ N  ]    3.4    GLN  67[ O  ]   9    ARG 117[ NH2]   3.7   LEU  62[ O  ]   
 10   LYS 192[ NZ ]    2.4    GLU 161[ OE2]   10    TRP  96[ NE1]   3.1   ASP  63[ OD1]   
 11   ARG 207[ NH1]    3.7    LYS 200[ O  ]   11    ARG 117[ NH2]   3.1   ASP  63[ OD1]   
 12   LYS 200[ NZ ]    2.8    SER 202[ OG ]   12    TYR 121[ OH ]   2.9   GLY  64[ O  ]   
 13   GLU 125[ OE2]    2.4    SER  66[ N  ]   13    ARG  92[ NH1]   3.6   SER  66[ OG ]   
 14    E:GLU 125[ OE2]    2.6    SER  66[ OG ]   14    GLY  93[ N  ]   3.2    GLN  67[ O  ]   
 15    E:GLY  93[ O  ]    3.2    GLN  67[ N  ]   15    THR 291[ N  ]   3.8    ASN  70[ OD1]   
 16    E:ASN  94[ OD1]    3.3    GLN  67[ NE2]   16    LYS 192[ NZ ]   3.7    GLU 161[ OE1]   
 17    E:LEU  91[ O  ]    3.3    LEU  69[ N  ]   17    ARG 124[ NH2]   3.0    ASP 172[ OD2]   
 18    E:ASP 220[ OD2]    2.5    HIS 173[ NE2]   18    ARG 124[ NH2]   3.1    SER 175[ OG ]   
 19    E:SER 184[ OG ]    3.9    HIS 173[ NE2]   19    LYS 200[ NZ ]   3.9    SER 202[ OG ]   
 20    E:ARG 207[ O  ]    3.6    ASN 213[ ND2]  20    ARG 207[ NE ]  3.8    ASN 213[ OD1]   
*. Table calculated with the PDBePISA server (105). 
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Figure 49. Intersubunit H-bonds in pentameric G13P 
(a) Side view of the interface BC. (b) A-domain interface. Residues forming H-bonds are shown in ball 
and stick representation. Residues from subunit B are labelled in purple. (c) E-loop-P-domain interface.  
 
The top view of the electrostatic potential representation of the pentamer, assigned as the outer 
capsid surface, exposes several positively charged residues that are arranged with 5-fold 
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symmetry (Figure 50). It may be expected that DNA containers such as capsids would display 
many positively charged side-chains at their inner surface to interact with DNA; nevertheless, 
the inner surface of G13P pentamer has few positive residues at its centre and periphery. 
Residues at the periphery of the pentamer are located at the bottom part of the P-domain, 
therefore they are likely to directly face other P-domains within a complete capsid particle and 
they might not be exposed to the inner surface. The overall negative charge inside the capsid 
must create an energy barrier during translocation of the negatively charged DNA into the 
procapsid. This repellent force offered by the inner surface could potentially contribute to drive 
the DNA out of the capsid during cell infection.  
 
 
Figure 50. Electrostatic surface representation of G13P pentamer 
Top (a), bottom (b) and side (c) views of the G13P pentamer. Exposed residues are indicated. The five-
fold symmetry breaks where the E-loop is absent on chain E  
 
Electrostatic surface representations of the G13P and Bb_PhRP pentamers and of the icosahedral 
asymmetric units of HK97 and T. maritima encapsulin showed that their outer and inner 
surfaces do not follow a pattern of charge (not shown). 
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All these oligomers expose a large number of positively charged residues at the outer surface 
(top view). In contrast, no pattern of charge is observed at the inner surface: HK97 and T. 
maritima encapsulin have more positively charged residues in comparison with the G13P 
pentamer and Bb_PhRP, that have a reduced number of positively charged residues. The 
biological significance for the presence of positive charge covering the virus it is not known.  
 
5.2 Structural comparison with HK97 and T4 capsid proteins and with 
other capsid-related proteins 
Despite the low sequence homology between capsid proteins or capsid-related proteins that 
exhibit the HK97-fold the adopted tertiary structure is remarkably similar (Table 13, Figure 51 
and Figure 53). Monomers from the hexameric and pentameric HK97 gp5 assembly superpose 
onto SPP1 G13P monomer, with a Cα rmsd of 3.03 Å (173 residues) and 2.99 Å (174 residues), 
respectively.  
Whilst SPP1 G13P has seven antiparallel β-strands at the core of the A-domain, HK97 gp5 has 
six. One additional common feature in this domain is the presence of the two α-helices (α7 & α9 
in SPP1, α5 & α6 in HK97 (Figure 6)) from the A-domain, which together with helix α5 (α3’ in 
HK97) and the E-loop represent the most emblematic features of the HK97-fold. These three α-
helices are rapidly identified from cryo-EM maps of complete capsids to produce cryo-EM 
protein models. The organisation of the P-domains is also comparable between G13P and gp5. 
In SPP1 G13P, helix α5 finds its counterpart in helix α3’ in HK97. Most of the long β-strands 
that define the bottom of the P-domain are found in G13P, although β2 & β4, equivalent to βB 
& βC in HK97, are shorter. 
Table 13. Structural superposition with G13P 
Moving model rmsd (Å) Residues aligned Total residues of 
moving model 
HK97 gp5-Hexamer-capsid 3.03 173 281 
HK97 gp5-Pentamer-capsid 2.99 174 281 
HK97 gp5-Hexamer-procapsid I 3.10 186 265 
HK97 gp5-Hexamer- procapsid II 3.29 187 265 
T4 gp24 2.98 201 409 
Bb_PhRP 3.23 189 300 
PfV 3.06 173 236 
T. maritima encapsulin 3.95 177 264 
HK97 pentamer capsid* 2.89 194 1405 
HK97 pentamer procapsid I* 1.269 34 1325 
Bb_PhRP * 5.73 770 1502 
T. maritima encapsulin* 5.33 770 1320 
PfV* 3.67 821 1180 
G13Pʼs structure length = 323 residues, Crystallised pentamer= 1600 residues. 
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Star (*) indicates crystallised or extracted from capsid pentamer assembly. 
 
The principal differences with HK97 gp5 are found in the N-terminus and the E-loop. The N-
terminus in G13P folds into two α-helices behind helix α5. The same region in HK97 exists as 
an extended polypeptide chain located above α3’. When viewed from top, the E-loop remains 
lined up with the P-domain in HK97 gp5 (hexamer). On the contrary, in G13P the E-loop 
creates an angle with the P-domain bending towards the five-fold axis. G13P bends more than 
the E-loop from pentameric gp5, suggesting that the conformation of the crystallised G13P 
might slightly vary at this region from the G13P present in the capsid (considering that the folds 
are rather alike and the T numbers the same) (Figure 51).  
 
 
Figure 51. Structural comparison of SPP1 and HK97 capsid proteins. 
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It is known that subunits of HK97 in the pentamer and hexamer structures only vary in 
conformation of the E-loop. It is expected that the SPP1 G13P follows the same behaviour, e.g. 
E-loop is lined up with the P-domain in the hexameric arrangement and acquires a more bent 
conformation in pentamers. The possibility of other differences between the crystallised G13P 
and that in the capsid cannot be ignored since the fold of the N-terminus and loops at the top of 
the A-domain is distinct from their counterpart in HK97. The N-terminus of G13P could be 
involved in interactions with the scaffolding protein, G11P, like the N-terminus from HK97 gp5 
is involved in directing the assembly of the procapsid (40). Additionally, the β8-β9 loop could 
adopt a position close to the top of the A-domain near helices α7 & α9 and thus close to the 
centre of the hexamer (or pentamer) as in HK97 (Figure 51b right). A spike of electron density 
of ~ 15 Å in diameter, attributed to G12P, was observed at the centre of the hexamers in 
decorated SPP1 capsids (41). The potential binding sites for G12P on G13P are the β8-β9 loop 
and helices α7 and α9 since they would be the elements closer to the 6-fold axis in the 
hexamers.  
Information concerning conformational changes in G13P during viral maturation is not 
available, although it is known that at the late stages of the assembly, the capsid does not 
undergo major changes in size (41). Based on the structural rearrangement that HK97 gp5 
undergoes during the transition from procapsid to mature capsid it is speculated that the 
crystallised G13P is likely to represent the state found in the mature capsid for two reasons. 
First, in the HK97 procapsid, the E-loops are closely packed against the A-domains, while in the 
mature capsid (like in G13P) they extend away (Figure 51). The second reason is the 
conformation of the long helix spanning half of the P-domain. In HK97 procapsids I and II, 
helix α3’ acquires a bent conformation while in the mature capsid it is not bent. In G13P, helix 
α5 is also not bent.  
 
Figure 52. Structural comparison of SPP1 and T4 capsid proteins. 
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T4 gp24 superposes onto G13P with a Cα rmsd of 2.98 Å for 201 residues. The same 
characteristics at the A- and P- domains that G13P shares with HK97 gp5 are also found in T4 
gp24. gp24 includes an insertion domain (chitin binding-like domain) absent in G13P. 
 
In T4 the insertion domain is suggested to play an analogous role in virus particle stabilisation 
to the covalent bond between residues K169 and N356 in HK97 since they occupy the same 
position that the E-loop in HK97, where K169 is located. Moreover, the interface created 
between the insertion domain and P-domain of adjacent subunits was found to have 
complementary hydrophobic and polar patches (37). In SPP1 there is no insertion domain 
analogous to those present in T4 (37), P22 (43) or φ29 (38) capsid proteins, or cementing 
protein like gpD in λ phage (53) or Soc in RB69 (T4-like) phage (120). Covalent bonding 
between G13P subunits has not been identified. From the PSI-BLAST used to design mutants in 
this study, it is clear that the HK97 residues responsible for the covalent bond, are absent in 
SPP1 (Figure 26). In G13P’s structure the sequence of the region where K169 in gp5 is located, 
is 72-TDDLV-76 (E-loop), and the sequence of the PL-1, where N356 is located, is 263-
GSQDI-267. The mechanism SPP1 uses to keep subunits together to bear the high pressure 
inside the capsid remains to be investigated. Further information will be available once G13P’s 
structure is fitted onto the EM-map of the complete capsid. 
 
A set of capsid-related proteins exhibiting the HK97-fold was superposed onto G13P. The Cα 
rmsd values for the superposition of A-subunits are as follows: Bb_PhRP (3.2 Å for 189 
residues), PfV (3.1 Å/173), T. maritima encapsulin (4.0 Å/177), M. xanthus encapsulin (3.4 
Å/180) and Ec_Pcp (3.6 Å/204) (Figure 53). (Not all the structures were included to keep the 
illustration clear). All structures display an α-helix at the N-terminus and the same overall 
organisation in A- and P-domains. The region where most fold discrepancies are detected is the 
E-loop. The E-loop is absent in Ec_Pcp and it is shorter in PfV. Although such loop in 
Bb_PhRP and T. maritima encapsulin is of comparable size to that in SPP1 and HK97, the fold 
exhibits some differences. In Bb_PhRP there is an extra α-helix which disrupts continuity of the 
loop and in T. maritima encapsulin it protrudes away from the P-domain, sticking out of the 
pentamer.  
 
115 
 
 
Figure 53. Structural comparison of proteins with the HK97-fold 
 
5.3 Structure-based analysis of modifications made to G13P 
In section 3.3 the logic to design single and double mutants was explained. This approach 
validated by the G13P’s X-ray structure since all mutated residues are located where initially 
predicted. Furthermore, in section 3.3.5 a potential mechanism by which mutations T104Y and 
A261W prevented aggregation was proposed.  
Truncated G13P versions illustrate the importance of secondary structure elements in protein 
solubility and inter subunit interactions. G13P_ΔC, which lacked strands β17&β18 and helix 
α10, was among the completely insoluble constructs. Its reduced solubility suggests that this 
portion promotes the correct folding of the adjacent elements, e.g. without strand β18, 
sandwiched between β6 and β12, the A-domain would collapse.  
Another subset of truncations at the N-terminus comprising G13P_ΔN15, ΔN21 and ΔN35 was 
insoluble. These constructs lacked a portion or all of the two helices, α1 and α2 (like ΔN35). 
The N-terminal segment could stabilise helix α5 and the β-strands at the bottom of the P-
domain. Constructs G13P_ΔN2, ΔN6 and ΔN10, lacking short segments of the polypeptide 
chain before helix α1 where soluble but aggregated (G13P_ΔN2 yield was extremely low after 
NAC and no SEC was performed), which suggests that the N-terminus is vital for the protein 
fold, but does not participate in inter-subunit contacts as only double mutants, with no 
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truncations, did not aggregate. The X-ray structure of G13P has shown that the truncation of 
complete secondary structure elements both at the N- or C-termini produced insoluble protein 
probably because these elements are essential for protein fold. 
 
5.4 The capsid protein as a marker of evolution  
dsDNA bacteriophages are the most abundant microorganisms on earth (1). Several studies 
point out that the HK97-fold is the archetype in the Caudovirales order (Figure 7), hence it 
could be the most widespread fold in viruses (121). This fold has not only been found in viruses 
infecting members of the Bacteria domain but also members of the Archaea (44) and Eukarya 
domains (122). 
The presence of the HK97-fold in Archaea was demonstrated by the finding of virus-like 
particles in Pyrococcus furiosus (44). The HK97-fold has also been identified in the eukaryotic 
viruses, specifically in the Herpesvirales order. From the cryo-EM structure of HSV-1 
determined at 8.5 Å resolution (122), it is thought that the floor domain of the capsid protein 
VP5, has a fold similar to HK97 gp5. This prediction is based on comparable dimensions and 
capsomers spacing and similar pattern of sequence-predicted secondary structure elements 
(123). However, since an X-ray structure is available only for the upper domain of VP5 (124), 
confirmation of the presence of the HK97-fold should await the X-ray structure determination 
of a full-length VP5. 
The HK97-fold is not, however, the only fold found in dsDNA viruses adopted to construct their 
capsids (Figure 54) (reviewed in references (42,125) ). Other common folds include the “viral 
jelly roll” or “viral β-barrel”, with the PRD1 virus as prototype (126). The BTV-fold (127) is 
another widespread fold, found in dsRNA viruses. Additionally, ssRNA Sindbis (128) and MS2 
(129,130) viruses use capsid proteins with alternative folds to build their capsids. 
The fact that capsid proteins of dsDNA phages have a common fold has led to a hypothesis that 
these viruses have evolved from a common ancestor, although deviations from the fold, like in 
the case of insertion domains, e.g. T4 (37), P22 (43) and φ29 (38) capsid proteins, or folded N-
termini, e.g. SPP1 (this study) and T4 capsid proteins, can occur (42,121,125,131-133).  
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Figure 54. Folds observed in viral capsid proteins 
(a) SPP1 G13P representing the HK97-lineage. (b) VP3 BTV representing the BTV-lineage, PDB 2BTV. 
(c) PRD1 P3 representing the PRD1-like lineage, PDB 1HX6. (d) MS2 capsid protein, PDB 2MS2. (e) 
Sindbis virus capsid protein, PDB 2SNW. 
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5.5 Conclusions 
 
The X-ray structure of the SPP1 capsid protein, G13P revealed that it has the HK97-fold, 
comprising an axial- (A) and peripheral (P) domains and extended (E-) loop. G13P crystallised 
in pentameric assemblies with the A-domains at the centre of the pentamer and the P-domains at 
its periphery. The E-loop rests on top of the neighbouring subunit. Both the fold and 
arrangement of subunits in the crystallised pentamer resemble those adopted by the HK97 
capsid protein gp5. The same fold has been observed in T4 capsid protein and capsid-related 
proteins of encapsulins and virus-like particles found in Pyrococcus furiosus.  
Structural analysis revealed that the pentamer is stabilised by several H-bonds and salt bridges 
and that the inner and outer surfaces have a partial negative and positive electrostatic charges, 
respectively. The produced structure explained why truncated versions of G13P were either 
insoluble or aggregated. The mutagenesis approach carried out to prevent aggregation into 
aberrant capsids was validated by this structure since both targeted residues where located 
where predicted on the basis of secondary structure prediction and multiple iteration PSI-
BLAST alignment with HK97. 
To date, G13P is the third capsid protein from a dsDNA bacteriophage for which the X-ray 
structure has been elucidated. As expected, it exhibits the HK97-fold further confirming the 
evolutionary relationship between dsDNA bacteriophages and evolution of Caudovirales from a 
common ancestor.  
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Chapter 6 
6. Production of full length and truncated G20C small terminase 
protein  
In order to grow crystals and assess the DNA-binding activity of the WT and truncated ST 
protein the WT protein and its Se-Met derivative were purified by chromatography. As both WT 
and Se-Met proteins were purified using identical protocols, only purification of the Se-Met 
protein (used for structure determination) is described in this chapter. The WT protein was used 
to perform the DNA-binding experiments. The three truncated versions of the WT protein were 
designed once the ST’s X-ray structure became available, to assess which structural domains are 
responsible for DNA-binding. Purification and crystallisation of these truncated versions is 
described in this chapter.  
 
6.1 Production of the G20C WT small terminase 
The following paragraphs describe how the purification of the Se-Met ST_WT, used for 
crystallographic studies, was carried out. The native protein was purified in the same way with 
the exception that AEC was omitted. The protocol by which the native G20C ST_WT was 
purified and crystallised has been published (134).   
It was possible to locate the ST gene based on sequence homology with the hypothetical STs 
from other thermophilic phages. The ST is usually encoded by a gene immediately preceding 
the LT and portal protein genes (motor operon). Such a gene has been identified in the G20C 
genome, with a size typical for a ST protein. This gene corresponds to the ORF P23p84 
(UniProtKB/TrEMBL A7XXB6) and to ORF P74p83 (UniProtKB/TrEMBL A7XXR0) in the 
closely related phages P23-45 and P74-26, with which G20C ST shares 99 and 98 % sequence 
identity, respectively. (Appendix 10) (7). 
The full-length gene encoding the hypothetical G20C ST was cloned into the expression vector 
pET28a between NdeI and HindIII restriction sites. B834 cells were transformed with the 
recombinant DNA and grown in Se-Met medium at 16°C to produce the POI at large scale. The 
induction was made with 1 mM IPTG. 
To proceed with NAC, the pelleted bacteria were resuspended in 25 mM Tris pH 7.5, 500mM 
NaCl, 10 mM imidazole and sonicated according to the described protocol. The NAC profile 
consisted of two peaks (Figure 55). Peak 1 contains numerous proteins that bound to the nickel 
beads with low affinity and a small amount of the ST_WT protein. Peak 2 contains less 
contaminants and the ST_WT is present in considerably higher amount than in peak 1. Fractions 
from peak 2 were pooled together to remove the N-terminal His-tag by thrombin protease-
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cleavage; at the same time the sample was buffer exchanged to remove imidazole. A second 
NAC was performed to separate the digested and non-digested samples. The digested sample, 
which included no tag, eluted in the flow-through of the purification. This flow-through was 
buffer exchanged to low salt-buffer in order to perform AEC (Figure 55b). The adsorbed sample 
was eluted with 25 mM Tris pH 7.5, 1 M NaCl. The AEC profile contains a single peak. SDS-
PAGE analysis of this major peak revealed that the sample still contains some contaminants. A 
final separation by size was made to remove other contaminants. The SEC profile shows one 
main specie eluting at 62 mL (Table 14) (Figure 55c). Fractions from SEC were pooled together 
and concentrated to setup crystallisation experiments (section 6.3.1). 
 
Figure 55. Purification of ST_WT 
(a) NAC profile and its corresponding SDS-PAGE. Only few fractions from peaks 1 and 2 are shown. (b) 
AEC for thrombin digested ST_WT sample. (c) SEC using a S200 16/60 column. Shaded areas were not 
concentrated. For (b) and (c) gels illustrate how the purification process evolved at every stage. (d) SEC-
MALLS for ST_WT. 
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ST_WT was loaded onto a SEC-MALLS column (Figure 55d) to determine MW. The 
calculated MW (167 kDa) is in good agreement with the expected MW of a 9-subunit oligomer 
(171.7 kDa). A comparison of oligomerisation states between ST will be made in Chapter 8. 
 
Table 14. SEC and SEC MALLS of ST_WT and constructs 
Construct Elution volume 
16/60 columns (mL) 
Elution volume 
10/30 columns (mL) 
Expected MW 
(kDa) 
Determined MW 
SEC-MALLS (kDa) 
ST_WT 62 10.4 19.1  162.7/9 = 18.1  
ST_ΔC 74 12 15.8 133.1/9= 14.8  
133.1/15.8= 8.4 
ST_ΔN 67 10.6 13.1 120.4/9= 13.4  
ST_NTD 82.3 17.4  6.2 7  
 
6.2 Design and purification of ΔC, ΔN and NTD constructs 
Several truncations based on the G20C ST_WT X-ray crystal structure were introduced to 
investigate the effect of removing individual domains or segments on DNA-binding compared 
to the ST_WT (Figure 56). Construct ST_ΔC (residues 1-138) included the NTD and OD, but it 
lacked the sequence-predicted α-helix that was disordered in the structure. Construct ST_ΔN 
(residues 54-171) included the predicted C terminal α-helix and OD. The third construct 
consisted of the NTD only (residues 1-52). The properties of each construct can be found in the 
appendix 3. 
ST_ΔC and ST_NTD constructs were produced by introducing a stop codon in primers so that 
both constructs remained in the same pET28a vector, containing the same restriction sites as the 
WT construct with an N-terminal His-tag (Appendix 1). Construct ST_ΔC was amplified by 
PCR and inserted into the LIC-3C vector that also includes an N-terminal His-tag cleavable by 
the 3C protease.  
All constructs were expressed in large scale using B834 cells at 16°C, with induction by 1 mM 
IPTG. The first NAC was performed in 25 mM Tris pH 7.5, 250mM NaCl. The eluted samples 
were digested with either thrombin or 3C proteases to carry out a second NAC followed by SEC 
(Figure 56b). The constructs ST_ΔC, ΔN and NTD eluted as one main species at ~ 74, 7 and 
82.3 mL, respectively (Table 14).  
Intriguingly, ST_ΔC and ST_ΔN did not migrate in the SEC column as expected. Assuming that 
both constructs keep the same oligomerisation state than the WT, nine copies of ST_ΔC (9 x 
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15.8 kDa = 142.1 kDa) are expected to elute faster than nine copies of ST_ΔC (9 x 13.1 Da= 
118.2 kDa) as the latter would be delayed for longer because of its smaller size. 
 
Figure 56. Constructs of G20C ST that have been purified 
(a) Secondary structure of ST constructs. The first and last residues of every construct are indicated. Star 
(*) corresponds to the JPRED prediction of α6-helix. (b) SEC performed in a S200 16/60 column for 
ST_WT, ST_ΔC, ST_ΔN and a S75 16/60 column. Fractions from every run are displayed at the right 
side of the chromatogram. The percent (w/v) of polyacrylamide is indicated below the gels.  
 
SEC was repeated for all the constructs in a S200 10/30 column equilibrated with 20 mM Tris 
pH 7.5, 1 M NaCl to further assess their behaviour (Figure 57a). The NTD eluted at 17.4 mL. 
ST_ΔN (12 mL) eluted later than ST_ΔC (10.6 mL) suggesting a change in the conformation or 
oligomerisation state of ST_ΔC.  
Fractions from the run in the S200 10/30 SEC column were loaded onto a 15 % (w/v) 
polyacrylamide gel. While the WT protein migrated similarly to the 21.5 kDa standard, ST_ ΔC 
and NTD migrated faster than the 6.5 kDa standard, as expected for smaller proteins. More 
intriguing is the finding that even in polyacrylamide gels ST_ ΔC behaved as a protein smaller 
than ST_ ΔN.  
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Figure 57. Characterisation of G20C ST constructs 
(a) Analytical SEC in a S200 10/30 column. Fractions from individual runs were analysed in SDS-PAGE 
(left side). (b) Analytical SEC in varying NaCl concentration for ST_ΔC. (c) SEC-MALLS for ST_WT 
and constructs.  
 
Another round of analytical SEC was carried out to investigate whether the oligomerisation 
state of ST_ΔC changed in response to the salt concentration (Figure 57b). The reasoning to test 
this approach is the observation that the removal of 33 residues (ST_ΔC) had a significant 
impact in the elution profile in comparison with ST_WT, while the removal of 53 residues 
(ST_ΔN) did not.  
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Figure 57b shows that the oligomerisation state of ST_ΔC did not change when eluted in 250 
mM, 500 mM or 1 M NaCl since the elution volume of the construct is ~12 mL in all tested 
conditions. Considering that the oligomerisation state of ST_ΔC did not change with increasing 
salt concentrations, it is assumed that ST_ΔN would not undergo any changes under the same 
conditions. Therefore the described SEC experiment was carried out only with ST_ΔC.  
Other approaches were used to study constructs ST_ΔC and ST_ΔN in depth. The first 
experiment performed consisted of the analysis of the recombinant DNAs to rule out the 
possibility of sample-swapping (Figure 58). ST_ΔC was cloned by introducing a stop codon 
after residue 138, therefore the 5’ and 3’ ends remained identical to the ST_WT. Therefore, 
using the primers used to amplify the WT protein it would be possible to amplify a fragment 
that differs in size to the WT gene by only one codon. ST_ΔN lacks the first 53 codons at the 5’ 
end, hence using the primers for the ST_WT would not lead to the amplification of any product 
(Figure 58a). It was demonstrated that the DNA samples were not swapped during cloning since 
using the mentioned primers, it was possible to amplify a ST_ΔN fragment of the same length 
as the ST_WT (Figure 58b). Conversely, the same primers failed to amplify any product using 
the ST_ ΔN DNA as template.  
 
Figure 58. Investigation of ST_ ΔC and ST_ ΔN recombinant DNAs 
(a) General approach to amplify a WT-size gene. (b) PCR of ST_ΔC and ST_ΔN using full length 
primers. The ST_WT was included as positive control.  
 
The ST_ΔC and ST_ΔN constructs were analysed by electrospray ionisation (EI) mass 
spectrometry to calculate their MW (per subunit) and estimate the agreement with the predicted 
one. Calculation of the MW allowed determining whether the constructs were correctly 
expressed and purified or degrading. The calculated MW for ST_ΔC and ST_ΔN were 15 782 
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Da and 13 136 Da, respectively, both in good agreement with the predicted 15 785 Da for 
ST_ΔC and 13 138 for ST_ΔN. 
SEC-MALLS was carried out to determine the MW of all ST constructs in solution and deduce 
the number of subunits (Figure 5.3c). For ST_WT and ST_ΔN, the calculated MW agreed well 
with that expected for a nine-subunit assembly (Table 14). The calculated MW of the NTD 
corresponded to that expected for a monomer. The estimated MW of ST_ ΔC was 133.1 kDa, 
which divided by nine potential subunits, yields 14.8 kDa per subunit. The calculated MW of 
the ST_ ΔC oligomer accounts for 8.4 copies, when divided by 15.8 kDa (one subunit of 
ST_ΔC). This technique suggests that ST_ΔC exists in solution as either eight- or nine-subunit 
assembly. 
 
6.3 Crystallisation of ST constructs  
6.3.1 Crystallisation of Se-Met ST_WT 
Se-Met crystals of ST_WT were grown using microseeding. Initially, native protein crystals 
grew in condition G8 from the INDEX screen (0.1 M Hepes pH 7.5, 0.2 M Ammonium acetate, 
25 % (w/v) PEG 3.35 K) after two weeks of setup. The protein concentration was adjusted to 15 
mg mL
-1
 with 20 mM Tris pH 7.5, 250 mM NaCl. Further optimisation experiments produced a 
variety of crystals in four similar conditions. The crystals from different drops were mixed 
together in 0.1 M Hepes pH 7.5, 0.4 M ammonium acetate, 30 % PEG to produce a seed stock.  
The conditions from which the crystals were fished were: 
a) 0.1 M Hepes pH 7.5, 0.4 M ammonium acetate, 30 % (w/v) PEG 3.35 K. 
b) 0.1 M Hepes pH 7.5, 0.3 M ammonium acetate, 25 % (w/v) PEG 3.35 K. 
c) 0.1 M Hepes pH 7.5, 0.2 M ammonium acetate, 24 % (w/v) PEG 3.35 K. 
d) 0.1 M Hepes pH 7.5, 0.4 M ammonium acetate, 27 % (w/v) PEG 3.35 K. 
The seed stock was used to setup hanging drop vapour diffusion experiments in 24-well trays. 
Se-Met protein purified by SEC was diluted to 21 mg mL
-1
. Hexagonal crystals of ~ 100 μm 
wide x 200 μm high grew in 0.1 M Hepes pH 7.5, 0.4 M ammonium acetate, 18 % (w/v) 
PEG3.35 K after two weeks of incubation at room temperature (Figure 59). The crystals were 
clustered in pairs, joined by their ends with an angle of ~140 °. The crystals were separated by 
breaking the contact surface and then cryo-cooled in liquid nitrogen using no cryo-protectant 
solution. The crystals diffracted to 3.28 Å resolution when tested with in-house equipment. The 
data collection was carried out at the I02 beamline at the Diamond Light Source, UK. 
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Figure 59  G20C ST_WT Se-Met crystals 
 
6.3.2 Crystallisation of ST_ΔC and ST_ΔN 
Constructs ST_ΔC and ST_ΔN were diluted to 15 mg mL-1 to setup sitting drop vapour 
diffusion experiments using the commercial screens PACT and INDEX. Well shaped crystals of 
ST_ ΔN were observed after 3 days of incubation in conditions numbered 25 and 37 from the 
INDEX and PACT screens, respectively (Figure 60). The shape of the crystals belonged 
predominantly to the cubic (Figure 60a) and triclinic systems (Figure 60c). Clusters of crystals, 
long needles and thin plates were also present in other conditions.  
After the crystals were observed and fishing was attempted, it was noticed that some crystals 
disappeared, suggesting that changes in temperature (from 18°C to room temperature) 
contributed to dissolve them.  
Crystals in Figure 60a grew in condition G10 from the INDEX screen: 0.2 M Na citrate, 20 % 
(w/v) PEG 3.35 K. These crystals dissolved after being observed under the microscope. Crystals 
from Figure 60b grew on condition H7, INDEX screen: 0.15 M DL-Malic acid pH 7, 20 % 
(w/v) PEG 3.35 K. crystals grown on this condition diffracted up to 10 Å resolution when tested 
in-house. No cryo-protectant was utilised. The crystals from Figure 60c were grown in 0.2 M 
NaNO3, 20 % (w/v) PEG 3.35 K, conditions from the PACT screen, condition E5. Cryo-
protectant solution containing 20mM Tris pH 7.5, 100 mM NaCl, 0.2 M NaNO3, 32 % (w/v) 
PEG 3.35 K was used to fish these crystals. Diffraction to 8Å was observed. The crystals in 
fFigure 60d grew in condition F9, PACT screen: 0.1 M Bis-Tris propane pH 6.5, 0.2 M Na/K 
tartrate, 20 % (w/v) PEG 3.35 K. Crystals fished from this condition diffracted to ~ 4.1 Å 
resolution. Cryo-protectant solution containing 0.1 M Bis-tris propane pH 6.5, 20 mM Tris pH 
7.5, 0.2M Na/K tartrate, 0.1 M NaCl, 20 % (w/v) PEG, 20% glycerol was used.  
 
127 
 
 
Figure 60. Crystals of G20C ST_ΔC and ST_ΔN 
Crystals of ST_ ΔC in (a) INDEX G10, (b) INDEX H7, (c) ST_ ΔC , PACT E5 and (d) PACT F9. (e),(f) 
ST_ ΔN in INDEX C9. Crystals were colourless; the colour observed is due to the light polariser used to 
take the pictures. 
 
Small needles of ST_ΔN were observed after 8 weeks of setup in condition C9 from the INDEX 
screen: 0.1 M Hepes pH 7.0, 1.1 M Na Malonate pH 7, 0.5 % (v/v) Jeffamine ED-2001
®
 pH 7. 
The needles were too small to attempt fishing to further expose them to X-rays, therefore they 
were used as seeds for subsequent crystallisation experiments.  
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6.4 Conclusions  
 
Se-Met ST_WT was purified by a variety of chromatographic techniques to carry out 
crystallisation experiments. Crystals that diffracted to ~ 3.3 Å resolution were grown optimising 
those conditions that were shown to produce crystals of native protein. It was determined that 
G20C ST exists as nine-mer in solution by SEC-MALLS.  
Three constructs of G20C ST were purified to perform DNA-binding activity assays: ST_ΔC, 
ST_ΔN and NTD. Even though it was observed that ST_ΔC migrates as if it was smaller than 
ST_ΔN in SEC and SEC-MALLS columns and in SDS-PAGE, it was confirmed by SEC-
MALLS and EI-MS that the MW of both constructs corresponds to the predicted one. The 
reason of this behaviour is likely to lie in the presence or absence of the C-terminal domain, as 
the NTD is not expected to participate in inter-subunit contacts that determine the 
oligomerisation state. Removal of the C-terminus, which is highly negatively charged from the 
WT protein, may induce conformational changes on ST_ΔC that lead to retarded elution in 
comparison with ST_ΔN. 
ST_ΔC was the subject of extensive experimental work because of the difference in MW 
observed in comparison with the WT protein (~ 6 kDa). The consideration that nine subunits are 
contributing to the difference in MW does not explain such difference in the SEC profiles. The 
crystallisation of ST_ ΔC and ST_ ΔN was carried out in order to gain insight into the 
organisation of such constructs. Crystallisation of these constructs is in progress.  
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Chapter 7 
7. Elucidation of structure of G20C small terminase 
7.1 Native protein crystals 
7.1.1 Data collection 
X-ray data were collected from a single cryo-cooled crystal at the I04-1 beamline at the 
Diamond Light Source, UK. Data were collected at a wavelength of 0.9200 Å with a crystal-to-
detector distance of 325.16 mm, 0.2° crystal rotation per image and 180° total crystal rotation 
(Figure 61). Crystal data are published in reference (134).  
 
Figure 61. Diffraction pattern of a native crystal of ST_WT 
 
7.1.2 Structure determination 
The 900 diffraction images were indexed using reflections in the resolution range 49.8-2.80 Å 
using the XDS (107) software. The crystal belonged to the P 21 21 2 space group with unit cell 
dimensions a= 94.3 Å, b= 125.6 Å and c=162.8 Å, and angles α, β, γ = 90°.  
Table 15 summarises the statistics of the X-ray data set.  
The calculated solvent content (119) for nine subunits in the asymmetric unit was 56.1 %. 
At the time the diffraction images of the native crystal were collected, X-ray crystal structures 
for SF6, P22 and 44RR ST were available. However, as it will be explained in Chapter 8, even 
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though they share similar domains, the spacing between domains varies. MR did not work in 
this case and hence the Se-Met version of G20C ST_WT was produced.  
 
7.2 Se-Met protein crystals 
7.2.1 Data collection 
900 images were collected at the I02 beamline at the Diamond Light Source, UK from a flash-
cooled crystal at a wavelength of 0.97950 Å (Figure 62, Table 15). The crystal was rotated by 
180° with 0.2° per image. The chosen wavelength corresponds to the energy absorption peak of 
Selenium atoms: 12,657.5 eV, as derived from a fluorescence scan performed before data 
collection (Figure 62a). Faint ice rings were observed at around 3.2 Å while strong diffraction 
spots corresponding to the protein crystal, were visible up to ~ 2.8 Å resolution. 
7.2.2 Structure determination 
Processing of diffraction images was carried out with XDS (107). XDS indexed reflections in 
the 45.39-2.51 Å resolution range in the space group H 3 (Table 15). The unit cell dimensions 
are a, b = 152.6 Å; c = 108.8 Å and angles α, β = 90, γ = 120° (hexagonal setting). 
The values for Rmerge and Rmeas values of the 32,286 unique reflections calculated by the 
Aimless software were 8.5 (138.2) % and 9.7 % (156.4) %, respectively (Table 15). 
SHELXC/D were used to identify and locate the selenium atoms (Figure 63). SHELXD 
produced a list of coordinates featuring 28 heavy atoms in the asymmetric unit. The coordinates 
of the 21 atoms with the highest occupancies (above 0.55) were separated for subsequent steps.  
Table 15. X-ray data statistics for G20C ST 
 Native crystal Se-Met crystal 
X-ray source Beamline I04-1,  
Diamond  LS, UK 
Beamline I02,  
Diamond  LS, UK 
Detector Pilatus 2M Pilatus 6M 
Wavelength (Å) 0.92000 0.97950 
Space group P 21 21 2 H 3 
Cell dimensions (Å) a = 94.3, b = 125.6  c = 162.8 
α, β, γ = 90° 
a, b = 152.6; c = 108.8 
α, β = 90, γ = 120° 
Resolution range (Å) 49.8-2.8 (2.89-2.80) 45.39-2.51 (2.61-2.51) 
No. of unique reflections 48371 (4371) 32286 (3586) 
Rmerge
†
 (%) 9.6(153.2) 8.5 (138.2) 
Rmeas (%) 10.4 (167.7) 9.7 (156.4) 
Average I/σ(I) 16.3 (1.3) 12.6 (1.2) 
Completeness (%) 99.9 (100.0) 99.7 (98.1) 
Multiplicity 6.8 (6.1) 4.6 (4.6) 
Table continues on the next page. 
Table 14. X-ray data statistics of G20C ST. Continuation 
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Values in parentheses are for the highest resolution shell. 
 
† Rmerge =Σhkl Σi |Ii(h) - ‹I(h)›|/ ΣhklΣiIi(h), where I(h) is the intensity of reflection h, ‹I(h)› is the average 
value of the intensity, the sum Σhkl is over all measured reflections and the sum Σi is over i measurements 
of a reflection. 
 
Subsequent data-processing involved density modification using the Parrot software (113). The 
output .mtz file and the amino acid sequence were used in the Buccaneer pipeline to perform 
model building after experimental phasing (114). Buccaneer built 726 residues, allocating 662 
of them in 6 nearly identical chains. The completeness of the model in terms of built residues 
was 84.4 % and the completeness of the chains 63.4 %. 
The chains were nearly identical, varying in length due to the absence of electron density at the 
C-terminus (see next chapter).  
 Native crystal Se-Met crystal 
CC (1/2) 0.999 (0.510) 0.996 (0.368) 
CC (1/2) DelAnom NA 0.671 (0.014) 
Wilson B-factor (Truncate) (Å
 2
) 62.3 63.9 
Number of atoms 9718 (9 chain x  137 residues) 6420 (3 chains x 137 
residues, 3 chains x 143 
residues) 
Solvent content (%) 56.1 43.1 
Number of reflections used in 
refinement 
 31224 
R-factor (%)  21.9 (36.5) 
Number of reflections used for 
Rfree 
 1056 
Rfree (%)  28.5 (37.4) 
Average atomic B-factor (Å
 2
)  81.0 
Rms BondLength ( Å)  0.010 
Rms BondAngle (°)  1.4 
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Figure 62. Data collection from G20C ST_WT Se-Met crystals 
(a) X-ray fluorescence scan. The peak (cyan line) and inflection (pink line) wavelengths are indicated. (b) 
Diffraction image. The resolution at the edge of the image is ~ 2.5 Å. 
 
 
 
Figure 63. Location of heavy atoms by SHELXC/D 
List (a) and graph (b) of occupancies of the heavy atoms identified by SHELXD. In (b) the horizontal and 
vertical axis plot the site number and occupancy, respectively. (c) Substructure solutions by SHELXD. (d) 
and (e) heavy atoms coordinates. 
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The initially built chains belonged to different oligomers. Individual chains were re-grouped 
into two groups of three chains each. Complete oligomers, containing 9 subunits are generated 
by the crystallographic 3-fold axis  
 
 
Figure 64.- Crystal arrangement in crystals of Se-Met labelled G20C ST 
 (a) Electron density map contoured at 1σ after solvent flattening by Parrot.  (b) Asymmetric unit 
containing two sets of trimers, each representing one third of two separate 9-mers. View along the Z (c) 
and Y (d) axes. 
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Figure 65. Validation and final structure limitations 
(a) Ramachandran plot. (b) Rotamer analysis. Purple bars represent stubbed side chains. (c-e) α2- α3 
connecting loop from chains B, C and E, respectively. Electron density maps correspond to the 2.51 Å 
resolution Se-Met G20C ST’s structure and are contoured at 1σ. 
7.2.3 Refinement and validation 
The model underwent several cycles of refinement and rebuilding which included rotamer 
analysis (Figure 65). The final value of R was 21.7 (36.5) % and that of Rfree, 28.5 (37.4) % 
(calculated from a test data set of 1056 reflections) (Table 15).  
In the current model, 96.86 % of the residues are in the preferred regions of the Ramachandran 
plot, 2.42 % in the allowed regions and 0.73 % are outliers. The outliers correspond to residues 
located at the loop connecting helices α2 and α3 where the electron density is somewhat unclear 
or available only for protein’s backbone (Figure 65c-e).  
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7.2.4 Structure determination of the native protein by molecular replacement 
One complete 9-subunit oligomer was generated using the crystallographic 3-fold symmetry and 
used for structure solution of native crystals by MR (Figure 66). No major difference in fold 
between native and Se-Met proteins was observed in spite of crystals belonging to different 
space groups. Oligomers do not pile on top of each other, instead they adopt slightly inclined 
mutual orientations (Figure 66).  
 
 
Figure 66. Crystal packing of native protein 
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7.2.5 Conclusions 
Crystal structures of the G20C ST_WT native and Se-Met derivative were determined to 2.50 
and 2.80 Å by SAD and MR, accordingly. First, anomalous difference data were used to solve 
the Se-Met structure. The Se-Met structure was then used for generating initial phases for the 
native data set by molecular replacement. Both structures have been refined.   
In contrast to the capsid protein of dsDNA bacteriophages, for the ST there is a bigger 
collection of X-ray structures available, implying higher tendency to be crystallised. The 
propensity to grow crystals could be in part due to the formation of circular oligomers ranging 
from 8-12 subunits. Oligomerisation is facilitated by tight interaction of subunits via their ODs. 
In general, full-length STs or truncated versions tend to crystallise in a wide variety of 
conditions, producing crystals that often diffract to high resolution. Table 16 offers a 
comparison of structure-quality indicators for available X-ray structural information on STs 
from several viruses (compiled using data available in September 2014).  
Table 16. X-ray statistics of ST structures 
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G20C
¥
 WT/ Pending 2.5 H 3 1.2 21.7 28.5 0.73 0.0100 1.4 
 
SF6  
(SPP1-like) 
G1P_WT(1-164) / 3ZQQ 4.0 R 32:H 4.1 20.0 28.2 3.3 0.002 0.66 
53-120 10-mer / 3ZQM 1.9 P 21 4.4 17.2 21.4 0 0.017 1.58 
53-120 10-mer / 3ZQN 2.2 P 41212 4.0 19.7 22.2 0 0.018 1.09 
53-120 9-mer / 3ZQO 1.7 P 21 3.1 18.3 23.4 0 0.015 1.42 
65-141 9-mer / 3ZQP 3.0 P 32 2.7 18.7 22.6 0 0.017 1.24 
Sf6  
(P22-like) 
gp1_WT(1-139) /3HEF 1.7 P 4 21 2 3.4 22.4 25.1 0 NA NA 
P22 gp3 1-140 / 3P9A 
 
gp3_WT- 1-162 
1.8 
 
3.4 
P 21 
 
P 21212 
1.8 
 
3.3 
17.7 
 
23.2 
21.6 
 
26.5 
0 
 
NA 
0.006 
 
0.009 
0.92 
 
1.21 
44RR  
(T4-like) 
gp16 26-112¶, 11-mer / 3TXQ 
 
gp1625-114, 12-mer / 3TXS 
2.8 
 
1.8 
P212121 
 
R3 
4.8 
 
5.0 
31.0 
 
23.3 
34.0 
 
27.7 
0.3 
 
0.3 
0.005 
 
0.008 
0.81 
 
1.02 
Prophage 
phBC6A51 
2AO9 1.9 P 21212 2.75 20.5 23.6 0.1 0.01 1.07 
NA Not available 
¥ Latest model version. 
¶ gp16 FL is 154 residues long 
The mean I/σ(I) corresponds to the outer shell values. 
See  
Table 2 for references.  
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Chapter 8 
8. Structure of G20C ST 
The current chapter contains a description of the Se-Met G20C ST’s X-ray structure and a 
detailed comparison with structures of other STs (section 1.8). The structural comparison 
attempts to identify fold similarities and potential role in DNA recognition.  
8.1 G20C ST monomer and oligomer 
8.1.1 Monomer 
G20C ST has a ring-like structure made up of nine subunits that surround a central channel 
(Figure 67a,b). Each individual subunit has an NTD and a central OD. Electron density was 
observed for residues 1-134, although for some subunits the density is interpretable for longer 
segments, up to residue 141 or 145, depending on the subunit. The last 25-37 C-terminal 
residues are disordered as no clear electron density was observed either in the Se-Met or native 
electron density map. 
The NTD, situated at the periphery of the assembly, comprises residues 1-52, which are 
organised into three short α helices: α1 (residues 3-15), α2 (19-30) and α3 (36-51) (Figure 67c). 
The NTD is connected to the OD by a 4-residue Ala-Leu-Pro-Ser linker. Two long antiparallel 
α-helices, α4 (residues 56-92) and α5 (107-137), connected by a short β-hairpin, comprising β1 
and β2 strands, form the OD.  
8.1.2 Oligomer and inter-subunits interactions 
The OD helices pack closely to form two concentric rings, the outer formed by helices α4 and 
the inner by helices α5. The central channel inner diameter at its most constricted part is ~ 25 Å, 
measured as the atom-to-atom distance between the Nη atoms of opposing R108 side-chains. 
This corresponds to a vdW radius of ~ 22 A. The maximum overall diameter and height of the 
assembly are 112 Å and 62 Å, respectively; measured for atoms protruding the most from the 
assembly. The chirality of the subunit packing within the oligomer is similar to that found in 
other ST oligomers, showing a left-handed twist (when the oligomer is viewed from the 
outside), so that every subunit is tilted by about 60° with respect to the central channel axis 
(Figure 67).  The NTDs establish two H-bonds with the OD of the adjacent subunit but not with 
its own OD. Superposition of the six subunits in the asymmetric unit using the OD as reference 
shows that each NTD occupies a slightly different position in the oligomer (Figure 67d). While 
the tertiary structure of the DBD (HTH-motif) remains the same, movement of the DBD is 
observed in all the directions, with a maximum displacement of 6.7 Å in helix α1 and of 6.2 Å 
in helix α3. 
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Figure 67. G20C ST structure 
(a) Top and (b) side view of the oligomer. Subunits are displayed in different colours to illustrate their 
organisation (c) Monomer. The NTD and OD, shown in red and blue, respectively, with their secondary 
structure elements numbered. (d) and (e) Displacement of the NTD with respect the OD. For clarity only 
four NTDs out of the six that form the asymmetric unit are displayed, the omitted two are located in 
intermediate positions. The total displacement of helices α1 and α4 are indicated. (f). Inter-subunit 
interactions. The residues participating in H-bonds are shown in ball and stick representation, with the 
carbon atoms coloured as the main chain. 
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The 9-mers are tightly packed against each other in the crystal, keeping the DBD in a fixed 
place, however it is unlikely that this rigidity is observed in solution, where the flexible linkers 
bridging the DBDs to the core would permit some adjustment in their positioning. This is 
consistent with observations made on the crystal structure obtained for SF6 ST (16). 
The ODs create a network of H-bonds and electrostatic interactions (Figure 67e,f) with adjacent 
ODs. In average, every subunit establishes 16 direct H-bonds with adjacent subunits (Table 17 
and Table 18). All chains use the same residues to establish the H-bonds with their neighbours, 
creating a circular network of H-bonds throughout the oligomer that contributes to the stability 
of the ST. Besides H-bonds, the complementarity of electrostatic charge between the inter-
subunit surfaces also plays an important role in the formation of the oligomer.  
 
Table 17. Interfaces at the G20C ST 9-mer* 
Structure 1 Structure 2 Interface 
area Å2 
Δ
i
G 
Kcal/mol 
NHB NSB NDS 
Subunit iNat 
i
Nres Surface Å
2 Subunit iNat 
i
Nres Surface Å
2 
A 150 44 10662 B 162 44 10318 819.3 -12.1 8 8 0 
B 141 44 10318 C 161 43 10548 820.6 -11.7 10 5 0 
C 129 37 10548 D 154 43 10669 785.8 -11.7 7 6 0 
D 150 44 10669 E 164 44 10313 818.5 -12.1 8 8 0 
E 142 44 10313 F 156 43 10534 817.6 -11.6 10 5 0 
F 130 37 10534 G 155 43 10668 784.9 -11.7 7 6 0 
G 149 44 10668 H 162 44 10314 818.0 -12.2 8 8 0 
H 143 44 10314 I 160 43 10539 818.7 -11.7 10 5 0 
I 128 37 10539 A 153 43 10662 784.6 -11.7 7 6 0 
       Average 807.6 -11.8 8 6 0 
*. Parameters calculated with the PDBePISA server (105).  
i
Nat - Number of interfacing atoms in the corresponding structure.  
i
Nres - Number of interfacing residues in the corresponding structure. 
Surface Å2 - Total solvent accessible surface area in square Angstroms. 
Interface area Å
2 
- Difference in total accessible surface areas of isolated and interfacing structures divided by two. 
ΔiG - Solvation free energy gain upon formation of the interface, in Kcal/M. Negative ΔiG corresponds to 
hydrophobic interfaces, or positive protein affinity. 
NHB - Number of potential H-bonds across the interface. 
NSB - Number of potential salt bridges across the interface. 
DS - Number of potential disulphide bonds across the interface. 
 
Table 18. H bonds formed by subunit G* 
 Interface FG    Interface GH 
## Subunit F   Dist. [Å]   Subunit G    ## Subunit G    Dist. [Å]   Subunit H    
1   LEU  14[ O  ]  2.90 ARG  69[ NH1]  1   LEU  14[ O  ]  3.00 ARG  69[ NH1]   
 2   GLU  62[ OE2]  2.67 ARG  71[ NH2]  2   GLU  62[ OE2]  2.36 ARG  71[ NH2]   
 3   ASP  76[ OD2]  2.89 TYR  81[ OH ]  3   ASP  76[ OD2]  2.88 TYR  81[ OH ]   
 4   SER  51[ OG ]  3.58 GLU  57[ OE2]  4   ARG  47[ NH2]  3.71 GLU  62[ OE2]   
 5   ARG  69[ NH1]  2.86 ASP 123[ OD2]  5   ARG  69[ NE ]  2.93 ASP 123[ OD2]   
 6   ARG  69[ NH1]  2.67 ASP 123[ OD1]  6   ARG  69[ NH2]  3.30 ASP 123[ OD1]   
 7   F:ASN  83[ND2] 3.17 TYR  88[ OH ]  7   ASN  83[ ND2]  3.33 TYR  88[ OH ]   
     8   ARG 118[ NH1] 3.36 ALA 110[ O  ]   
*. Table calculated with the PDBePISA server (105). 
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8.1.3 The disordered C-terminus 
The predicted secondary structure for the last 34 residues at the C-terminus features an α-helix 
(*α6, with LVSVEELVAEVVD sequence) from residues 154-166, connected to α5 by a 16-
residue linker (GHVGSTTAGALPSATE) which has no predicted secondary structure. The 
reason of this disorder is likely to be the flexibility afforded by the long connecting region 
which is rich in simple amino acids such as Gly, Ala, or Thr. This helix is similar to that 
observed at the C-terminus of the P22 ST structure, but differs markedly from the β-barrel 
found in SF6 ST. More information about the C-terminus is provided later in this chapter and 
the following one, including a discussion of its potential functional role.  
 
8.2 Electrostatic surface of G20C ST 
The electrostatic potential surface of the complete oligomer was calculated in CCP4mg, 
showing an area of positive charge around the outside of the oligomer. A close analysis revealed 
that this is created by the side chains of residues K11 and K31, R32, K33 (Figure 68a,c), all of 
them located at the loop that connects α2 with α3 in the NTD. These patches create a ring of 
positive charge around the periphery of the molecule, offering a potential binding site for DNA 
through formation of complementary electrostatics interactions.  
The cross-section of the oligomer exposing the central channel shows that side chains of 
residues R108, R118, K121 and K135 which are exposed into the tunnel, form four rings of 
positive charge spanning the height of the assembly (Figure 68b). In contrast to the observations 
supporting a peripheral binding mode of DNA, this observation makes it difficult to completely 
discard the channel as potential binding site for DNA, given that the diameter of the channel is 
consistent with the diameter of dsDNA (~ 23 Å vdW diameter).  
Figure 68d shows a side view of the electrostatic surface of the oligomer calculated with NTDs 
omitted from the PDB file, to illustrate patches of positive charge at the outer surface of the OD. 
A protein construct missing the NTD (putative DBD) was designed and purified to test its 
capability to bind DNA (See Chapter 10).  
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Figure 68. Electrostatic surface of G20C ST 
(a) Top and (b) cross section views of the oligomer. (c) Close up of the NTD. (d) Side view of the barrel 
formed by ODs. Residues responsible for the positive charge patches are shown in ball and stick. Figures 
not to scale.  
 
8.3 Comparison of G20C fold with other ST 
From the available ST crystal structures it is evident that despite low sequence homology some 
architectural features are shared between them even when they belong to viruses from different 
families (Figure 12 and Figure 70). The number of subunits observed in crystal structures is 9 in 
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the case of G20C, SF6 (which also forms 10-mers) (16), P22 (14) and PhBC6A51 (70), 8 
subunits in Sf6 (68) and 11 or 12 subunits in 44RR (69). At the monomer level, all ST share 
features, namely a HTH-motif (NTD), a helical core (OD) and a variable CTD, which can be 
flexible or adopt a folded conformation.  
G20C ST exhibits an NTD almost identical to that of SF6 (16,135) and Sf6 (68) (Figure 69a), 
where a helix-turn-helix (HTH) motif has been identified in the segment comprising helices α2 
and α3. In G20C and Sf6, the NTD consists of three helices, while in SF6 a fourth helix is 
observed. In the case of phBC6A51 (70), the first four N terminal α helices superpose well with 
those of SF6, suggesting that a HTH motif is also likely to exist to carry out a similar function 
as in SF6 and Sf6 (16,136). Previous biochemical data on SF6 and Sf6 ST demonstrated that 
this domain is the DNA-binding domain (DBD). 
P22 does not exhibit a clear boundary between the NTD and OD. Instead of an NTD 
characterised by a HTH motif, it has a purely helical core assembly that resembles the OD of 
other STs (10). When structural superposition was performed, it was clear that helices α1 & α2 
of G20C, SF6 and Sf6 superpose well with helices α2 & α3 from P22 ST, respectively (Figure 
69a). P22 α4 does not superpose with helix α3 from other STs but it follows a similar direction 
and is possible that a motif able to serve the same function as the NTD also exists in P22 
between α3 and α4 and their connecting loop. 
G20C OD superposes well onto that from other STs (Figure 69b left). G20C, Sf6 and 44RR 
present two long antiparallel helices separated by a turn at the bottom of the assembly, as the 
core of the OD. The length and orientations of the helices are comparable, however, α4 in Sf6 is 
considerably bent (Figure 69b centre). One difference to the described OD from G20C, Sf6 and 
44RR, is observed in SF6 and P22, which present a bent β-hairpin composed of β1 and β2 
strands (Figure 69b right). PhBC6A51 only exhibits two short helices exactly in the same 
orientation as those in SF6 and P22. The structural feature common to ODs of all STs is the 
presence of two helices, suggesting that it is essential for oligomer assembly. The length of the 
helix or the presence of β-hairpins appear to be non-essential features that may influence the 
oligomer stability. 
Except for SF6 and 44RR, the overall outer diameter is similar for all the assemblies (Figure 
69c). Nonetheless, because of the flexibility of the linker connecting the DBDs with the ODs, it 
is possible for SF6 ST to adopt a more compact configuration. In the case of 44RR, the OD is 
the only feature ordered in the structure since a large portion of the NTD appears as a chain with 
no obvious secondary structure and the CTD is not present. Secondary structure predictions for 
those segments missing in the crystal structures of the STs are provided in the paragraphs 
below. 
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Figure 69. Structural comparison of ST 
(a) Superposition of NTDs. Each ST is shown in different colour. The numbering of secondary structure 
elements is the same as in figure 1.12. (b) OD superposed by secondary structure. Left –all ST and right 
two different subgroups of ST. (c) Superposed G20C, Sf6, P22 and PhBC6A51 oligomers. (d) Conserved 
structural features between the diverse oligomers, from left to right: OD, β-barrel and β-hairpin. 
 
The distribution of the NTDs in G20C, SF6 (not included in the superposition of the complete 
oligomers), Sf6, PhBC6A51 ST and the helical cores in P22 ST is similar (Figure 69c). The 
average distance between NTDs calculated for SF6 is ~34 Å (Table 19). In G20C the average 
spacing between NTDs is ~36.5 Å, in good agreement with the spacing observed in SF6. 
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Likewise, ST from Sf6 and PhBC6A51 exhibit a similar separation between the NTDs. The 
measured distances correspond to the distance between the Cα of one residue at the loop of the 
HTH motif and its counterpart in the adjacent NTD. 
 
Table 19. Distance between NTDs 
The residue of which the Cα was used as reference in every ST is indicated. 
--- For 44RR the NTD is disordered. 
 
Besides the circular organisation and spacing between NTDs, other characteristics are common 
between the STs (Figure 70). Of particular note is the arrangement of ODs between G20C and 
44RR, where the spacing is very alike in spite of the larger diameter of the channel on 44RR ST 
(Figure 69d left). SF6, Sf6, P22 and PhBC6A51 ST present a β-stranded barrel on top of the 
main core (Figure 69d centre). Such β-barrel was shown to be important in defining the 
oligomerisation state of SF6 ST (16).  
8.3.1 Secondary structure and amino acid sequence analysis: Domain prediction and 
domain mosaic array. 
The alignment of the secondary structure elements and amino acid sequences of all the full 
length ST proteins shows the generally good conservation of domains (refer to Figure 70 
throughout this section).  
The sequence length of the STs is analogous, ranging from 140 (Sf6) to 171 (G20C) residues. 
With exception of P22, the domain organisation of all the STs is similar, comprising the NTD, 
OD and CTD (See the domain boundaries on Figure 70). Three to four α-helices form the NTD, 
two α-helices, sometimes accompanied by a β-hairpin, form the OD, and the C-terminal 
segment contains a β-strand, accompanied in some cases by an α-helix. Several STs have 
deviations from the common fold. The first example is offered by the Sf6 OD, where the OD 
comprises the long helices α4, α5 and the short α6. Helices α5 and α6 are separated by only a 1-
residue kink (Figure 12 and Figure 70).  
Helices α5 and α6 in PhBC6A51 represent the second example of structural diversity among 
STs. Two α-helices are separated from each other by a distorted helical turn that prevents the 
formation of a single longer helix.  
 
 
 G20C SF6 Sf6 P22 44RR PhBC6A51 
Distance (Å) 36.5 34 33.3 28.7 --- 34.4 
Residue R32 Published G39 L88 --- G59 
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Figure 70. Comparison of the STs from different phages 
(a) Secondary structure elements extracted from the X-ray structures. Star (
*
) indicates features predicted 
by JPred. 
¥
 indicates modelled features based on secondary structure prediction. The areas shaded in grey 
represent the part of the NTD that superpose onto one another. The vertical red and green lines delimit the 
NTD and CTD, respectively. The length of each element is proportional to the number of residues (b) 
Alignment of amino acid sequences for every ST included in the discussion. The areas shaded in yellow 
represent the α-helices of the HTH motifs at the NTD and the predicted α-helices at the CTD, the blue 
areas, either the observed or predicted secondary structure elements at the CTD. 
 
In contrast to the alignment of the secondary structure elements, aligning the amino acid 
sequences is almost impossible due to very low sequence identity (<20 %), exemplifying how 
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the sequence changes faster during evolution than the three dimensional structure (Figure 70b) 
(137). 
The available X-ray structures of STs are the most detailed source of structural information 
regarding the oligomerisation state, domain organisation and identification of potential sites for 
DNA-binding. In G20C, P22, 44RR and PhBC6A51 ST the CTD is incomplete or not present in 
the crystal structure. Prediction of the secondary structure for these disordered regions revealed 
that the CTD segment is likely to comprise either a β-strand (which is present in the structures 
of SF6, Sf6 and P22 and PhBC6A51 STs) followed by one α-helix or only an α-helix as 
predicted for G20C and 44RR STs. 
For P22 ST it was previously proposed that α7 in solution exists in the form of either an 
unstructured polypeptide or folded α-helix, both transient conformations being present in an 
equilibrium state (14). This observation was reinforced by the finding of longer assemblies on 
negatively stained samples that included a feature consistent with an α-helix (found above the β-
barrel).  
The absence of helix *α6 in the G20C ST X-ray crystal structure could be explained by two 
different hypotheses. It is possible that helix *α6 is structured in solution but the flexibility of 
the long linker directs it away from other *α6 helices. In the second scenario the putative helix 
*α6 could fold upon binding to DNA with other parts of the molecular motor.  
Both hypotheses are supported by the absence of electron density for the CTD in native and Se-
Met crystals, and by crystallisation experiments performed with ST_ΔC and ST_ΔN. ST_ΔC 
crystallised in multiple conditions (around 45 % of the tried conditions) while ST_ΔN only 
produced crystals in one condition. Although helix *α6 could be ordered, the amino acid 
sequence reinforces the existence of an unfolded helix *α6 in two ways:  
 
a) As in P22, the G20C CTD is predicted to contain one α-helix as seen in 44RR and 
PhBC6A51 STs. The similar architecture of the NTD and OD between the cited STs, 
points out that the fold of the C-terminus could also be alike. There is room for the 
potential formation of an α-helical barrel on top of the assemblies; nonetheless, 
important differences arise when looking closely at the sequence of the predicted helix: 
in P22, helix α7 is rich in positively charged residues, while in G20C and 44RR ST the 
last helix is rich in negatively charged residues. In PhBC6A51 the number of positive 
residues equals the number of negative residues.  
Moreover, G20C ST *α6 presents the signature characteristics of intrinsic disorder 
(138), which are (i) low sequence complexity (in *α6 50% of the residues correspond to 
Val/Leu), with low content of bulky hydrophobic residues and (ii) high content of polar 
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or charged residues (50% are polar or charged residues: His/Glu/Lys). Additionally, 
intrinsic disordered regions suffer from the lack of hydrophobic amino acids that help to 
bury a hydrophobic core to acquire tertiary structure. The sequences of the C terminal α 
helices from other STs follow a similar pattern. 
b) Although the G20C α5-*α6 linker is quite long, in phages P22 and PhBC6A51 the 
linkers β3-α7 and β1-α8, are not long enough to account for the disorder of the 
complete missing fragment. The sequence of G20C α5-*α6 connection confirms its 
nature of flexible linker as it contains the traditional features of linkers (138): high 
content in polar uncharged (37.5%) or small amino acids (31.3%) and Pro (6.3%).  
Disordered or unstructured regions are not uncommon features in proteins. Dyson and Write 
reviewed several proteins that present coupled folding and binding, which is the property of 
intrinsically disordered regions or complete proteins to fold upon binding to their target(138). A 
classic example is the kinase-inducible domain (pKID) of the transcription factor cyclic-AMP-
response-element-binding protein (CREB), which contains the KID-binding (KIX) domain of 
the CREB-binding protein (CBP) (Figure 71a). To function as a regulator of the expression 
target genes, KID must be phosphorylated at Ser133 by the protein kinase A (PKA) to then form 
complexes with KIX. KID is unstructured in isolation, but the solution structure of the 
phosphorylated KID complexed with the hydrophobic core region of KIX, showed that KID 
undergoes a conformational change to fold into two perpendicular α-helices. Further 
experiments demonstrated the pSer133 is essential to stabilise the pKID-KIX complex (139). 
Phosphorylated CREB regulates a variety of genes in response to cAMP by interacting with 
components of the basal transcription machinery. CREB is involved in diverse physiological 
processes, for instance, in the central nervous system it modulates development, plasticity, 
circadian entrainment, neuroprotection and resiliency (140). 
Crane-Robinson et al revised the importance of N- and C-terminal portions present in several 
DNA binding motifs and showed examples of how some extended segments contribute to 
interaction with either the minor or major groove (141). The protein Antennapedia (Antp) offers 
one example of terminal extensions interacting with DNA (Figure 71b). The N terminus of Antp 
contains four positively charged residues, including the Arg at position five, highly conserved in 
other arms or tails from DNA binding proteins. The X-ray structure determined to 2.4 Å 
resolution, and NMR structure of the Antp homeodomain (~60 residues organised into three α-
helices with the second and third helices form a HTH motif that interacts with DNA) showed 
that the recognition helix (α3) of the HTH motif is inserted into the major groove of the DNA, 
while part of the N-terminus extends along the minor groove (142).  
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Figure 71. Examples of unstructured protein regions 
(a) Coupled binding-folding of KID (blue ribbon) upon binding to KIX. Although the hydrophobic core 
of KIX consists of three α-helices, for simplicity reasons, the complete KIX is shown as a protein contour. 
The phosphorylated Ser133 is shown in ball and stick representation. (b) Complex of Antp-DNA (left). 
Right, Superposition of G20C_NTD (red) with Antp-DNA complex. PDB code: KID: 1KDX, Antp: 
9ANT. 
 
Antp is one of the homeotic genes clustered in the Antennapedia complex (ANT-C) that control 
the identity of body segments in Drosophila melanogaster. Some dominant mutations in the 
Antp gene produce abnormalities at the thorax or head of the flies which include the 
transformation of antennae into legs or vice versa (143). 
The identified HTH motif of G20C ST superposes onto Antp with an rmsd of 2.4 Å for 44 
residues of G20C NTD. More details about the superposition with the HTH motif on Antp 
homeodomain and other proteins are provided in section 8.4. 
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8.3.2 Mosaic boundary in small terminases 
It is recognised that many species of virus possess genomes which are composed of mosaics or 
modules. These modules, which may be single or collections of genes, are defined as regions 
with a degree of similarity found when genomes from two or more related phages are compared. 
These regions are considered to be genome sections that were horizontally exchanged among 
phages and potentially other species during their evolution (144). Analysis of 152 genome 
sequences of P22-like phages demonstrated that mosaic boundaries correlate with protein 
domain boundaries within the ST gene, specifically between the N-terminal region (NTD + OD) 
and CTD in the ST (24). Moreover, the studied sequences in these genomes were classified 
according to eight mosaic boundaries that are the result of the combination of four different N-
terminal regions with four different C-terminal regions. Similarly, the C-terminal region of the 
ST relate to a number of NTDs of the LT (24,144).  
Figure 72 shows the manual alignment of the C-terminus of the STs considered in this project 
based on the X-ray structure and secondary structure prediction, without insertions. It is 
important to note that alignment by commonly employed software does not reveal conserved 
patterns. It is evident that the CTD of the six ST can be classified into a three different 
subgroups according to the secondary structure elements displayed. The first group (SF6, Sf6) 
features a β-strand seen in two ST crystal structures. The second group (PhBC6A51, P22, 
44RR), features one β-strand followed by one α-helix. The last group, which includes only 
G20C, exhibits one α-helix.  
 
Figure 72. Alignment of CTDs 
Manual alignment of CTDs. The vertical green line delimits the CTD. The areas shaded in yellow 
represent the predicted α-helices, while the blue areas, either the observed or predicted β-strands at the 
CTD. The domain boundaries of P22 and Sf6 are squared in black-lined boxed. Areas shaded in purple 
and orange indicate residues shared by all the STs or a subgroup of them, respectively. The cyan triangles 
point the start of the LT protein. 
Concerning the interaction of the ST CTD with the LT NTD, it has been reported for the P22 ST 
that removal of the CTD impairs the formation of ST-LT complexes, pointing out that its role in 
the DNA translocation is to generate communication between the ST and LT. The close 
relationship between P22 and Sf6 ST CTD with their LT NTD is evident from the sequence 
analysis performed by Leavitt et al (24), where the ST CTD is part of the mosaic that contains 
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the LT gene, suggesting that both regions are exchanged together to ensure interaction. 
Interestingly, the mosaic boundaries in P22 and Sf6, which lie within regions G126-V133 and 
D113-V120 align with the initial portion of SF6 and PhBC6A51 CTD.  
The relevance of the overlap between the ST and LT genes is potentially another way to ensure 
that both proteins remain together, however, in Sf6 and 44RR no overlap occurs since the LT 
gene continues immediately after the ST stop codon.  
 
8.3.3  The central channel 
The role of the central channel in DNA binding has been the subject of much debate. Earlier in 
section 1.8 the diameter at the narrowest part of the channel was introduced to assess whether it 
is sufficiently wide to accommodate DNA. These channels, however, are not regular cylinders 
with the same diameter throughout (Figure 73). For instance in G20C, the central part of helices 
α4 and α5 creates an area of ~25 Å diameter, while their top part and connecting small β-hairpin 
define areas of 27.9 and 54.1 Å diameter, respectively. These are interatomic distances 
measured between opposing atoms protruding the most towards the tunnel axis and not van der 
Waals (vdW) distances. The vdW diameter would be ~ 3 Å narrower. For comparison, the vdW 
diameter of DNA is ~23 Å .  
Similar analysis of other STs demonstrates that the β-strand at the C-terminus of SF6, Sf6, P22 
and PhBC6A51 STs, defines the most constricted part of the channel, and that there is no strict 
correlation between the number of subunits and the diameter of the channel. As example, G20C, 
SF6 and P22 assemble into nonamers, however their narrowest diameter is 25, 14.3 and 19.4 Å 
respectively. 44RR is one exception to the previous assumption as it is formed by the largest 
number of subunits and also exhibits the widest channel, 27.8 Å for the 12-mer.  
From the displayed distances, it is fair to hypothesise that only 44RR ST could accommodate B-
form DNA inside the central channel and potentially G20C. Although for phages P22 and Sf6 it 
is proposed that the central channel is the binding site for DNA, several aspects refute this 
hypothesis. On one hand, in P22 there is only an apparent remnant of a HTH motif to bind 
DNA, while on the other hand, the channel hast two ~ 19.6 Å constrictions. No experimental 
evidence is available to establish whether the channel is involved in DNA-binding. Likewise, 
for Sf6 it has been proposed that the body region of the assembly nicely accommodates DNA, 
however, analysis of the published structure showed that no part on this assembly would have a 
vdW diameter big enough to host DNA. Moreover, at the intersection of the neck and body 
regions in Sf6 ST, the atom-to-atom distance of the most protruding residues is 15.5 Å. This 
part would be wider if the distance between Cα was considered, which raises questions about 
where these long side chains would reside if DNA is present in the tunnel. It has been 
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speculated that the ST could disassemble or undergo conformational changes to open and 
incorporate DNA or to expand; nonetheless, experimental evidence is yet to be presented to 
support such theory. 
 
 
Figure 73. The central channel in ST from dsDNA phages 
Representation of the central channel for every structurally characterised ST. The drawn architecture of 
the channel is approximately to scale. The displayed distances correspond to atom-to-atom distances 
between the side chains protruding towards the inner channel. Where two distances are provided for the 
same area of the channel, the largest one corresponds to the distance between atoms of the Cα backbone 
and not to side chains. 
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8.4 Model of interaction of a single NTD with dsDNA  
In section 8.3.1, it was discussed how G20C ST_NTD superposed onto Antp-DNA complex, a 
protein that helped to exemplify that unstructured termini can interact with DNA. Even though 
the rmsd is 2.4 Å (calculated using CCP4mg), the coordinates of G20C ST_NTD were 
submitted to the PDBeFold server to search for structures in complex with DNA that could align 
to ST_NTD with higher quality. The PDBeFold server searches through the RCSB Protein Data 
Bank for structures with similar secondary structure elements. The target structures are 
organised according to the Quality (Q)-score that is an estimate of the quality of the Cα-
alignment, maximised by the secondary structure matching (SSM) alignment algorithm. 
Identical structures have a Q-score value of 1, the higher the score, the better the match. 
The first match, the Mycobacterium tuberculosis hypoxic response regulator DosR C-terminal 
domain (DosR CTD) is shown just as the reference as it was not crystallised in complex with 
DNA. The second best match for the purpose of this project is the structure of the human 
telomeric repeat-binding factor 2 (HTRF2) in complex with its dsDNA telomeric site (145). The 
Q-score is 0.49, compared to 0.52 of DosR, and the rmsd of the superposition is 1.8 Å (Figure 
74, Table 20). Other parameters provided by PDBeFold are the P score that represents the minus 
logarithm of the P value, which is probability to score a certain value of S, by chance, when 
matching two structures A and B. The S score is defined as a sum of quality scores Q. S varies 
from 0 to k (ideal alignment). k is the number of secondary structure elements present in a 
structure. The Z score measures statistical significance of the match, the higher the score, the 
higher the statistical significance (106). 
 
Table 20. Protein domains with similar fold to G20C ST_NTD identified by PDBeFold 
## Q P Z rmsd Nalgn Ngaps Q-%sse Match T-%sse Target 
 
1 0.5178 3.502 5.345 1.80 43 2 100 3C57:B 100 M. tuberculosis hypoxic 
response regulator DosR CTD 
7 0.4874 2.915 4.872 1.80 44 3 100 1W0U:A 100 HTRF-DBD-DNA complex 
 
9 0.4624 3.163 5.077 1.95 43 2 100 3N97:A 100 RNA_Pol_σ70-D4 –DNA 
complex 
31 0.4212 1.628 
 
3.653 2.36 45 3 100 9ANT:A 100 Antennapedia Homeodomain-
DNA complex 
- Root mean square deviation, rmsd, calculated distance between Cα atoms of matched residues. 
- Length of alignment, Nalgn, length of alignment. Number of matched residues. 
- Number of gaps, Ngaps. 
- Percent of matched secondary structure elements, Q- %sse, percent of the secondary structure of 
query identified on the match. T-%sse, percent of the secondary structure of the target identified 
on the query. 
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Figure 74. Superposition of G20C ST_NTD onto HTH-DNA complexes 
Matching protein-DNA complexes found by the PDBeFold search. G20C NTD (red) superposed onto the 
HTRF2, RNA polymerase sigma 70-factor domain 4 and Antp. DNA is in different tones of blue/yellow 
as the DNA sequences are different. Elements of the HTH motif are indicated as H1-T-H2, being H2 the 
recognition helix. Helices α2 and α3 are shown only for the G20C NTD. H1= α2 and H2=α3. The G20C 
ST_NTD N- and C-termini are labelled in red. Close up view at protein-DNA interactions is on the right. 
In each case the residues in ball and stick representation correspond to residues from the protein 
crystallised with DNA and not to the G20C NTD. 
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Besides the HTRF CTD and Antp homeodomain, G20C ST_NTD also superposed onto the σ70 
factor domain 4 of the Thermus aquaticus RNA polymerase (146) (Figure 74). The three 
mentioned matches present the HTH motif, with the recognition helix, H2, fitted into the major 
groove of the DNA. Charged and polar side chains projecting out of H2 establish H bonds with 
the phosphate backbone or bases of DNA. G20C ST_NTD superposes well onto the complete 
HTH motif present in the HTRF, Antp and RNA_Pol σ70-D4, with helices α2 and α3 
representing H1 and H2 from the HTH motif, respectively.   
Differences in the fold are observed at the N- or C-termini, and at the H1-H2 connecting loop. 
In the HTRF2 and Antp the N-terminus creates several H-bonds with DNA, in contrast, in the 
G20C ST, the initial N-terminal portion does not form an extended polypeptide chain since it is 
part of helix α1. Moreover, according to the superposition, residues 1-5 are situated far away 
from DNA, discarding the possibility of the N-terminal segment playing a role in interacting 
with DNA. Concerning the HTRF2, the crystallised species corresponds to residues 446-500. 
While the N-terminus of the construct may have been free in solution, the H-bonds established 
with DNA are likely to be a consequence of the truncation since the conformation adopted by 
the full length protein is likely to be different (145).  
In all identified homologues the H1-H2 connecting loop is less extended than in G20C. 
Although H2 is the main element that interacts with DNA, in G20C the loop is rich in positively 
charged residues, suggesting that it may contribute to interaction with DNA (Figure 68). 
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8.5 Conclusion  
Structure and sequence-based comparison of G20C ST with other STs showed that in spite of 
low sequence homology, several shared structural features are conserved, both at monomer and 
oligomer levels. For example, the presence of the HTH motif at the NTD, the OD consisting of 
two α-helices and the arrangement of several subunits into a circular assembly with comparable 
spacing between NTDs. The flexibility of the CTD can be interpreted as another characteristic 
in common between some STs since this region is disordered in G20C, P22, 44RR and 
PhBC6A51 phages. Structural differences arising between STs can be used to classify the 
structures according to their individual domains: subsets of STs contain an HTH motif in the 
NTD, others incorporate β-hairpins in their ODs and other STs are expected to have one β-
strand followed by one α-helix at the CTD.  
Furthermore, structural analysis revealed that the NTDs are the potential binding sites for DNA. 
The degree of variation in the channel diameter and number of subunits in the assembly while 
keeping a conserved spacing between individual NTDs, suggests that the channel may play a 
non-essential role in DNA recognition. Close structural homology with HTH motifs of several 
characterised DNA-binding proteins further reinforces the view that the HTH motif of G20C is 
directly involved in DNA interaction. A model for this protein-nucleic acid interaction will be 
proposed in chapter 10.  
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Chapter 9 
9. Production of DNA for DNA-binding activity experiments 
The current experimental evidence describing direct in vitro binding of the ST to DNA has 
utilised several sources of DNA. As described in the introduction, for some dsDNA phages the 
recognition site for the ST is known and well characterised. Such information allowed the 
design of appropriate DNA fragments to include in DNA-binding experiments, e.g. in the case 
of SF6, three variants of the SPP1 pac site were generated to test binding by surface plasmon 
resonance (SPR) (16). For Sf6, a systematic search of the recognition site was carried out. 
Initially EMSA including a fragment of 1,836 bp, selected because it features the ST and LT 
genes, were performed (68). Further experiments included random DNA fragments of varied 
lengths, or supercoiled DNA (136). The latest research on this phage has delimited the region 
with pac site activity to a 30 bp sequence by determining its ability to support the initiation of 
packaging by a P22 prophage that carried a hybrid ST. This hybrid featured the NTD and OD 
from Sf6, but the C-terminus from P22 ST (24). The DNA sequence used on PaP3 ST was a 239 
bp fragment that included the cos site (15). The cos site was first identified in λ phage and used 
for DNA-binding experiments (147). For P22 ST, the gene 3, which codes for the ST but also 
includes the pac site, was used for biochemical characterisation (14).  
The approach followed to investigate the G20C ST interaction with DNA is described in the 
present and following chapters. 
9.1 Design of viral and non-viral 1kbp DNA fragments: G20C_F1 and 
pUC18_F1 
To evaluate the capability of G20C’s ST to bind DNA, 1 kbp DNA fragments of viral and non-
viral origin were amplified. At the beginning of this project, Severinov’s lab in Moscow, kindly 
provided us with G20C’s genomic DNA. At that time they had just sequenced the genome and 
partially annotated it, however, no further information was available about whether a 
recognition site for the ST existed to start the translocation process, its sequence or location.  
Originally, the G20C’s ST WT was identified by its sequence homology with the putative small 
subunit from thermophilic dsDNA bacteriophages P23-45 and P74-26 (7) and by its genomic 
context. In many dsDNA phages the organisation of the molecular motor is a recurrent 
arrangement that comprises the gene encoding the ST overlapping downstream with a short 
portion of the LT gene. The LT gene is separated from the portal protein gene by a sequence of 
varying length.  
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As it was discussed in section 1.10.2, for several phages, the ST recognition site lies within the 
gene encoding the ST itself or a region close to this gene. The region comprising (Figure 75a,c) 
positions 42,098-43,097 in G20C’s genome was amplified using the pair of primers: forward 5’ 
CGC CCT CCT CTT TTC CAC CGC GGA TGA GCT 3’ and reverse: 5’ GGG AGC AAT 
AAT CCA GCC CTG GCT TCC AGG 3’. This region includes 516 bp that correspond to the 
ST gene, at the centre of the 1 kbp fragment (only G20C_F1 henceforth) plus 300 bp upstream 
and 184 bp downstream. The downstream region corresponds to a fraction of the LT gene 
(Figure 75a,c and Figure 76a). The overlapping region between the ST and LT genes is 20 bp 
long.  
 
 
Figure 75. 1 kbp DNA fragments: G20C_F1 and pUC18_F1 
(a) G20C genome (left) and pUC18 plasmid (right). Structural and functional elements of the G20C 
genome and pUC18 are indicated. (b) Scheme of G20C_F1 comprising the ST and portion of the LT 
genes. (c) Scheme of pUC18_F1 comprising the illustrated functional elements.  
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The fragment pUC18_F1 amplified covered the region 185-1,185 on the original plasmid 
(Figure 75a, c and Figure 76a). The designed primers were: Forward: 5’ ATG CGG TGT GAA 
ATA CCG CAC 3’ and Reverse: 5’ GTT GGA CTC AAG ACG ATA CTT 3’. Some functional 
elements of the plasmid, like the N-terminal part of the β-galactosidase (lacZa), the lac operon 
and promoter, the multiple cloning site (MCS) region and a portion of the replication origin are 
included in pUC18_F1. 
 
 
Figure 76. Nucleotide sequence of 1kbp fragments 
(a) G20C_F1 and (b) pUC18_F1. The first and last residues of each fragment are shaded in purple. Every 
structural or functional element is shaded following the same colouring scheme from the previous figure. 
A-tracts are shown in bold letters. 
 
Several A-tracts are present in both DNA fragments (Figure 76). Although A-tracts contribute 
to the bending of DNA, making it more prone to interact with DNA-binding proteins, the 
purpose of the experiments carried out on this project addressed sequence specificity rather than 
159 
 
the influence of the DNA’s conformation. The degree of curvature of the designed fragments 
was not determined. Both sequences are expected to have a similar degree of curvature in spite 
of pUC18_F1 having more A-tracts than G20C_F1. The irregular spacing between the A- tracts 
might attenuate the effect of the A-tracts since they are not continuous, and therefore do not 
reinforce each other to produce bending. 
 
9.2 Amplification of G20C_F1 and pUC18_F1 
The experimental stage of the production of G20C_F1 and pUC18_F1 consisted of using 
recombinant DNA from the motor operon (cloned from the genomic DNA) as the template to 
amplify G20C_F1. The full-length plasmid pUC18 was the template to produce pUC18_F1. The 
manufacturer’s instructions for the DreamTaq DNA polymerase (Thermo SCIENTIFIC) were 
followed to set up the PCR (Figure 76), using the program described below.   
 
G20C_F1 / pUC18_F1 
 
   94°C 2 min 
94°C 30 s 
60°C 30 s 
72°C 45 s 
72°C 5 min 
 
36 cycles 
 
100 μl PCR reactions were set up and run in a 0.75 % agarose gel stained with SYBR Safe (Life 
technologies). The main band approximately 1 Kbp in size was excised from the gel and 
purified with the GeneJET gel extraction kit (Fermentas, Life Sciences). DNA concentration 
was measured in ng·μL-1 and converted to μM to follow the procedure described in section 2.16. 
 
 
Figure 77. PCR for G20C_F1 and pUC18_F1 
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9.3 Amplification of 150 bp fragments 
In addition to the two 1 kbp DNA fragments described above, eight 150 bp fragments were 
amplified from the G20C genome, named G20C_F2 – F9 (Figure 78). Some of these segments 
lay either within the G20C_F1 sequence or in regions adjacent to its 3’ end. The purpose of 
producing shorter DNA fragments was to track the region recognised by the ST to start with 
DNA translocation. The regions comprised by each fragment and corresponding primers are 
listed in Table 21.  
The proposed strategy consisted of detecting binding to a long DNA and then to screen the 
binding to shorter fragments within or adjacent to G20C_F1. The region covered by the 150 bp 
fragments on G20C genome was 42,098 – 43,197. The fragments overlapped each other by 20 
bp at 5’ and 3’ ends.  
All forward and reverse primers included 21 bp linker regions which were complementary to 
another subset of primers labelled with different fluorophores. After nested PCRs, every 
fragment would be labelled with a pair of fluorophores suitable for fluorescence resonance 
energy transfer (FRET). This technique uses a biomolecule, DNA in our case, covalently linked 
to fluorescent probes, the energy donor (D) and acceptor (A). Exciting probe D by a light source 
leads to the release of energy, which is transferred to probe A. For this energy transfer to happen 
the probes need to be close together.  
 
Figure 78. Strategy to locate the packaging initiation site in the G20C genome 
 
In the hypothetical case that DNA uses the NTDs to wrap around the ST, the ST would be able 
to discriminate the fragment containing the recognition region from the rest. Then the DNA 
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would acquire a bent conformation due to the presence of several NTDs, bringing both labelled 
ends to proximity, which would allow measuring the amount of energy transferred to probe A 
from probe D. Short distances, high FRET states, would only be achieved by fragments that 
bend around the ST. Fragments that did not interact with the ST would not bend and the probes 
would remain away from each other in a low FRET state.  
Fragments were amplified by PCR using DreamTaq
TM
 DNA polymerase following the 
manufacturer’s instructions and the program below: 
 
   94°C 2 min 
94°C 30 s 
60°C 30 s 
72°C 10 s 
72°C 5 min 
 
During this thesis project only the fragment G20C_F3 was partially characterised in the 
presence of the construct ST_NTD due to time limitations. 
 
Table 21. Primers to amplify 150 bp fragments from G20C’s genome 
Fragment Region 
amplified 
Primers 
 
G20C_F1 42,098 – 43,097   Forward: 5’ CGC CCT CCT CTT TTC CAC CGC GGA TGA GCT 3’ 
Reverse: 5’GGG AGC AAT AAT CCA GCC CTG GCT TCC AGG 3’ 
 
G20C_F2  
 
42,138 – 42,287 
Forward: 5’ CCA GGA GGA CGC AGG GCA GGT  GAC GAC 
CTG GTT CAG AGC CTG GCG ACT CC 3’ 
Reverse: 5' TAA GGA ACC CCC TAT CCG GGG  CGA ATG CAC 
ACG TCG CAA AGG GTC TCG TA   3' 
 
G20C_F3  
 
42,268 – 42,417 
Forward: 5’ CCA GGA GGA CGC AGG GCA GGT  CTT TGC 
GAC GTG TGC ATT CGT AAA TAC GA 3’ 
Reverse: 5' TAA GGA ACC CCC TAT CCG GGG  TCC CTA AAA 
CTC ACG CTC ATC GCT TTC TA   3' 
 
G20C_F4 
 
42,398 – 42,547 
Forward: 5’ CCA GGA GGA CGC AGG GCA GGT  ATG AGC 
GTG AGT TTT AGG GAC AGG GTG CT 3’ 
Reverse: 5' TAA GGA ACC CCC TAT CCG GGG  AAG AAG CTC 
TCT AGC CTC GGC TAG GAC GT   3' 
 
G20C_F5 
 
42,528 – 42,677 
Forward: 5’ CCA GGA GGA CGC AGG GCA GGT  CCG AGG 
CTA GAG AGC TTC TTT CCG CCT TG 3’ 
Reverse: 5' TAA GGA ACC CCC TAT CCG GGG  CTT CCA TCA 
TGG CGT TGT AGT TGC GGA GC   3' 
 
G20C_F6 
 
42,658 – 42,807 
Forward: 5’ CCA GGA GGA CGC AGG GCA GGT  CTA CAA 
CGC CAT GAT GGA AGG CTT GAC CG   3’ 
Reverse: 5' TAA GGA ACC CCC TAT CCG GGG  AGT ACC TTG 
AGG CTA TTG AGC AGA GCG GT   3' 
 
G20C_F7 
 
42,788 - 42,937  
Forward: 5’ CCA GGA GGA CGC AGG GCA GGT  CTC AAT 
AGC CTC AAG GTA CTA GGC CAT GT 3’ 
Reverse: 5' TAA GGA ACC CCC TAT CCG GGG  CCT AGA AGC 
TCA AAG AAC TTG TCG CTA GG   3' 
Table continues on the next page 
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Table 20. Primers to amplify 150 bp fragments from G20C’s genome. Continuation 
Fragment Region 
amplified 
Primers 
 
 
G20C_F8 
 
42,918 – 43,067 
Forward: 5’ CCA GGA GGA CGC AGG GCA GGT  AAG TTC  
TTT GAG CTT CTA GGC TAC AAG CC 3’ 
Reverse: 5' TAA GGA ACC CCC TAT CCG GGG  CCG GGC GAA 
GAG CTC AAA CAC GGC CTC TA   3' 
 
G20C_F9 
 
43,048 – 43,197 
Forward: 5’ CCA GGA GGA CGC AGG GCA GGT  TGT TTG 
AGC TCT TCG CCC GGC CTG GAA GC 3’ 
Reverse: 5' TAA GGA ACC CCC TAT CCG GGG  GTC TAC GTT 
GAA GCT GAA CCT CGG TGG TG   3' 
pUC18_F1* 185 - 1,185 Forward: 5’ ATG CGG TGT GAA ATA CCG CAC 3’  
Reverse: 5’ GTT GGA CTC AAG ACG ATA CTT 3’ 
 
* Region corresponding to pUC18 vector 
      Forward linker,         Reverse linker 
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Chapter 10 
10. DNA-binding activity of the G20C small terminase 
This chapter summarises the experiments carried out to test whether G20C ST_WT exhibited 
DNA-binding activity and the conditions under which activity is evident. Likewise, the 
constructs ST_ΔC, ST_ΔN and ST_NTD, missing individual domains, were tested to assign a 
role in DNA binding to every domain. The available experimental information about the 
function of the ST from dsDNA phages, namely recognition of DNA was used to compare with 
that of G20C ST. As a literature review, section 10.4 condenses the data available that describe 
the regulation of the LT ATPase and nuclease activities by the ST. Finally, the structure and 
functional data produced on this project for G20C ST were combined to produce a model of the 
potential G20C ST-DNA interaction. 
 
10.1 DNA-binding by the G20C ST_WT 
The initial screening to detect any DNA-binding activity in G20C ST_WT consisted of 
investigating its capability to bind G20C_F1 and pUC18, which correspond to DNA of viral and 
non-viral origin (Figure 79a).  
Bovine serum albumin (BSA) on its own, and in the presence of G20C_F1 was included in the 
initial screen as the negative protein control to demonstrate how the binding exhibited by the 
ST_WT is a property of DNA-interacting proteins that is not present in random proteins such as 
BSA. Temperature was another variable tested. The optimal growth temperature of Thermus 
thermophilus, host of G20C phage, is 65 ºC. Since the extent of binding observed at 37 ºC 
appears to be the same at 60 ºC, it was decided to characterise G20C ST at 37 ºC. At 37 ºC 
proteins from thermophilic microorganisms are expected to be highly stable. Further 
biochemical characterisation could involve incubation at the G20C’s physiological temperature. 
Samples of Se-Met labelled protein and a 2
nd
 batch of DNA were included to screen the 
properties of the reagents available for the experimental work. The Se-Met ST_WT did not 
exhibit binding to DNA. The reason for such behaviour could either be due to the presence of 
Selenium atoms, or the time elapsed between the protein purification and the setup of the DNA-
binding experiments. All other experiments were carried out with native protein freshly 
purified. G20C ST_WT exhibited binding to the second batch of DNA. Batches of DNA were 
produced following the same protocol and tested before being included in the shown 
experiments.  
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Once binding to DNA was detected, a more detailed experiment was set up to test sequence 
specificity using several protein:DNA molar ratios (Figure 79b). Binding to viral and non-viral 
DNA was investigated in order to identify whether G20C ST exhibits any preference towards its 
own DNA since this is the first structural and biochemical characterisation performed on G20C 
ST and no information about the specific recognition site is available.  
 
Figure 79. EMSA to investigate the DNA-binding activity of G20C ST_WT 
(a) Initial screen and additional controls. * G20C Se-Met Se-Met labelled, # second batch of G20C_F1, 
¥
 
Incubation at 37 ºC, 
£
 Incubation at 60 ºC. Final reaction conditions: 25 mM Tris pH 7.5, 113 mm NaCl, 
20 mM Mg
+2
, 10 mM ATP (b) Binding of G20C ST_WT to G20C_F1 (viral) and pUC_F1 DNA (non-
viral) fragments. Final reaction conditions: 25 mM Tris pH 7.5, 100 mm NaCl, 20 mM Mg
+2
, 10 mM 
ATP. The red arrowheads indicate the positions of high MW species.  
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G20C ST_WT bound in a concentration dependent manner to both G20C_F1 and pUC18_F1 
(Figure 79b). DNA molecules 1 kbp long, mixed with G20C ST_WT in the ratios 250:1 to 
2,000:1 (protein to DNA), exhibited retarded migration by EMSA as compared to DNA alone, 
indicating that complexes with DNA were formed. The extent of retardation increased when the 
molar ratio of ST_WT was higher, suggesting that multiple ST_WT molecules could bind to a 
single DNA molecule in a potentially cooperative manner. 
G20C ST_WT did not form tightly bound complexes of specific stoichiometry with DNA since 
defined bands, that would form in the case of strong protein:DNA interactions, were replaced by 
diffuse DNA bands that represent transient complexes that re-equilibrate during electrophoresis. 
In other words, several 9-mers could possibly interact with a single DNA molecule. Having 
more 9-mers in the reaction means that more complexes can form on each DNA molecule 
therefore increasing the retardation of migration. Since the interaction with DNA seems not to 
form only one type of complex, and the interaction is relatively weak, it is likely that these 
complexes dissociate into their protein or nucleic acid components, leaving every component 
free to bind to other molecules or complexes.  
According to the experimental data, G20C ST_WT does not have preference for a specific DNA 
sequence. The binding to either viral or non-viral DNA fragments shows no difference despite 
having different origins and a sequence homology of 21.2 %. The same behaviour is observed 
for both fragments at the same molar ratios. The only difference observed is the formation of 
two faint, but discrete, bands when G20C ST_WT is incubated with viral DNA at ratio 2000:1. 
The two bands could correspond to two stable high MW species, and migrate similar to the 10 
kbp standard. Such bands are not observed when non-viral DNA is mixed with G20C ST_WT. 
10.1.1 Adjusting the buffer reaction conditions  
At the same time that the preliminary experiments (Figure 79a) to investigate binding to DNA, 
optimal temperature and random proteins binding to DNA as control were run, the buffer 
conditions were varied in order to determine what reagents were necessary for complex 
formation (Figure 80a). Our experiments follow a similar protocol used for observing the 
binding of Sf6 ST to DNA (68). In these assays DTT as well as ATP and Mg
+2
 was included in 
the reaction buffer. For G20C ST, it was observed that DTT does not affect the formation of 
ST:DNA complexes. However, the presence of either ATP or Mg
+2
 resulted in DNA shifts that 
were similar to the shifts observed in the presence of all components.  
Several Mg
+2
 concentrations were tested to identify whether variations in Mg
+2
 or its 
replacement by Mn
+2
, Ca
+2
 or Zn
+2
 cations produced differences in the DNA-binding. Reactions 
including 5-30 mM Mg
+2 
and 10 mM Mn
+2
, Ca
+2
 or Zn
+2 
were setup using molar ratios 2,000:1 
and 1,000:1. To discount any effect of the increasing ionic strength, the total ionic strength of 
the final reaction volume was adjusted to be the same in all reactions by varying the NaCl 
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concentration. It was observed that the binding to DNA follows the same behaviour when the 
concentrations of Mg
+2
 changed. No significant differences were observed when 10 mM of 
another divalent cation was included in the reaction. For all subsequent experiments and for gel 
b in Figure 79a 20 mM Mg
+2
 and 1 mM ATP were used. 
 
Figure 80. Effect of ATP, DTT and metal in binding to DNA 
a) EMSA to test the effect of 1 mM ATP, 20 mM Mg
+2
 and 1mM DTT in DNA-binding. Lanes 1 and 2 
contain the protein- and DNA-only controls. Lanes 3-7 include both components in 500:1 molar ratio. (b) 
Effect of Mg
+2
 concentration and other metals in DNA-binding. Lanes 1 and 12 contain DNA controls in 
20 mM Mg
+2
. Reactions from both lanes also contain 25 mM Tris pH 7.5 and 1 mM ATP. 
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10.2 DNA-binding of the G20C ST_ΔC, ΔN and NTD constructs 
Interaction with DNA was clearly evident for the ST_WT. The purpose of designing and 
producing truncated constructs was to assess the role of the terminal and core domains in 
binding to DNA. Figure 81 shows the screen carried out for each construct mixed with 
G20C_F1 in ratios ranging from 500:1 to 3,000 for ST_ΔC and ΔN constructs, and 4,500–
13,500 for ST_NTD. ST_ΔC and ΔN were demonstrated to be 9-mers in solution, hence the 
ratios are calculated for 9-mers of truncated protein to 1 kbp DNA molecules. Since ST_NTD 
exists as a monomer in solution, the molar ratios used were chosen considering this in 
determining the ratio of ST_WT: 1 kbp molecule, where every molecule of 9-mer contributes 9 
NTDs, for instance, the molar ratio 4,500:1 (NTD:DNA) includes the same number of NTD 
molecules as does the ratio 500:1 for 9-mer:1kbp DNA. The same logic was followed to include 
ratios 9,000:1 and 13,500:1, ST_NTD: 1 kbp.  
ST_ΔC showed increased binding to G20C_F1 in molar ratios 1,000:1 - 3,000:1, while ST_ΔN 
only showed residual binding. The ST_NTD construct did not show any binding (Figure 81). 
All experiments were carried out in 25 mM Tris pH 7.5, 100 mM NaCl, 1 mM ATP, 20 mM 
Mg
+2
. 
 
Figure 81. EMSA of  DNA binding activity of the G20C ST_ΔC, ΔN and NTD constructs 
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The gel on Figure 82 compares the DNA-binding activity of all G20C ST constructs produced 
on this study when incubated with G20C_F1 and pUC18_F1. With the exception of ST_NTD, 
all the reaction show ratios of 2,000:1 as it is the only ratio where ST_ ΔN exhibits residual 
binding. The equivalent ratio, 18,000:1, for ST_NTD was set up. In contrast to ST_WT, which 
clearly bound to both DNA fragments, constructs ST_ΔC and ST_ΔN exhibited dramatic loss 
of binding at the same ratios. Similarly to ST_WT, no difference is observed for the constructs 
when incubated with DNA of viral and non-viral origin, suggesting that the recognition of 
DNA, under the tested experimental conditions, is non-sequence specific.  
 
Figure 82. EMSA of the binding of G20C_WT and constructs to viral and non-viral DNA  
 
To further investigate the DNA-binding activity of ST_NTD in presence of G20C_F3 native 
EMSA experiments were carried out (Figure 83). 7.5 % polyacrylamide gels were prepared and 
run in [0.5X tris borate EDTA (TBE) [5X TBE: 13.5 g Tris, 6.88 boric acid, 1.163 g EDTA]]. 
Reactions including ST_NTD (monomer in solution) to 150 bp DNA molar ratio of 50:1–
2000:1 were prepared in 25 mM Tris pH 7.5, 50 mM NaCl and 10 mM Mg
+2
. An EMSA was 
carried out in native polyacrylamide gels, as opposed to agarose, as this made it feasible to 
detect differences in protein migration with Coomassie blue stain as well as DNA with SYBR® 
Safe. 
No binding of G20C ST_NTD to G20C_F1 was observed at any molar ratio of the experimental 
set up.  
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Figure 83. EMSA testing the binding of G20C ST_NTD to 150 bp fragments 
The top picture corresponds to the SYBRsafe® stain. At the bottom, the same gel stained with Coomassie 
blue.  
 
10.3 Functional comparison of ST:DNA binding activity from 
different viruses 
Binding to DNA has been proved for G20C (this study), SF6 (16), Sf6 (68,136), P22 (14,73), 
PaP3 (15), and Lambda (147) STs, however the nature of the recognised sequence and how the 
structural domains achieve binding to DNA are still important questions in order to understand 
the DNA translocation process. 
G20C ST is not the only ST that interacts with both viral and non-viral DNA. Sf6 ST besides 
interacting with ~1,800 bp linear DNA fragments that comprise Sf6 ST-LT region (68), also 
showed binding to random linear DNA fragments from a DNA ladder, with apparent increased 
affinity towards long DNA. Moreover, Sf6 formed more stable complexes with commercial 
supercoiled DNA than with long linear DNA, suggesting that the information that this ST 
recognises lies in the supercoiling of the DNA (conformation) rather than in the sequence itself 
(136). Nevertheless, Sf6 possesses a unique pac site, close to the ST gene, that is able to start 
DNA packaging in vitro (24). 
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P22 ST also demonstrated binding to viral and random DNA (73). The DNA binding activity of 
SF6 was only assessed with viral DNA that included the region corresponding to the ST and LT 
genes. For SF6, the SPP1 recognition site was used as it has been shown that both SPP1 and 
SF6 ST proteins, and probably the pac sites are homologous (148). No experiments including 
non-viral DNA were published to demonstrate whether SF6 ST discriminates the pac site from 
another source of DNA. However, the NTD of SF6 does not show any preference for sequences 
of viral origin (Maria Chechik, unpublished data). PaP3 ST only binds to cos-containing PaP3 
genomic DNA but fails to bind to fragments of the same length taken downstream of the cos 
site.  
The set of experiments carried out for G20C ST allowed the identification of DNA-binding 
activity towards both viral and non-viral DNA. Nevertheless, these experiments were not 
designed to identify or allocate any specific ST recognition site. In the structurally similar Sf6 
ST, from in vivo experiments, the pac site has been assigned to a short sequence located at the 
centre of the region coding for the DBD and OD, between bp 154-183. When this sequence was 
compared with P22 pac site, it was found that Sf6 has seven of the thirteen bp that are essential 
for recognition in P22 (Figure 84). Moreover, the encoded amino acids of both pac sites reside 
at the top of the external α-helix, immediately after the DBD, in case of Sf6. It is of note that 
both P22 and Sf6 pac sites are in the same position in the oligomer, pointing towards the fact 
that the recognition sequence remains within the region coding for the protein sequence 
responsible for DNA binding, possibly to avoid being separated during horizontal gene 
exchange (24). The alignment of Sf6 or P22 pac sites with the region around G20C ST did not 
show significant sequence homology. Nonetheless, when G20C OD was superposed onto that of 
Sf6, it was found that some of residues encoded by the pac region on Sf6 and P22, which are the 
same in these two ST, are also present in G20C (Figure 84). Additionally, some similarities 
(charged or nonpolar residues) between G20C OD and that of either Sf6 or P22 are observed.  
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Figure 84. Location of Sf6 and P22 pac sites within G20C ST sequence 
(a) Comparison of the amino acids encoded by Sf6 and P22 pac sites with those of G20C. The colouring 
of amino acids is: red, for identical, purple for hydrophobic residues, and gold for residues with the same 
charge. Squared areas correspond to the residues encoded by the minimum DNA sequence with pac 
activity. (b) Location of residues from (a) on the X-ray structure. Figure format adapted from (24). 
 
Although G20C belongs to the Siphoviridae family and Sf6 and P22 to Podoviridae, this 
manual alignment based on secondary structure raises the question about how related are the 
DNA-recognition mechanisms used by phages from different families. More experiments 
should be performed to confirm the presence and location of a pac site in phage G20C, which 
could be “hidden” somewhere in the genome and due to the lack of homology with other pac 
sites could not be detected.  
The experiments performed in this study establish the G20C ST NTD as the DNA-binding 
domain (G20C ST NTD will be referred as G20C DBD henceforth) since its removal leads to 
only residual binding activity in comparison with ST_WT. It is important to notice that the 
removal of the CTD dramatically reduces the binding activity too, though not to the same extent 
that removal of the DBD. The residual binding of ST_ΔN is attributed to positively charged 
residues (Figure 68d) at the outer surface of the OD that become exposed when the DBD is 
removed. The same residual binding activity was observed for SF6 ST constructs missing the 
DBD. SF6 ST_ΔN constructs, like G20C ST_ΔN expose positive residues at the outer surface 
as well, in fact, mutation of one of these residues further diminished the DNA-binding activity 
(16). 
In SF6 and Sf6 STs, the NTD has been established as the DBD because its removal in SF6 (16), 
or mutations of positively charged residues, in Sf6, greatly decreases or abolishes the DNA 
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binding activity (136). Functional studies on Sf6 revealed that mutation of positively charged 
residues at the start of the NTD (unstructured in the crystal structure) and at helices α3, α4 and 
α6 to negatively charged residues, significantly reduced the DNA binding activity. Only the first 
of the above described mutations was introduced at the NTD, while the rest, in helices α3 and 
α4 were at immediately adjacent areas (136). For SPP1 ST, constructs missing the CTD but 
keeping the NTD or featuring the CTD of SF6 ST bound to DNA; conversely the construct 
missing the first 62 residues did not (148).  
The behaviour of the CTD in DNA-binding appears to be more versatile. On SF6 ST, removal 
of the CTD in constructs missing the DBD did not produce decreased DNA-binding activity but 
produced 10-subunit assemblies, in contrast to 9-subunit assemblies that formed when the CTD 
was present (16). For Sf6 there is no published information about the role of the CTD in binding 
to DNA. The DNA-binding activity of P22 ST was ablated in comparison to the WT when the 
C-terminal 22 residues, where the unstructured helix α7 is predicted to be, were removed. This 
portion of P22 ST is speculated to be the DBD since the HTH motif, present in G20C, SF6 and 
Sf6, is absent. Experimental evidence that discards the participation of other portions of P22 ST, 
for instance some α helices from the helical core, in binding to DNA are still necessary to assign 
such function to the P22 ST CTD (14,73).  
G20C ST presents unique characteristics in the sense that both DBD and CTD contribute to 
different extents in DNA-binding activity. The DBD accounts for most of the binding, but the 
presence of the CTD greatly increases the interaction with DNA. G20C ST shares similar 
architecture for the DBD with SF6 and Sf6 ST, and for the three of them the DBD seems to be 
the most essential domain, however, G20C ST differs in that the CTD is also required for 
efficient DNA binding, while in SF6 and Sf6, no role in DNA-binding has been given to the 
CTD. G20C and P22 ST share the involvement of the CTD in recognition of DNA although in 
G20C ST, its deletion does not lead to the complete loss of activity. For 44RR or PhBC6A51 ST 
no functional studies on individual domains were published.  
 
10.4 Revising the ST-LT interaction: Regulation of the LT ATPase 
and nuclease activities and complex formation 
 
10.4.1 Regulation of the LT ATPase and nuclease activities by the ST 
In addition to the DNA-binding activity, the ST also modulates the LT enzymatic activities.   
SPP1, T4, P22 and PaP3 ST increase the ATPase activity of their respective LT though some 
peculiarities apply to each system. In SPP1 it was observed that the presence of the ST (G1P) 
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increases the amount of hydrolysed ATP (13) and further studies demonstrated that the SPP1 
portal (G6P) also stimulates this activity, although to a lesser extent than the ST. ATP 
hydrolysis was increased even higher when the LT (G2P), ST and portal were combined (149). 
What is interesting is the fact that keeping concentrations of G2P and G6P constant while 
increasing the amount of G1P leads to the increase in the ATPase activity, however it decreases 
when the G1P reaches a certain ratio with respect to G2P. The same behaviour is observed when 
both G1P and G2P concentrations are constant but that of G6P increases (149). T4 gp17-
ATPase (LT) is only stimulated by the ST_WT (gp16) and by a gp16 NTD-CTD construct but 
not by the individual central or terminal domains (17,69,150). For P22 ATPase (gp2) it was 
demonstrated that the ST (gp3) and pac-containing DNA are required to produce a significant 
rise in ATP hydrolysis in comparison to gp2 with DNA alone. Moreover, removal of the last 22 
residues in gp3, abolished ATP hydrolysis (14). PaP3 ST (p01) exists in solution as either 
monomer or dimer, but it is the dimer species that increases the ATPase (p03) activity the most 
in a ratio p03:p01 of 1:1 or 1:2 (15).  
SPP1 (13) and T4 (69) STs bind to DNA but do not hydrolyse ATP, while P22 (14) ST displays 
residual ATPase activity on its own, which is absent when DNA is supplied. PaP3 p01 does not 
exhibit any ATPase activity on its own (15). 
For the DNA-translocation process to be successful it is indispensable that the LT nonspecific 
endonuclease activity is reduced after cutting at the packaging initiation site, such inhibition in 
some phages is provided by the ST.   
The endonuclease activity of SPP1 G2P is not inhibited when G2P and G6P concentrations are 
constant but G1P’s is low. As the amount of G1P rises, the function of G2P endonuclease is 
permanently inhibited. G6P in the other hand is not able to prevent such inhibition when G2P 
and G1P concentrations are constant, but G1P’s is high, even with increasing amount of G6P 
(149). In T4 phage, WT gp16 and a NTD-CTD construct inhibit gp17 endonuclease whereas 
very high concentrations of the central OD are required to achieve the same degree of inhibition. 
Individual NTDs or CTDs alone are not enough to stop digestion of DNA when incubated with 
gp17 (69). P22 gp2 endonuclease activity is reinforced by the presence of ATP, indicating how 
both ATPase and endonuclease cross-talk to regulate the latter activity. Addition of gp3 inhibits 
DNA digestion but such inhibition is not overcome even if ATP is present (151). In a similar 
example of domain cross-talk, the Sf6 LT endonuclease activity is also increased by a higher 
concentration of ATP. This study, involving the Sf6 ST and LT, did not address the effect of 
DNA in the experiment (152). Studies on PaP3 p03 showed increased endonucleolytic activity 
towards commercial DNA when p01 concentration was raised to a p01:p03 ratio of 4:1 (74). 
The ST has been shown to be involved in in vitro DNA packaging. T4 gp16 stimulates DNA 
packaging in in vitro experiments that mimic in vivo packaging due to the inclusion of crude 
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lysate of E.coli cells infected with phage terminase-deficient phage (16am17am23amrII), T4 
rII
+
 phage DNA, and phage completion gene products (neck-tail and head completion proteins 
required for phage assembly) in addition to the recombinant gp16 and gp17. am stands for 
amber mutations, which generate the stop codon UAG. Phages carrying this mutation are 
generally able to infect only one type of bacterial strain, known as the amber suppressor since in 
these strains phages recover the altered function. r stands for rapid, which corresponds to a 
mutation that causes faster lysis of bacteria than the WT. rII loci refers to the position in the T4 
chromosome (153). In contrast, gp16 inhibits the DNA packaging produced by functional 
systems that only feature expanded procapsids, gp17_ΔC (lacking the last 33 residues) and 
linear plasmid DNA, pointing out that at least in vitro gp16 is dispensable for the translocation 
process (154). It was shown that inhibition of DNA packaging only occurs when the central OD 
is present as gp16 WT, ΔN, ΔC and OD were able to inhibit the packaging while individual 
domains and the ΔN-ΔC construct stimulated the DNA packaging (69).  
 
10.4.2 ST-LT Complex formation 
The mechanism the two terminase proteins use to interact with each other before or while 
attached to the procapsid is less well characterised than their individual functions or combined 
behaviour. The presented functional data on ST and LT on phages SPP1, T4 and P22 indicate 
that both components of the molecular motor communicate to increase the rate of ATP 
hydrolysis, in the presence of DNA for T4 and P22, and to diminish the endonuclease activity of 
LT. The formation of ST-LT complexes has been partially characterised for phages SPP1, T4, 
P22 and λ. 
Investigation of the SPP1 molecular motor components suggests that both terminases and portal 
proteins form functional complexes in vitro. Glycerol gradients performed on SPP1 G1P and 
G6P showed that both proteins physically interact to form a complex of estimated mass of ~ 
1,000 kDa. Moreover, the same study, based on the ATPase experiments carried out described 
above, indicates that the adduct with the stoichiometry G2P1·G1P2·G6P1 presents the highest 
rate of ATP hydrolysis (149). Experiments with truncated SPP1 G1P and truncated versions 
immobilised by polyclonal antibodies on protein A-sepharose columns showed that the DBD 
accounts for most of the interaction with G2P since the WT and one construct missing segment 
III (CTD) retained G2P in the column after washes with increasing NaCl concentrations, while 
the ΔN construct did not retain G2P even at low NaCl concentration. These experiments were 
performed in the absence of DNA. The domain in G1P recognised by the polyclonal antibodies 
is not mentioned to discard steric hindrance that could have occurred if G1P uses the same 
domain that the antibody recognises to interact with G2P (148).  
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Early research on P22 showed that gp3 copurified with gp2 in an apparent ~ 200 KDa complex, 
when it was intended to purify gp2 from cells containing the corresponding gene for both 
proteins (155). Later it was proven that gp3 CTD is essential to produce species of higher MW 
than the separate gp3 oligomer and gp2 monomer. Whereas FL gp3 forms complexes with gp2, 
one construct missing the last C-terminal 22 residues that also prevented binding to viral or 
random DNA, failed to produce complexes with gp2 (14,73). 
The ST (gpNu1) and LT (gpA) in λ phage associate into two different active species. The first 
one consists of a homogeneous 114.2 kDa heterotrimer composed of one copy of gpA and two 
of gpNu1. The second assembly is a 528 (± 34) kDa, referred as 13.3S species, for which 
stoichiometry is not clear, though a pentamer of heterotrimers ([gpA-gpNu12]5) would have a 
similar molecular weight (570.9 kDa) (156). 
 
10.5 Proposed model of interaction for G20C ST-DNA complex 
The combination of structural and biochemical data points towards a wraparound model where 
DNA surrounds the G20C ST (Figure 85). The model is proposed in view of the following 
evidence:  
 The exposure of several positively charged residues at the DBD creates a positive 
electrostatic potential around the ST that could attract the negatively charged DNA 
phosphate backbone and induce bending in DNA. 
 The spacing between DBDs in G20C, SF6, Sf6 ST is ~ 34 Å irrespective of differences in 
the oligomerisation state, suggesting that the number of subunits is less relevant to produce 
a functional assembly than the spacing between DBDs.  
 The identification on G20C ST of the HTH motif that is part of the DBD in SF6 and Sf6 ST, 
and which was crystallised in complex with DNA in HTRF2, RNA_Pol_σ_70_D4 and Antp 
protein also indicates that the HTH motif on G20C ST could be responsible for the 
interaction with DNA. 
 G20C ST DBD is able to adjust its position, as evidenced by up to 6.7 Å positional 
differences in individual subunits of the crystal structure. Hypothetically, in solution the 
DBDs will have more freedom to move and adjust their position. In the absence of 
precipitating agents or high salt concentrations, G20C ST is not forced to precipitate in an 
ordered way, hence the space restraints in the crystal are unlikely to occur in vivo. 
 Even though the central channel in G20C is almost wide enough to accommodate DNA, we 
speculate that this channel is a consequence of the need to array the DBDs at regular 
distances in circular arrangement. In agreement with this notion is the observation that SF6 
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ST did not show binding to DNA when the DBDs were removed and that both SF6 and Sf6 
ST bind to DNA even though the channel is too narrow to host DNA.  
In the proposed complex the DNA wraps around the G20C ST with the recognition helix (α2) 
establishing contacts with the major groove. The H-bonds between the DBD and DNA could be 
mediated by polar and charged residues coordinated with the phosphate-sugar backbone and 
exposed edges of nucleotide bases, there could be also water-mediated H-bonding interactions.  
One difference with the wraparound model proposed for SF6 ST is the position of DNA. While 
on SF6, the recognition α helices face the outwards of the assembly and DNA is exactly at the 
periphery, in G20C ST the recognition α helices are located pointing towards the top of the 
assembly. DNA would be therefore seated on top of the assembly. Although on Sf6 ST, the 
HTH motif clearly exists, the recognition helix is less exposed suggesting that DNA binding, 
may be dependent on more prominent angular and positional adjustments of individual DBDs. 
 
Figure 85. Model of G20C ST-dsDNA interaction 
Top (a) and side (b) views of the wraparound G20CS ST-dsDNA model. (c) Complementarity of the 
G20C DBD recognition helix with the major groove. The DNA was extracted from the X-ray structure of 
the Drosophila nucleosome, PDB 2NQB (157) . 
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The assumption that the DNA is seated on top of the G20C assembly fits well with the 
characteristics of the DBD-OD linker, which is not as long as in SF6 ST, but still it can provide 
the required up-and-down movement of the DBD to fit with DNA. From the structure it is 
known that the DBD can also move from side to side, which may be required to fit the 
recognition helices into the major grooves. Restriction in the movement of the DBD is also 
demonstrated by the high number of conditions from the commercial screens that produced 
crystals of G20C ST_ΔC, suggesting that removing the CTD reduces disorder in the molecule to 
some extent and that the DBD’s location is not subject to a high degree of variation. 
A second difference with the SF6 ST-DNA model is the role assigned to the CTD. In SF6 it was 
demonstrated that the CTD is not required for DNA recognition but it is involved in defining the 
oligomeric state (16). In G20C ST the removal of the CTD significantly decreased binding to 
DNA. It is proposed that on the basis of the EMSA data presented and the high proportion of 
negatively charged residues, the CTD’s role in binding is to repel the DNA and direct it to the 
surface provided by the DBD, or alternatively facilitate positional rearrangement of individual 
DBDs during binding to DNA. 
Although the model presented is based on the X-ray structure and data from experiments 
described above, it should be looked at with some caution as there are some aspects that limit its 
reliability. One of the principal limitations of this model is the width (Atom-to-atom: 25 Å, 
vdW: ~ 22 Å) of the central channel and the presence of four rings of positive charge along its 
height. B-form DNA has an atom-to-atom distance and vdW diameters that are ~ 20 and ~ 23 Å, 
respectively, implicating that if any conformation rearrangement to widen the channel occurred, 
DNA would fit inside. Another limitation of our model is that none of the experiments 
performed in this project were designed to assess DNA binding within the central channel and 
therefore discarding this option is based on the observations that binding to DNA is achieved 
principally by the DBD.  
In the past, models of protein structures involved in binding to DNA or models for ST-DNA 
interactions have been proposed, however further experimental work has made evident a 
misinterpretation. Both examples presented below are a reminder that the elucidation of the 
mechanism for recognition of DNA by the ST requires the X-ray crystal structure of the ST in 
complex with DNA.  
In 2008 the 3D reconstruction of gp3 FL (1-162) at 18 Å resolution was used to map the 
location of the CTD by comparing it with a construct (1-127) which lacked the CTD. The 
difference between two maps, the narrower part of the assembly, was assumed to be the location 
of the CTD, the domain being responsible to bind to DNA. Later, in 2012, the X-ray structure of 
construct gp13 Δ1-139 solved at 1.75 Å and reconstruction of FL gp3, combined with Cryo-EM 
data revealed the location of the C-terminus. The C-terminus was shown to be situated above 
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the widest part of the assembly, in the opposite direction of where it was first proposed, with the 
β1-β2 β-hairpin occupying the position where the CTD was speculated to be. Moreover, in the 
latter study, a population with an extended barrel on top of the widest part, formed by the α-
helical cores, was identified by cryo-EM. This extended barrel was demonstrated to account for 
the disordered helix α7.  
According to the structural superposition performed in this study, using CCP4mg and G20C 
DBD (residues 1-52), Sf6 DBD (residues 10-53) and SF6 DBD (residues 5-60), the HTH motif 
on Sf6 that aligns with that from G20C and SF6 involves helices α2 and α3, the latter being the 
recognition helix. The proposed model to describe the Sf6 NTD-dsDNA interaction in 2010 
presented helix α1 inserted into the major groove and based on this study a new publication 
included a wraparound model with DNA. In view of our observations, a wraparound model 
directly from the X-ray structure, using the identified recognition helix on Sf6 DBD, helix α3, 
would not be accurate as it would imply significant changes in the orientation of this helix to 
adjust to the major grooves on the DNA.  
 
10.6 Conclusions 
 
The set of experiments carried out identified that G20C ST is a functional protein which binds 
to 1 kbp DNA fragments of viral and non-viral origin. The viral DNA comprised a region of the 
G20C’s genome that includes the ST gene, a region upstream of this gene and another short 
portion of the LT gene. Interestingly, although the NTD was demonstrated to be the DBD, the 
CTD was shown to also contribute to the observed binding of the WT protein to DNA. 
Combined with the X-ray crystal structure, the experimental data described in this chapter are 
consistent with a wraparound model that describes the way G20C ST interacts with DNA. This 
model and those available in the literature are subject to change as only a crystal structure in 
complex with DNA will provide the degree of accuracy necessary to understand the DNA-
recognition process during early stages of bacteriophage assembly. 
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Chapter 11 
11. Conclusions and suggested future approaches 
Molecular motors in dsDNA bacteriophages translocate viral genomes into preformed capsids. 
The molecular motor is composed of the portal protein, embedded in a single vertex of the 
procapsid, and the small and large terminase proteins. The small terminase recognises DNA and 
presents it to the large terminase, which generates cuts to produce genome-sized DNA 
fragments. The large terminase in addition can act as an ATPase to provide the driving-force of 
the molecular motor.  
The main outcomes of this project are the X-ray structures of the SPP1 capsid protein and 
G20Cʼs ST, determined by SAD at 3.0 and 2.5 Å resolution, respectively (Table 9 and Table 
15).  
G13P, the SPP1 capsid protein, is organised into A- and P-domains and E-loop (Figure 48). 
G13P crystallised as 5-subunit assemblies that provided information about the potential 
arrangement of subunits in the capsid as they resemble the organisation of the HK97 capsid 
morphological units. G13P adopts the HK97-fold (39), similar to the capsid protein of T4 (37) 
and several other capsid-related proteins, e.g. encapsulins (Figure 51 and Figure 53).  
The G20C ST monomer is comprised of two domains: the NTD and OD. G20C ST oligomerises 
into 9-subunit circular structures (Figure 67). Structural comparison with SF6 (16), P22 (14), 
Sf6 (68) and other STs revealed that the G20C NTD has a HTH motif and that the OD shares 
some architectural characteristics with that from other STs. Shared characteristics between 
oligomers include the circular array, formation of a central channel, overall diameter and 
spacing between individual NTDs. DNA-binding experiments with G20C ST_WT and truncated 
versions demonstrated binding to both viral and non-viral DNA. Moreover, the NTD was 
established as the most essential portion for DNA binding, although the CTD was also 
demonstrated to be important. The involvement of both the NTD and CTD in DNA-binding had 
not been previously observed in STs. A wrap-around model to describe the interaction of G20C 
ST with DNA is proposed on the basis of the performed biochemical experiments and structural 
analysis (section 8.4).  
Both proteins contribute to the structural knowledge of viral capsid construction and the viral 
assembly process. As aforementioned, as of September 2014, G13P is the third crystal structure 
for a dsDNA bacteriophage capsid protein and the second for a Siphovirus, in spite of the fact 
that Caudovirales outnumber all other organisms in our planet by a factor of ~ 10. Moreover the 
elucidation of the SPP1 capsid structure positions this bacteriophage as the most extensively 
characterised by structural analysis, since there are X-ray structures available for all the 
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components of the molecular motor (11,16,22), and there are also NMR structures of the 
connector proteins (61) and cryo-EM structures of the tail (60) and complete capsids at late 
stages of morphogenesis (41).  
G20C ST is the first ST characterised for a thermophilic phage and the first protein from G20C 
phage for which the X-ray structure was elucidated and biochemical characterisation was 
carried out. It was not until 2012 when the X-ray structures of SF6, P22 and 44RR ST were 
published that a significant amount of structural information became available. G20C ST posits 
a dilemma when it comes to address the potential mechanism of interaction with DNA since the 
atom-to-atom diameter of the central channel is almost wide enough to accommodate B-form 
DNA and this would suggest that the DNA could be threaded through it. The only phage for 
which it is reasonable to hypothesise that the DNA could be threaded through the channel is 
44RR, where the channel diameter is wide enough to accommodate DNA. However, the 
variability in subunit number of ST oligomers refutes channel involvement in DNA-binding. 
Intriguingly, G20C ST also presents an NTD that was identified as DBD. Moreover the CTD 
also plays an important role in binding to DNA.  
The structural conservation of most of the SPP1 capsid protein with other capsid proteins and 
some shared characteristics of G20C ST with the available X-ray structures of ST, provide 
further evidence toward the hypothesis that all dsDNA tailed phages have evolved from a 
common ancestor.  
Further work will focus on the fitting of the SPP1 capsid protein’s X-ray structure into the 
available cryo-EM maps of the complete capsid to investigate how G13P interacts with the G6P 
portal protein. Mutations will be introduced, at the identified surfaces of P- and A-domains, to 
promote formation of complexes involving the portal protein surrounded by a single layer of 
capsid proteins. The longer term goal may be to attach the capsid-portal complexes onto 
surfaces, where after assembly of the molecular motor, it would be possible to deliver DNA 
through these barriers. Combining X-ray and EM data to produce a pseudo-atomic model of a 
complete capsid would be invaluable for understanding inter- and intra-capsomer interactions 
during different stages of capsid assembly. 
Future work with the G20C ST involves the production of higher-quality crystals. Further 
approaches to characterise the DNA-binding activity may include mutagenesis in the putative 
DBD to investigate residues relevant for binding. Additionally, shorter DNA fragments could be 
used to identify a packaging-initiation site with a minimal size that could be used for 
crystallisation of the ST-DNA complex.  
The available constructs can be used, together with G20C LT, to determine whether G20C ST 
CTD is the LT-binding domain. Other experiments including the ST and LT could be performed 
in the presence of both proteins to investigate their properties including DNA-binding, ATPase 
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and nuclease activities. Some biochemical characterisation may have to be performed at higher 
temperatures to account for the high optimal growth temperature of Thermus thermophilus. 
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Appendices  
Appendix 1. Primers for SPP1 G13P and G20C ST constructs 
Clone  N-Residue C-Residue Tag- Vector Forward primer 5' → 3'  Reverse 5' → 3' 
G13P_WT  M1-A2 A324 N’ His -pET28a  GG AAT TCT CAT ATG GCA TAC 
ACA AAA ATT TCA G 
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_WT-GST M1-A2 Ala 324 N’ GST -pGEX CC CTG GGA TCC ATG GCA TAC 
ACA AAA ATT TCA 
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_ΔC M1-A2 N286 N’ His -pET28a GG AAT TCT CAT ATG GCA TAC 
ACA AAA ATT TCA G 
CCA GAA CTC GAG TTA GTT TTC TGT 
GAA TTT TAC GCC 
G13P_ΔN2 M1-T4 A324 N’ His -pET28a ATTCT CAT ATG ACA AAA ATT TCA 
GAT GTT 
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_ΔN6 M1-D8 A324 N’ His -pET28a ATTCT CAT ATG GAT GTT ATC GTA 
CCG GAG  
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_ΔN10 M1-P12 A324 N’ His -pET28a GGAATTCT CAT ATG CCG GAG TTA 
TTT AAC CCG TAC G 
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_ΔN15 M1-P17 A324 N’ His -pET28a AT TCT CAT ATG CCG TAC GTC ATT 
AAC ACA ACA 
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_ΔN15 M1-P17 A324 N’ GST -pGEX CCCTG GGA TCC CCG TAC GTC ATT 
AAC ACA ACA 
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_ΔN21 M1-T23 A324 N’ His -pET28a AT TCT CAT ATG ACA ACA CAA 
CTT TCT GCC TTC 
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_ΔN21 M1-T23 A324 N’ GST -pGEX CC CTG GGA TCC ACA ACA CAA 
CTT TCT GCC 
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_ΔN35 M1-T37 A324 N’ His -pET28a GGA ATTCT CAT ATG ACA GAT 
GAC GAA TTG AAT GCA C 
CCA GAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_FL_G64W M1-A2 A324 N’ His -pET28a G TAC TGG AAT GAC CTA GAC TGG 
GAT TCC CAA GTG TTG AAC 
GTT CAA CAC TTG GGA ATC CCA GTC 
TAG GTC ATT CCA GTA C 
G13P_FL_D100R M1-A2 A324 N’ His -pET28a AGT TCT CAC CGT TTA GCG  CGC TAA ACG GTG AGA ACT 
G13P_FL_T104Y M1-A2 A324 N’ His -pET28a TTA GCG GCA TAC CTT TCC GGT  ACC GGA AAG GTA TGC CGC TAA 
G13P_FL_D194W M1-A2 A324 N’ His -pET28a CGC AGT TAA ACA ATG GTT GAT 
TGA 
TCA ATC AAC CAT TGT TTA ACT GCG 
G13P_FL_A261W M1-A2 A324 N’ His -pET28a CA ACA GAA ACA GCC CGT AAC 
GCT TGG GG TTC CCA AGA TAT TC 
G AAT ATC TTG GGA ACC CCA AGC 
GTT ACG GGC TGT TTC TGT TG 
G13P_FL_L262W M1-A2 A324 N’ His -pET28a CGT AAC GCT TGG GGT TCC 
CAA 
TTG GGA ACC CCA AGC GTT ACG 
       
Appendix 1. Primers for SPP1 G13P and G20C ST constructs. Continuation 
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Clone  N-Residue C-Residue Tag- Vector Forward primer 5' → 3'  Reverse 5' → 3' 
G13P_FL_T104Y; A261W  M1-A2 A324 N’ His -pET28a Primer containing 2nd mutation Primer containing 2nd mutation 
G13P_FL_G64W;T104Y  M1-A2 A324 N’ His -pET28a Primer containing 2nd mutation Primer containing 2nd mutation 
G13P_FL_G64W;A261W  M1-A2 A324 N’ His -pET28a Primer containing 2nd mutation Primer containing 2nd mutation 
* G13P_V10-I35AT M1-A2 A342 N’ His -pET28a GG AAT TCT CAT ATG GCA TAC 
ACA AAA ATT TCA G 
CCAGAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
* G13P_A11-V34AT M1-A2 A340 N’ His -pET28a GG AAT TCT CAT ATG GCA TAC 
ACA AAA ATT TCA G 
CCAGAA CTC GAG TTA TGC TTG TAG 
TCT GTG TT 
G13P_V10-I35AT_ΔC330 M1-A2 K329 N’ His -LIC 3C GG AAT TCT CAT ATG GCA TAC 
ACA AAA ATT TCA G 
 CCA GAA CTC GAG TTA CTT AGG 
GTC GTA CAC 
G13P_V10-I35AT_ΔC314 M1-A2 D313 N’ His -LIC 3C GG AAT TCT CAT ATG GCA TAC 
ACA AAA ATT TCA G 
CCA GAA CTC GAG TTA GTC CGT AGG 
CGT TCT 
G13P_A11-V34AT_ΔC328 M1-A2 K327 N’ His -LIC 3C GG AAT TCT CAT ATG GCA TAC 
ACA AAA ATT TCA G 
 CCA GAA CTC GAG TTA CTT AGG 
GTC GTA CAC 
G13P_A11-V34AT_ΔC312 M1-A2 D311 N’ His -LIC 3C GG AAT TCT CAT ATG GCA TAC 
ACA AAA ATT TCA G 
CCA GAA CTC GAG TTA GTC CGT AGG 
CGT TCT 
G13P_V10-I35AT-C’_tag M1-A2 A342 C’ His -pET22b (Non 
cleavable) 
GGA GAT ATA CAT ATG GCA 
TAC ACA AAA ATT TCA         
GTG GTG GTG CTC GAG TGC TTG TAG 
TCT GTG TTT 
G13P_A11-V34AT-C’_tag M1-A2 A340 C’ His -pET22b (Non 
cleavable) 
GGA GAT ATA CAT ATG GCA 
TAC ACA AAA ATT TCA         
GTG GTG GTG CTC GAG TGC TTG TAG 
TCT GTG TTT 
G13P_ ΔN6_T104Y; A261W M1-D8 A324 N His -LIC- (Non 
cleavable) 
ATC ACC ACC ACC AC ATG GAT 
GTT ATC GTA CCG GAG  
TGA GGA GAA GGC GCG TTA TGC TTG 
TAG TCT GTG  
G13P_FL_T104Y; A261W M1-A2 A324 pET22b (Untagged) GGA GAT ATA CAT ATG GCA 
TAC ACA AAA ATT TCA   
GTG GTG GTG CTC GAG TTA TGC TTG 
TAG TCT      
G13P_FL_G64W;T104Y M1-A2 A324 pET22b (Untagged) GGA GAT ATA CAT ATG  GCA 
TAC ACA AAA ATT TCA         
GTG GTG GTG CTC GAG TTA TGC TTG 
TAG TCT         
G13P_V10-I35ATΔ330-HMBP M1-A2 K329 N’ His -HMBP CAG GGG CCC GGA TCC ATG 
GCA TAC ACA AAA       
TGC CTG GAC GTC GAC  TTA CTT AGG  
GTC GTA        
Clone  N-Residue C-Residue Tag Forward primer 5' → 3'  Reverse 5' → 3' 
G20C_ST_WT M1-S2 T171 pET28a GGA CAA CAT ATG AGC GTG 
AGT TTT AGG GAC 
GGC AAG CTT CTA GGT CTT AG 
GCG CTT CAT C  
G20C_ST_WT-C’_tag M1-S2 T171 C’ His- pET22b GAA GGA GAT ATA CAT ATG 
AGC GTG AGT TTT AGG G 
GTG GTG GTG CTC GAG GGT CTT 
AGG CGC TTC  
 
   
    Appendix 1. Primers for SPP1 G13P and G20C ST constructs. Continuation 
Clone  N-Residue C-Residue Tag Forward primer 5' → 3'  Reverse 5' → 3' 
G20C_ST_NTD M1-S2 A52 N’ His- pET28a G CTT CTT TCC GCC TAG TTG 
CCT TCC CTT GAA G           
TTC AAG GGA AGG CAA CTA GGC 
GGA AAG AAG 
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G20C_ST_ΔC M1-S2 G138 N’ His-pET28a C AAG GTA CTA GGC TAG CAT 
GTC GGG TCC  AC 
GT GGA CCC GAC ATG CTA GCC 
TAG TAC  CTT    
G20C_ST_ΔN M1-P54 T171 N’ His-LIC 3C TTC CAG GGA CCA GCA ATG 
CCT TCC CTT GAA GAC 
TGA GGA GAA GGC GCG CTA GGT 
CTT AGG CGC TTC 
 
Unless otherwise stated, all the tags were cleavable. 
Codons in Cyan correspond to introduced stop codons, codons in yellow highlight the introduced mutation. 
Restriction sites: NdeI in blue, XhoI in green, BamHI in purple, SalI in orange, HindIII in pink  
* Primers that amplify the FL protein are mentioned, for details see section 3.4.1 
 
 
Appendix 2. List of buffers to purify SPP1 G13P and G20C ST constructs 
Clone  Affinity chromatography buffer SEC buffer Final result 
G13P_WT  25 mM Tris pH 7.5, 75mM NaCl + 
10/500 mM Imidazole/ HT  
25mM Tris  pH 7.5, 75mM NaCl  
§
 
Aggregation into capsid-like particles 
G13P_WT-GST 25 mM Tris pH 7.5, 75mM NaCl + 
50mM glutathione (to elute) / 
glutathione resin 
25mM Tris  pH 7.5, 75mM NaCl Soluble  
Too low yield in NAC, SEC 
G13P_ΔC X X Soluble when induced in Artic Express 
cells 
G13P_ΔN2 25 mM Tris pH 7.5, 150mM NaCl + 
10/500 mM Imidazole / FF 
X Too low yield 
Aggregation 
G13P_ΔN6 25 mM Tris pH 7.5, 150mM NaCl + 
10/500 mM Imidazole / HT 
25 mM Tris pH 7.5, 150mM NaCl Soluble 
Aggregation 
G13P_ΔN10 25 mM Tris pH 7.5, 150mM NaCl + 
4/500 mM Imidazole / FF 
25 mM Tris pH 7.5, 150mM NaCl Aggregation  
     
   Appendix 2. List of buffers to purify SPP1 G13P and G20C ST constructs. Continuation 
Clone  Affinity chromatography buffer SEC buffer Final result 
G13P_ΔN15 X X Insoluble 
G13P_ΔN15-GST X X Insoluble 
G13P_ΔN21 X X Insoluble 
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G13P_ΔN21-GST X X Insoluble 
G13P_ΔN35 X X Insoluble 
G13P_FL_G64W 25 mM Tris pH 7.5, 10mM NaCl + 
10/500 mM Imidazole/ HT 
25 mM Tris pH 7.5, 10mM NaCl Soluble 
Formation of 1x10
6
 Da aggregates 
No crystals grown 
G13P_FL_D100R 25 mM Tris pH 7.5, 10mM NaCl + 
10/500 mM Imidazole/ HT 
X Soluble 
Too low yield 
G13P_FL_T104Y 25 mM Tris pH 7.5, 10mM NaCl + 
10/500 mM Imidazole/ HT 
25 mM Tris pH 7.5, 10mM NaCl Soluble   -  Too low yield  
Monomers and aggregates in SEC 
G13P_FL_D194W 25 mM Tris pH 7.5, 10mM NaCl + 
10/500 mM Imidazole/ HT 
X Soluble 
Too low yield 
G13P_FL_A261W  
 
25 mM Tris pH 7.5, 10mM NaCl + 
10/500 mM Imidazole/ HT 
 
 
 
25 mM Tris pH 7.5, 10mM NaCl 
 
Soluble  -  Too low yield  
Monomers and aggregates in SEC 
G13P_FL_L262W Soluble  -  Too low yield  
Apparently monomer 
G13P_FL_T104Y; A261W  Soluble – Monomer - Needles 
G13P_FL_G64W;T104Y  Soluble – Monomer -  No crystals 
G13P_FL_G64W;A261W  Aggregation  
G13P_V10-I35AT 25 mM Tris pH 7.5, 10 or 500mM 
NaCl + 10/500 mM Imidazole/ HT 
25 mM Tris pH 7.5, 10mM NaCl 
25 mM Tris  pH 7.5, 500mM NaCl 
Soluble – Monomer -  Degradation - No 
crystals G13P_A11-V34AT 
G13P_V10-I35AT_ΔC330  
X 
 
 
 
X 
 
 
 
Insoluble 
 
G13P_V10-I35AT_ΔC314 
G13P_A11-V34AT_ΔC328 
G13P_A11-V34AT_ΔC312 
G13P_V10-I35AT-C’_tag 25mM pH 7.5, 500mM NaCl + 10/500 
mM Imidazole/ HT 
25mM pH 7.5, 500mM NaCl 
 
Soluble – Monomer -  Degradation - No 
crystals G13P_A11-V34AT-C’_tag 
Appendix 2. List of buffers to purify SPP1 G13P and G20C ST constructs. Continuation 
Clone  Affinity chromatography buffer SEC buffer Final result 
G13P_ ΔN6_T104Y; A261W 50 mM Tris pH 7.5, 500mM NaCl + 
10/500 mM Imidazole/ HT 
25 mM Tris pH 7.5, 500mM NaCl Soluble – Mix of aggregate and monomer  
u-G13P_FL_T104Y; A261W A: 25 mM Tris pH 7.5, 10 mM NaCl 
B: 25 mM Tris pH 7.5, 500mM NaCl 
/FFQ 
 
10 mM Tris pH 7.5, 200mM NaCl 
 
Soluble – Monomer – Crystals 
Se-Met purified with same conditions 
u-G13P_FL_G64W;T104Y Soluble – Monomer – No crystals  
G13P_V10-I35ATΔ330-HMBP 25 mM Tris pH 7.5, 200mM NaCl + 
10/500 mM Imidazole/ HT 
X Too low yield 
Clone  Affinity chromatography buffer SEC buffer Final result 
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G20C_ST_WT 25 mM Tris pH 7.5, 500mM NaCl + 
10/500 mM Imidazole/ HT 
25 mM Tris pH 7.5, 250mM NaCl Soluble, 9-mer, crystallised 
G20C_ST_WT-C’_tag  
25 mM Tris pH 7.5, 200mM NaCl + 
10/500 mM Imidazole/ HT 
 
25 mM Tris pH 7.5, 250mM NaCl 
 
 
Soluble, used for activity assays. 
 
G20C_ST_NTD 
G20C_ST_ΔC 
G20C_ST_ΔN 
X indicates that no chromatography was carried out 
HT- His Trap column, FF- FF crude column, FFQ- Fast flow Q column 
§ More details in the text  
Note: For most of the constructs several purifications with varying NaCl concentrations were made, however no changes were observed in the chromatography 
profiles. 
 
 
 
 
 
 
 
 
Appendix 3. Properties of SPP1 G13P and G20C ST constructs 
Clone  Residues 
 No tag 
MW *  
kDa 
pI (- tag) Abs 0.1 % 
(= 1 g/L) * 
Residues 
With tag 
MW (+ tag) 
kDa 
pI (+ tag) Abs 0.1 % 
(= 1 g/L) 
¥
 
G13P_WT  327 35.636 4.95 1.035 344 37.518 5.49 0.984 
G13P_WT-GST 329 35.766 4.89 1.032 555 62.178 5.21 1.283 
G13P_ΔC 289 31.299 4.70 0.956 306 33.181 5.19 0.901 
G13P_ΔN2 325 35.401 4.95 1.000 342 37.283 5.49 0.950 
G13P_ΔN6 321 34.972 4.88 1.013 338 36.854 5.40 0.961 
G13P_ΔN10 317 34.545 4.95 1.025 334 36.427 5.49 0.972 
G13P_ΔN15 312 33.945 5.01 1.043 329 35.827 5.58 0.988 
G13P_ΔN15-GST 313 33.944 4.93 1.043 539 60.356 5.25 1.301 
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G13P_ΔN21 306 33.257 5.01 1.020 323 35.139 5.58 0.965 
G13P_ΔN21-GST 307 33.256 4.93 1.020 533 59.668 5.25 1.287 
G13P_ΔN35 292 31.833 5.01 1.066 309 33.715 5.58 1.006 
G13P_FL_G64W 327 35.765 4.95 1.189 344 37.647 5.49 1.126 
G13P_FL_D100R 327 35.677 5.11 1.034 344 37.559 5.68 0.982 
G13P_FL_T104Y 327 35.698 4.95 1.075 344 37.580 5.49 1.022 
G13P_FL_D194W 327 35.707 5.02 1.187 344 37.589 5.59 1.128 
G13P_FL_A261W 327 35.751 4.95 1.186 344 37.633 5.49 1.127 
G13P_FL_L262W 327 35.709 4.95 1.187 344 37.591 5.49 1.128 
G13P_FL_T104Y; A261W  327 35.813 4.95 1.226 344 37.695 5.49 1.164 
G13P_FL_G64W;T104Y  327 35.827 4.95 1.225 344 37.709 5.49 1.164 
G13P_FL_G64W;A261W  327 35.880 4.95 1.335 344 37.762 5.49 1.268 
G13P_V10-I35AT 345 37.396 4.94 0.993 362 39.278 5.42 0.946 
G13P_A11-V34AT 343 37.183 4.94 0.999 360 39.065 5.42 0.951 
G13P_V10-I35AT_ΔC330 332 35.721 4.61 1.040 351 37.867 4.87 0.981 
G13P_V10-I35AT_ΔC314 316 33.849 4.61 0.891 335 35.995 4.89 0.838 
G13P_A11-V34AT_ΔC328 330 35.508 4.61 1.046 349 37.655 4.87 0.987 
G13P_A11-V34AT_ΔC312 314 33.636 4.61 0.897 333 35.783 4.89 0.843 
G13P_V10-I35AT-C’_tag NC NC NC NC 350 38.179 5.20 0.963 
 
Appendix 3. Properties of SPP1 G13P and G20C ST constructs. Continuation 
 
Clone  Residues 
 No tag 
MW *  
kDa 
pI (- tag) Abs 0.1 % 
(= 1 g/L) * 
Residues 
With tag 
MW (+ tag) 
kDa 
pI (+ tag) Abs 0.1 % 
(= 1 g/L) 
¥
 
G13P_A11-V34AT-C’_tag NC NC NC NC 348 37.967 5.20 0.978 
G13P_ ΔN6_T104Y; A261W --- --- --- --- 328 36.053 5.23 1.176 
u-G13P_FL_T104Y; A261W 324 35.531 4.89 1.235 --- --- --- --- 
u-G13P_FL_G64W;T104Y 324 35.545 4.89 1.235 --- --- --- --- 
G13P_V10-I35ATΔ330-HMBP 334 35.922 4.61 1.027 724 78.846 5.03 1.310 
Clone  Residues 
 No tag 
MW *  
kDa 
pI (- tag) Abs 0.1 % 
(= 1 g/L) * 
Residues 
With tag 
MW (+ tag) 
kDa 
pI (+ tag) Abs 0.1 % 
(= 1 g/L) 
¥
 
G20C_ST_WT 174 19.074 4.94 0.234 190 20.825 5.66 0.215 
G20C_ST_WT-C’_tag NC NC NC NC 179 19.858 5.32 0.225 
G20C_ST_NTD 55 6.198 5.55 0.240 72 8.080 6.70 0.184 
G20C_ST_ΔC 141 15.785 5.39 0.283 158 17.667 6.29 0.253 
G20C_ST_ΔN 122 13.138 4.72 0.227 141 15.284 5.37 0.195 
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--- Not applicable, for example no tag was included 
*   Includes the additional residues left after tag removal 
¥    
Assuming all pairs of Cys residues form cysteines 
NC-  Non-cleavable tag  
Note: only G13P-AT constructs included Cys residues (four in the Zn-binding domain) 
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Appendix 4. H-bonds between subunits F-A from HK97 gp5 
## Structure 1 Dist. [Å] Structure 2 
1  F:MET 119[ N  ]   3.20  A:ALA 147[ O  ]  
2  F:ILE 121[ N  ]   2.87  A:GLU 149[ O  ]  
3  F:ILE 125[ N  ]   2.84  A:VAL 151[ O  ]  
4  F:ALA 187[ N  ]   2.93  A:ASP 161[ O  ]  
5  F:HIS 188[ ND1]   3.30  A:SER 172[ OG ]  
6  F:TRP 189[ N  ]   2.99  A:PRO 170[ O  ]  
7  F:TRP 189[ NE1]   3.19  A:LYS 169[ O  ]  
8  F:TYR 206[ OH ]   2.54  A:GLU 153[ OE1]  
9  F:ARG 210[ NE ]   2.90  A:GLU 153[ OE1]  
10  F:ARG 210[ NH2]   3.05  A:GLU 153[ OE2]  
11  F:ARG 280[ NH2]   3.04  A:SER 246[ OG ]  
12  F:ARG 294[ NE ]   3.44  A:ASP 290[ OD2]  
13  F:ARG 294[ NH2]   3.29  A:ASP 290[ OD2]  
14  F:TYR 295[ OH ]   2.54  A:ASP 256[ OD2]  
15  F:GLN 301[ NE2]   3.90  A:THR 304[ OG1]  
16  F:GLN 301[ NE2]   3.75  A:PHE 297[ O  ]  
17  F:LYS 317[ NZ ]   3.07  A:GLU 267[ O  ]  
18  F:GLN 117[ O  ]   3.47  A:SER 145[ OG ]  
19  F:MET 119[ O  ]   3.04  A:GLU 149[ N  ]  
20  F:MET 119[ SD ]   3.32  A:THR 143[ OG1]  
21  F:ILE 125[ O  ]   3.53  A:GLU 153[ N  ]  
22  F:MET 126[ O  ]   3.06  A:ARG 372[ NH2]  
23  F:THR 185[ O  ]   2.65  A:VAL 163[ N  ]  
24  F:ALA 187[ O  ]   3.26  A:ASP 161[ N  ]  
25  F:TRP 189[ O  ]   2.86  A:SER 172[ N  ]  
26  F:GLY 214[ O  ]   3.45  A:ASN 158[ ND2]  
27  F:ASN 291[ O  ]   3.15  A:ASN 291[ ND2]  
28  F:GLU 292[ O  ]   3.08  A:ASN 291[ N  ]  
29  F:PRO 300[ O  ]   2.70  A:TRP 309[ N  ]  
30  F:GLN 301[ O  ]   2.73  A:GLY 310[ N  ] 
 
Appendix 5: H-bonds between subunits G-F from HK97 gp5 
## Structure 1 Dist. [Å] Structure 2 
1  G:PHE 176[ N  ]   3.83  F:ASP 110[ O  ]  
2  G:THR 185[ OG1]   3.29  F:GLN 195[ OE1]  
3  G:ARG 338[ NH2]   3.00  F:ASP 198[ O  ]  
4  G:ARG 338[ NH2]   3.07  F:ASP 199[ OD1]  
5  G:ARG 365[ NH1]   2.96  F:ASP 199[ OD1]  
6  G:ARG 365[ NH2]   3.17  F:ASP 199[ OD2]  
7  G:ARG 350[ N  ]   3.80  F:GLU 348[ O  ]  
8  G:SER 346[ OG ]   2.49  F:GLU 348[ OE1]  
9  G:ARG 347[ N  ]   3.49  F:GLU 348[ OE1]  
10  G:GLU 348[ N  ]   3.31  F:GLU 348[ OE1]  
11  G:ARG 350[ N  ]   3.22  F:ARG 350[ O  ]  
12  G:ASP 173[ OD2]   3.09  F:SER 104[ N  ]  
13  G:GLU 171[ OE2]   3.50  F:SER 104[ N  ]  
14  G:GLU 344[ OE2]   2.58  F:ARG 194[ NH2]  
15  G:GLU 344[ OE1]   3.18  F:ARG 347[ NH2] 
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Appendix 6.  Sequence and primers of engineered protein G13P-A11-
V34AT 
 
 
 Engineered protein G13P-A11-V34AT 
(a), (b) Nucleotide and amino acid sequence of G13P-A11-V34AT. The region corresponding to AT is 
highlighted in brown. Areas in cyan correspond to the annealing sites for the primers.  
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Appendix 7. Primers for the engineered protein G13P-A11-V34AT 
Template Fragment  
Amplified 
Designed Primers  
 
G13P_FL 
A: 
1-777 (G13P) 
1_F      5’   GG AAT TCT CAT ATG GCA TAC ACA AAA ATT TCA G  3’ 
 
VI-R    5`TTC GCA TTT CGG GCA AGC  TGT TTC TGT TGG TAC TTC  3` 
 
 
Anti-TRAP 
B: 
766-849 (G13P -AT- G13P) 
VII-F    5`  GAA GTA CCA ACA GAA ACA GCT TGC CCG AAA TGC GAA 3` 
 
VIII-R  5’    ACG GTT GAT AAG AAT ATC AAC ACC TTT ACC GGA GCA 3’   
 
G13P_FL 
C: 
838-1021 (G13P) 
IX-F     5`    TGC TCC GGT AAA GGT GTT GAT ATT CTT ATC AAC CGT  3’ 
 
1_R      5’   CCA GAA CTC GAG TTA TGC TTG TAG TCT GTG TT  3’ 
Areas highlighted in brown correspond to the AT sequence. NdeI and XhoI restriction sites are 
highlighted in cyan and salmon, respectively. 
 
Appendix 8. Sequencing results of G13P-V10-I35AT 
>8928925.seq - ID: Heta_Col_1_T7-T7 on 2011/12/17-9:47:8 automatically edited with PhredPhrap, start 
with base no.: 42  Internal Params: Windowsize: 20, Goodqual: 19, Badqual: 10, Minseqlength: 50, 
nbadelimit: 1 
TTTAAGAAGGAGATATACCATGGGCAGCAGCNATCNNNNNNANNNTCACAGCAGCGGCCTG
GTGCCGCGCGGCAGCCATATGGCATACACAAAAATTTCAGATGTTATCGTACCGGAGTTATT
TAACCCGTACGTCATTAACACAACAACACAACTTTCTGCCTTCTTCCAGTCAGGAATTGCGG
CAACAGATGACGAATTGAATGCACTTGCAAAAAAAGCGGGCGGCGGTAGCACTTTAAACAT
GCCGTACTGGAATGACCTAGACGGAGATTCCCAAGTGTTGAACGACACTGACGACCTTGTAC
CGCAAAAAATCAACGCTGGACNAGATAAAGCTGTCCTTATCCTTCGCGGTAACGCTTGGAGT
TCTCACGATTTAGCGGCAACACTTTCCGGTTCTGACCCAATGCAGGCTATCGGCTCCCGTGTA
GCGGCATACTGGGCGCGCGAAATGCAAAAGATTGTTTTCGCTGAACTTGCAGGTGTGTTCTC
TAACGNTGATATGAAAGACAACAAACTCGATATCTCTGGAACGGCTGACGGTATTTATTCAG
CGGAAACTTTCGTTGATGCATCTTACAAGCTTGGAGATCATGAAAGCTTACTTACAGCTATC
GGTATGCATTCTGCTACNATGGCAAGCGCAGTTAAACAAGACTTTGATTGAGTTTGTCAAAG
ATTCCCAAAGTGGTATCCGTTTTCCCGACATACATGAANTAAGCGTGTAATCGTAGATGANT
CTNATGCCANTAGAAAACGCTTGAAGATGGAACTAAGGTATTCNCATTCTTACTTTGTTCGG
GAGCTGNGCTCTAGGANTACGCAGAAANGACNAACCGGNAAGTCCCCAACAGAAAACAGTT
GCTTTGCCCNNAAATGCGAACGTGCTGGNTGAAATCGAAGGTNNCCCCGTGCCCGGCTT 
 
>8912716.seq - ID: Heta_Col_1_pET-RP-pET-RP on 2011/12/14-19:49:39 automatically edited with 
PhredPhrap, start with base no.: 16  Internal Params: Windowsize: 20, Goodqual: 19, Badqual: 10, 
Minseqlength: 50, nbadelimit: 1 
CNGGCTTTGTTACAGCCGGATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTTATGCCCNNTAA
NNNGTGTTTGAATTGAACGATACGGATTTTCTTAGGGTCGTACACGCGTTGCCAGTTCGCAC
CGTTAGCAAGTTCTTCGTCCGTAGGCGTTGTTCCCGCCATAGCGTTTTCTGTGAATTTTACGC
192 
 
CGCGCGGGTGTAAAACAAAGTGTTTACGGTTGATAAGAATATCGATAACACCTTTACCGGAG
CAAGCCGGGCACGGGGTACCTTCGATTTCACCAGCACGTTCGCATTTCGGGCAAGCAACTGT
TTCTGTTGGGACTTCCGGTTGTCCTTCTGCGTATCCTAGAGCACCAGCTCCGAACAAGTAAG
ATGTGAATACCTTAGTTCCATCTTCAAGCGTTTCTACTGGCATAGAATCATCTACGATTACAC
GCTTATTCATGTATGTCGGGAAACGGATACCACTTTGGGAATCTTTGACAAACTCAATCAAG
TCTTGTTTAACTGCGCTTGCCATCGTAGCAGAATGCATACCGATAGCTGTAAGTAAGCTTTCA
TGATCTCCAAGCTTGTAAGATGCATCAACGAAAGTTTCCGCTGAATAAATACCGTCAGCCGT
TCCAGAGATATCGAGTTTGTTGTCTTTCATATCATCGTTAGAGAACACACCTGCAAGTTCAGC
GAAAACAATCTTTTGCATTTCGCGCGCCCAGTATGCCGCTACACGGGAGCCGATAGCCTGCA
TTGGGTCAGAACCGGANAGTGTTGCCGCTAAATCCGTGAGAACTCCAAAGCGTTACCGCNN
AAGGATAANGGACAGNCTTTATCTTTGTCCNAGCGGTTGAATTTTTTTGCGGGTACAAAGGT
CNGTCA 
 
Appendix 9. Sequencing results of G13P-A11-V34AT. 
 
>8937685.seq - ID: Stigma_Col_1_T7-T7 on 2011/12/20-10:42:20 automatically edited with PhredPhrap, 
start with base no.: 35  Internal Params: Windowsize: 20, Goodqual: 19, Badqual: 10, Minseqlength: 50, 
nbadelimit: 1 
TTTGTTTAACTTTAAGAAGGNGNNNNACCATGGGCAGCAGCCATCNTCANNATCATCACAGC
AGCGGCCTGGTGCCGCGCGGCAGCCATATGGCATACACAAAAATTTCAGATGTTATCGTACC
GGAGTTATTTAACCCGTACGTCATTAACACAACAACACAACTTTCTGCCTTCTTCCAGTCAGG
AATTGCGGCAACAGATGACGAATTGAATGCACTTGCAAAAAAAGCGGGCGGCGGTAGCACT
TTAAACATGCCGTACTGGAATGACCTAGACGGAGATTCCCAAGTGTTGAACGACACTGACG
ACCTTGTACCGCAAAAAATCAACGCTGGACAAGATAAAGCTGTCCTTATCCTTCGCGGTAAC
GCTTGGAGTTCTCACGATTTANCGGCAACACTTTCCGGTTCNGANCCAATGCAGGCTATCGG
NTCNCGTGTAGCGGCATACTGGGCGCGCNAAATGCAAAAGATTGTTNTCNCTGAAC 
 
 
>8912718.seq - ID: Stigma_Col_1_pET-RP-pET-RP on 2011/12/14-19:48:31 automatically edited with 
PhredPhrap, start with base no.: 53  Internal Params: Windowsize: 20, Goodqual: 19, Badqual: 10, 
Minseqlength: 50, nbadelimit: 1 
GNTGGTGGTGGTGCTCGAGTTATNNNNNNANNNNGTGTTTGAATTGAACGATACGGATTTTC
TTAGGGTCGTACACGCGTTGCCAGTTCGCACCGTTAGCAAGTTCTTCGTCCGTAGGCGTTGTT
CCCGCCATAGCGTTTTCTGTGAATTTTACGCCGCGCGGGTGTAAAACAAAGTGTTTACGGTT
GATAAGAATATCAACACCTTTACCGGAGCAAGCCGGGNACGGGGTACCTTCGATTTCACCA
GCACGTTCGCATTTCGGGCAAGCTGTTTCTGTTGGTACTTCNGGTTGTCCTTCTGCGTATCCT
AGAGCACCA 
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Appendix 10. Sequences of  G20C, P23-45 and P74-26 STs 
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Appendix 10. Conservation of ST from thermophilic phages G20C, P23-45 and P75-26 
Multiple sequence alignments to illustrate (a) amino acid sequence conservation, (b) secondary structure 
conservation and (c) nucleotide sequence conservation between G20C ST and ORF P23p84 and ORF 
P74p83 from phages P23-45 and P75-26. Figures a and b were prepared using the PRALINE server. 
Figure c was made using ClustalW.  
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Appendix 11. Derived Publications 
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Abbreviations 
 
A-domain Axial domain 
AEBSF 4-(2-Aminoethyl)-benzenesulfonyl fluoride hydrochloride  
AEC Anion exchange chromatography 
Anti-TRAP Anti-Tryptophan RNA-binding attenuation protein 
ATP Adenosine triphosphate 
bp  base pairs 
CCP4 Computational collaborative project 4 
CTD C-terminal domain 
CV Column volume 
cryo-EM Cryo-Electronic microscopy 
DBD DNA-binding domain 
DNA Deoxyribonuclease acid, ds for double stranded 
EI Electrospray ionisation 
EMSA Electrophoretic mobility shift assay 
FL Full length  
FRET Fluorescence resonance energy transfer 
GST Glutathione S-transferase 
GXP Gene X product 
HEPES 2-[4-(2-hydroxyethyl) piperazin-1-yl] ethanesulfonic acid 
IPTG Isopropyl-β-D-thiogalacto-pyranoside 
LB Luria-Bertani medium  
LT Large terminase 
MES 2-(N-morpholino) ethanesulfonic acid 
MPD 
MR 
2-methylpentane-2,4-diol 
Molecular Replacement 
MW Molecular weight  
NAC Nickel affinity chromatography 
NMR Nuclear magnetic resonance 
NTD N-terminal domain 
OD Oligomerisation domain 
orf open reading frames 
PCR Polymerase chain reaction 
PDB Protein data bank 
P-domain Peripheral domain 
pET Plasmid for expression by T7 RNA polymerase 
POI Protein of interest 
Psi-BLAST Position-specific iterated basic local alignment search tool 
rpm revolutions per minute 
rmsd Root mean square deviation 
SDS-PAGE Sodium dodecyl sulphate- polyacrylamide gel electrophoresis 
SEC-MALLS Size exclusion chromatography – Multiple-angle laser light scattering  
SPR Surface plasmon resonance 
ST Small terminase 
WT Wild type 
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